{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T07:36:44Z","timestamp":1795246604413,"version":"4.10.3"},"reference-count":1246,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Energy metabolism is indispensable for sustaining physiological functions in living organisms and assumes a pivotal role across physiological and pathological conditions. This review provides an extensive overview of advancements in energy metabolism research, elucidating critical pathways such as glycolysis, oxidative phosphorylation, fatty acid metabolism, and amino acid metabolism, along with their intricate regulatory mechanisms. The homeostatic balance of these processes is crucial; however, in pathological states such as neurodegenerative diseases, autoimmune disorders, and cancer, extensive metabolic reprogramming occurs, resulting in impaired glucose metabolism and mitochondrial dysfunction, which accelerate disease progression. Recent investigations into key regulatory pathways, including mechanistic target of rapamycin, sirtuins, and adenosine monophosphate-activated protein kinase, have considerably deepened our understanding of metabolic dysregulation and opened new avenues for therapeutic innovation. Emerging technologies, such as fluorescent probes, nano-biomaterials, and metabolomic analyses, promise substantial improvements in diagnostic precision. This review critically examines recent advancements and ongoing challenges in metabolism research, emphasizing its potential for precision diagnostics and personalized therapeutic interventions. Future studies should prioritize unraveling the regulatory mechanisms of energy metabolism and the dynamics of intercellular energy interactions. Integrating cutting-edge gene-editing technologies and multi-omics approaches, the development of multi-target pharmaceuticals in synergy with existing therapies such as immunotherapy and dietary interventions could enhance therapeutic efficacy. Personalized metabolic analysis is indispensable for crafting tailored treatment protocols, ultimately providing more accurate medical solutions for patients. This review aims to deepen the understanding and improve the application of energy metabolism to drive innovative diagnostic and therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41392-025-02141-x","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:44:01Z","timestamp":1739850241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":450,"title":["Energy metabolism in health and diseases"],"prefix":"10.1038","volume":"10","author":[{"given":"Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4093-0332","authenticated-orcid":false,"given":"Lei-Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"2141_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/00033790.2018.1564936","volume":"76","author":"KL Caneva","year":"2019","unstructured":"Caneva, K. L. Helmholtz, the conservation of force and the conservation of vis viva. Ann. Sci. 76, 17\u201357 (2019).","journal-title":"Ann. Sci."},{"key":"2141_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/00033790.2023.2205429","volume":"80","author":"S Katzir","year":"2023","unstructured":"Katzir, S. The use of the conservation of living force before Helmholtz. Ann. Sci. 80, 337\u2013356 (2023).","journal-title":"Ann. Sci."},{"key":"2141_CR3","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"SM Fendt","year":"2024","unstructured":"Fendt, S. M. 100 years of the Warburg effect: a cancer metabolism endeavor. Cell 187, 3824\u20133828 (2024).","journal-title":"Cell"},{"key":"2141_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M Belanger","year":"2011","unstructured":"Belanger, M., Allaman, I. & Magistretti, P. J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14, 724\u2013738 (2011).","journal-title":"Cell Metab."},{"key":"2141_CR5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41580-022-00486-7","volume":"23","author":"C Scholtes","year":"2022","unstructured":"Scholtes, C. & Giguere, V. Transcriptional control of energy metabolism by nuclear receptors. Nat. Rev. Mol. Cell Biol. 23, 750\u2013770 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2141_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/er.2017-00064","volume":"38","author":"WC Lee","year":"2017","unstructured":"Lee, W. C., Guntur, A. R., Long, F. & Rosen, C. J. Energy metabolism of the osteoblast: implications for Osteoporosis. Endocr. Rev. 38, 255\u2013266 (2017).","journal-title":"Endocr. Rev."},{"key":"2141_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.bioeng.3.1.57","volume":"3","author":"MS Jafri","year":"2001","unstructured":"Jafri, M. S., Dudycha, S. J. & O\u2019Rourke, B. Cardiac energy metabolism: models of cellular respiration. Annu. Rev. Biomed. Eng. 3, 57\u201381 (2001).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"2141_CR8","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1007\/s12035-023-03329-4","volume":"60","author":"I Korczowska-Lacka","year":"2023","unstructured":"Korczowska-Lacka, I. et al. Selected biomarkers of oxidative stress and energy metabolism disorders in neurological diseases. Mol. Neurobiol. 60, 4132\u20134149 (2023).","journal-title":"Mol. Neurobiol."},{"key":"2141_CR9","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk, G. D. et al. Cardiac energy metabolism in heart failure. Circ. Res. 128, 1487\u20131513 (2021).","journal-title":"Circ. Res."},{"key":"2141_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1172\/JCI96702","volume":"128","author":"SA Hannou","year":"2018","unstructured":"Hannou, S. A., Haslam, D. E., McKeown, N. M. & Herman, M. A. Fructose metabolism and metabolic disease. J. Clin. Investig. 128, 545\u2013555 (2018).","journal-title":"J. Clin. Investig."},{"key":"2141_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1210\/endrev\/bnad032","volume":"45","author":"C Conte","year":"2024","unstructured":"Conte, C., Cipponeri, E. & Roden, M. Diabetes Mellitus, energy metabolism, and COVID-19. Endocr. Rev. 45, 281\u2013308 (2024).","journal-title":"Endocr. Rev."},{"key":"2141_CR12","first-page":"708","volume":"17","author":"S Crunkhorn","year":"2018","unstructured":"Crunkhorn, S. Cancer: Disrupting energy metabolism. Nat. Rev. Drug Disco. v. 17, 708 (2018).","journal-title":"Nat. Rev. Drug Disco. v."},{"key":"2141_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41423-021-00792-8","volume":"19","author":"JM Marchingo","year":"2022","unstructured":"Marchingo, J. M. & Cantrell, D. A. Protein synthesis, degradation, and energy metabolism in T cell immunity. Cell. Mol. Immunol. 19, 303\u2013315 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"2141_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ni.3398","volume":"17","author":"SC Cheng","year":"2016","unstructured":"Cheng, S. C. et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 17, 406\u2013413 (2016).","journal-title":"Nat. Immunol."},{"key":"2141_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1039\/D0CS01610A","volume":"51","author":"W Ji","year":"2022","unstructured":"Ji, W. et al. Optical\/electrochemical methods for detecting mitochondrial energy metabolism. Chem. Soc. Rev. 51, 71\u2013127 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"2141_CR16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.apsb.2020.10.007","volume":"11","author":"Y He","year":"2021","unstructured":"He, Y. et al. Energy metabolism disorders and potential therapeutic drugs in heart failure. Acta Pharm. Sin. B 11, 1098\u20131116 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"2141_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ccell.2024.03.005","volume":"42","author":"N Niu","year":"2024","unstructured":"Niu, N. et al. Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Cancer Cell 42, 869\u2013884.e869 (2024).","journal-title":"Cancer Cell"},{"key":"2141_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-019-1150-2","volume":"569","author":"S Chowdhry","year":"2019","unstructured":"Chowdhry, S. et al. NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling. Nature 569, 570\u2013575 (2019).","journal-title":"Nature"},{"key":"2141_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2020.10.021","volume":"33","author":"H Lv","year":"2021","unstructured":"Lv, H. et al. NAD(+) metabolism maintains inducible PD-L1 expression to drive tumor immune evasion. Cell Metab. 33, 110\u2013127.e115 (2021).","journal-title":"Cell Metab."},{"key":"2141_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/BF01506215","volume":"17","author":"K Lohmann","year":"1929","unstructured":"Lohmann, K. \u00dcber die Pyrophosphatfraktion im Muskel. Naturwissenschaften 17, 624\u2013625 (1929).","journal-title":"Naturwissenschaften"},{"key":"2141_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.70.1816.381.b","volume":"70","author":"CH Fiske","year":"1929","unstructured":"Fiske, C. H. & Subbarow, Y. Phosphorous compounds of muscle and liver. Science 70, 381\u2013382 (1929).","journal-title":"Science"},{"key":"2141_CR22","doi-asserted-by":"crossref","unstructured":"Lipmann, F. in Advances in Enzymology and Related Areas of Molecular Biology, Vol. 1, (eds Nord, F. F. & Werkman, C. H.) 99\u2013162 (Wiley, 1941).","DOI":"10.1002\/9780470122464.ch4"},{"key":"2141_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/chir.20494","volume":"20","author":"J Gal","year":"2008","unstructured":"Gal, J. The discovery of biological enantioselectivity: Louis Pasteur and the fermentation of tartaric acid, 1857\u2013a review and analysis 150 yr later. Chirality 20, 5\u201319 (2008).","journal-title":"Chirality"},{"key":"2141_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF00356976","volume":"4","author":"R Kohler","year":"1971","unstructured":"Kohler, R. The background to Eduard Buchner\u2019s discovery of cell-free fermentation. J. Hist. Biol. 4, 35\u201361 (1971).","journal-title":"J. Hist. Biol."},{"key":"2141_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1085\/jgp.8.6.531","volume":"8","author":"O Meyerhof","year":"1927","unstructured":"Meyerhof, O. Recent investigations on the aerobic and an-aerobic metabolism of carbohydrates. J. Gen. Physiol. 8, 531\u2013542 (1927).","journal-title":"J. Gen. Physiol."},{"key":"2141_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.1943.02840250093030","volume":"122","author":"O., M.","year":"1943","unstructured":"O., M. A Symposium on Respiratory Enzymes. Addresses Given at an Institute Held at the University of Wisconsin, September 11-17, 1941. J. Am. Med. Assoc. 122, 569\u2013569 (1943).","journal-title":"J. Am. Med. Assoc."},{"key":"2141_CR27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"2141_CR28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.yexmp.2010.08.006","volume":"89","author":"LM Ferreira","year":"2010","unstructured":"Ferreira, L. M. Cancer metabolism: the Warburg effect today. Exp. Mol. Pathol. 89, 372\u2013380 (2010).","journal-title":"Exp. Mol. Pathol."},{"key":"2141_CR29","first-page":"307","volume":"160","author":"O Warburg","year":"1925","unstructured":"Warburg, O. On the formation of lactic acid with growth. Biochem. Zeitschr. 160, 307\u2013311 (1925).","journal-title":"Biochem. Zeitschr."},{"key":"2141_CR30","first-page":"482","volume":"204","author":"O Warburg","year":"1929","unstructured":"Warburg, O. Is aerobic glycolysis specific to tumors? Biochem. Z. 204, 482\u2013483. Is aerobic glycolysis specific to tumors? Biochem. Zeitschr. 204, 482\u2013483 (1929). 1929.","journal-title":"Biochem. Zeitschr."},{"key":"2141_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1126\/science.6264596","volume":"213","author":"E Racker","year":"1981","unstructured":"Racker, E. & Spector, M. Warburg effect revisited: merger of biochemistry and molecular biology. Science 213, 303\u2013307 (1981).","journal-title":"Science"},{"key":"2141_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On the origin of cancer cells. Science 123, 309\u2013314 (1956).","journal-title":"Science"},{"key":"2141_CR33","first-page":"319","volume":"152","author":"O Warburg","year":"1924","unstructured":"Warburg, O., Posener, K. & Negelein, E. \u00dcber den Stoffwechsel der Tumoren. Biochem. Zeitschr. 152, 319\u2013344 (1924).","journal-title":"Biochem. Zeitschr."},{"key":"2141_CR34","first-page":"257","volume":"228","author":"O Warburg","year":"1930","unstructured":"Warburg, O. Note on the metabolism of tumors. Biochem. Zeitschr. 228, 257\u2013258 (1930).","journal-title":"Biochem. Zeitschr."},{"key":"2141_CR35","doi-asserted-by":"publisher","first-page":"41582","DOI":"10.18632\/oncotarget.6057","volume":"6","author":"JM Garcia-Heredia","year":"2015","unstructured":"Garcia-Heredia, J. M. & Carnero, A. Decoding Warburg\u2019s hypothesis: tumor-related mutations in the mitochondrial respiratory chain. Oncotarget 6, 41582\u201341599 (2015).","journal-title":"Oncotarget"},{"key":"2141_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.molcel.2020.12.012","volume":"81","author":"A Luengo","year":"2021","unstructured":"Luengo, A. et al. Increased demand for NAD(+) relative to ATP drives aerobic glycolysis. Mol. Cell. 81, 691\u2013707.e696 (2021).","journal-title":"Mol. Cell."},{"key":"2141_CR37","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1042\/bj0310645","volume":"31","author":"HA Krebs","year":"1937","unstructured":"Krebs, H. A. & Johnson, W. A. Metabolism of ketonic acids in animal tissues. Biochem. J. 31, 645\u2013660 (1937).","journal-title":"Biochem. J."},{"key":"2141_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1042\/bj0320113","volume":"32","author":"HA Krebs","year":"1938","unstructured":"Krebs, H. A., Salvin, E. & Johnson, W. A. The formation of citric and alpha-ketoglutaric acids in the mammalian body. Biochem. J. 32, 113\u2013117 (1938).","journal-title":"Biochem. J."},{"key":"2141_CR39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12013-013-9750-1","volume":"68","author":"M Akram","year":"2014","unstructured":"Akram, M. Citric acid cycle and role of its intermediates in metabolism. Cell Biochem. Biophys. 68, 475\u2013478 (2014).","journal-title":"Cell Biochem. Biophys."},{"key":"2141_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1023\/A:1012946715673","volume":"34","author":"JN Prebble","year":"2001","unstructured":"Prebble, J. N. The philosophical origins of Mitchell\u2019s chemiosmotic concepts: the personal factor in scientific theory formulation. J. Hist. Biol. 34, 433\u2013460 (2001).","journal-title":"J. Hist. Biol."},{"key":"2141_CR41","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2011.0615","volume":"86","author":"MA Shampo","year":"2011","unstructured":"Shampo, M. A., Kyle, R. A., Steensma, D. P. & Paul, D. Boyer-Nobel prize for work on ATP synthase. Mayo Clin. Proc. 86, e51 (2011).","journal-title":"Mayo Clin. Proc."},{"key":"2141_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0967772019866954","volume":"29","author":"RP Rubin","year":"2021","unstructured":"Rubin, R. P. Carl and Gerty Cori: a collaboration that changed the face of biochemistry. J. Med. Biogr. 29, 143\u2013148 (2021).","journal-title":"J. Med. Biogr."},{"key":"2141_CR43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/brv.12140","volume":"90","author":"A Stincone","year":"2015","unstructured":"Stincone, A. et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. Camb. Philos. Soc. 90, 927\u2013963 (2015).","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"2141_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.101146","volume":"11","author":"L Chen","year":"2024","unstructured":"Chen, L. et al. Homeostatic regulation of NAD(H) and NADP(H) in cells. Genes Dis. 11, 101146 (2024).","journal-title":"Genes Dis."},{"key":"2141_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0021-9258(19)44468-2","volume":"248","author":"CR Kahn","year":"1973","unstructured":"Kahn, C. R., Neville, D. M. Jr. & Roth, J. Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance. J. Biol. Chem. 248, 244\u2013250 (1973).","journal-title":"J. Biol. Chem."},{"key":"2141_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.170678","volume":"190","author":"JS Flier","year":"1975","unstructured":"Flier, J. S., Kahn, C. R., Roth, J. & Bar, R. S. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190, 63\u201365 (1975).","journal-title":"Science"},{"key":"2141_CR47","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/S0021-9258(19)42825-1","volume":"249","author":"CR Kahn","year":"1974","unstructured":"Kahn, C. R., Freychet, P., Roth, J. & Neville, D. M. Jr. Quantitative aspects of the insulin-receptor interaction in liver plasma membranes. J. Biol. Chem. 249, 2249\u20132257 (1974).","journal-title":"J. Biol. Chem."},{"key":"2141_CR48","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1172\/JCI133156","volume":"129","author":"JS Flier","year":"2019","unstructured":"Flier, J. S. & George, M. 2019 Association of American Physicians Ronald Kahn: The Louisville Slugger of metabolic science. J. Clin. Investig. 129, 5066\u20135070 (2019).","journal-title":"J. Clin. Investig."},{"key":"2141_CR49","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/27376","volume":"395","author":"JM Friedman","year":"1998","unstructured":"Friedman, J. M. & Halaas, J. L. Leptin and the regulation of body weight in mammals. Nature 395, 763\u2013770 (1998).","journal-title":"Nature"},{"key":"2141_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay, N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer 16, 635\u2013649 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"2141_CR51","doi-asserted-by":"publisher","first-page":"xxvii","DOI":"10.1016\/0163-7827(81)90173-9","volume":"20","author":"GO Burr","year":"1981","unstructured":"Burr, G. O. The essential fatty acids fifty years ago. Prog. Lipid Res. 20, xxvii\u2013xxix (1981).","journal-title":"Prog. Lipid Res."},{"key":"2141_CR52","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay, R. Essential fatty acids: the work of George and Mildred Burr. J. Biol. Chem. 287, 35439\u201335441 (2012).","DOI":"10.1074\/jbc.O112.000005"},{"key":"2141_CR53","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0021-9258(20)78281-5","volume":"82","author":"GO Burr","year":"1929","unstructured":"Burr, G. O. & Burr, M. M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 82, 345\u2013367 (1929).","journal-title":"J. Biol. Chem."},{"key":"2141_CR54","doi-asserted-by":"crossref","unstructured":"Burr, G. O. & Burr, M. M. On the nature and r\u00f4le of the fatty acids essential in nutrition. J. Biol. Chem. 86, 587\u2013621 (1930).","DOI":"10.1016\/S0021-9258(20)78929-5"},{"key":"2141_CR55","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/171076a0","volume":"171","author":"J Baddiley","year":"1953","unstructured":"Baddiley, J., Thain, E. M., Novelli, G. D. & Lipmann, F. Structure of coenzyme A. Nature 171, 76 (1953).","journal-title":"Nature"},{"key":"2141_CR56","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1042\/BST20140176","volume":"42","author":"FL Theodoulou","year":"2014","unstructured":"Theodoulou, F. L., Sibon, O. C., Jackowski, S. & Gout, I. Coenzyme A and its derivatives: renaissance of a textbook classic. Biochem. Soc. Trans. 42, 1025\u20131032 (2014).","journal-title":"Biochem. Soc. Trans."},{"key":"2141_CR57","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1093\/eurheartj\/ehaa152","volume":"41","author":"M Nicholls","year":"2020","unstructured":"Nicholls, M. Fritz Albert Lipmann. Eur. Heart J. 41, 2608\u20132609 (2020).","journal-title":"Eur. Heart J."},{"key":"2141_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1126\/science.150.3692.19","volume":"150","author":"K Bloch","year":"1965","unstructured":"Bloch, K. The biological synthesis of cholesterol. Science 150, 19\u201328 (1965).","journal-title":"Science"},{"key":"2141_CR59","doi-asserted-by":"publisher","first-page":"1120373","DOI":"10.3389\/fmolb.2023.1120373","volume":"10","author":"A Chattopadhyay","year":"2023","unstructured":"Chattopadhyay, A. & Sharma, A. Smith-Lemli-Opitz syndrome: a pathophysiological manifestation of the Bloch hypothesis. Front. Mol. Biosci. 10, 1120373 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"2141_CR60","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1073\/pnas.70.10.2804","volume":"70","author":"JL Goldstein","year":"1973","unstructured":"Goldstein, J. L. & Brown, M. S. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc. Natl Acad. Sci. USA 70, 2804\u20132808 (1973).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR61","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1073\/pnas.71.3.788","volume":"71","author":"MS Brown","year":"1974","unstructured":"Brown, M. S. & Goldstein, J. L. Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Proc. Natl Acad. Sci. USA 71, 788\u2013792 (1974).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR62","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1093\/eurheartj\/ehz723","volume":"40","author":"M Nicholls","year":"2019","unstructured":"Nicholls, M., Brown, M. S. & Goldstein, J. L. Michael S. Brown and Joseph L. Goldstein, were jointly awarded the Nobel Prize in Physiology or Medicine 1985 \u2018for their discoveries concerning the regulation of cholesterol metabolism\u2019. Eur. Heart J. 40, 3447\u20133449 (2019).","journal-title":"Eur. Heart J."},{"key":"2141_CR63","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1146\/annurev.bi.46.070177.004341","volume":"46","author":"JL Goldstein","year":"1977","unstructured":"Goldstein, J. L. & Brown, M. S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu. Rev. Biochem. 46, 897\u2013930 (1977).","journal-title":"Annu. Rev. Biochem."},{"key":"2141_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/scientificamerican1184-58","volume":"251","author":"MS Brown","year":"1984","unstructured":"Brown, M. S. & Goldstein, J. L. How LDL receptors influence cholesterol and atherosclerosis. Sci. Am. 251, 58\u201366 (1984).","journal-title":"Sci. Am."},{"key":"2141_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1126\/science.3513311","volume":"232","author":"MS Brown","year":"1986","unstructured":"Brown, M. S. & Goldstein, J. L. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34\u201347 (1986).","journal-title":"Science"},{"key":"2141_CR66","doi-asserted-by":"crossref","unstructured":"Sharma, A. et al. Impaired skeletal muscle mitochondrial pyruvate uptake rewires glucose metabolism to drive whole-body leanness. Elife. 8, e45873 (2019).","DOI":"10.7554\/eLife.45873"},{"key":"2141_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9004830","volume":"2022","author":"B Jiang","year":"2022","unstructured":"Jiang, B. et al. Database mining detected a cuproptosis-related prognostic signature and a related regulatory axis in breast cancer. Dis. Markers 2022, 9004830 (2022).","journal-title":"Dis. Markers"},{"key":"2141_CR68","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013\u20131021 (2019).","journal-title":"Science"},{"key":"2141_CR69","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel, A. E. et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell 183, 1848\u20131866.e1826 (2020).","journal-title":"Cell"},{"key":"2141_CR70","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jacc.2020.11.069","volume":"77","author":"N Perakakis","year":"2021","unstructured":"Perakakis, N., Farr, O. M. & Mantzoros, C. S. Leptin in leanness and obesity: JACC state-of-the-art review. J. Am. Coll. Cardiol. 77, 745\u2013760 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2141_CR71","doi-asserted-by":"crossref","unstructured":"de Candia, P. et al. The pleiotropic roles of leptin in metabolism, immunity, and cancer. J. Exp. Med. 218, e20191593 (2021).","DOI":"10.1084\/jem.20191593"},{"key":"2141_CR72","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan, K., Werner, M. & Chandel, N. S. Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 32, 341\u2013352 (2020).","journal-title":"Cell Metab."},{"key":"2141_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf1956","volume":"9","author":"K Nishio","year":"2023","unstructured":"Nishio, K. et al. Defective import of mitochondrial metabolic enzyme elicits ectopic metabolic stress. Sci. Adv. 9, eadf1956 (2023).","journal-title":"Sci. Adv."},{"key":"2141_CR74","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1200\/JCO.2016.67.9712","volume":"34","author":"BD Hopkins","year":"2016","unstructured":"Hopkins, B. D., Goncalves, M. D. & Cantley, L. C. Obesity and cancer mechanisms: cancer metabolism. J. Clin. Oncol. 34, 4277\u20134283 (2016).","journal-title":"J. Clin. Oncol."},{"key":"2141_CR75","doi-asserted-by":"publisher","first-page":"e20201606","DOI":"10.1084\/jem.20201606","volume":"218","author":"X Bian","year":"2021","unstructured":"Bian, X. et al. Lipid metabolism and cancer. J. Exp. Med. 218, e20201606 (2021).","journal-title":"J. Exp. Med."},{"key":"2141_CR76","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin, J., Byun, J. K., Choi, Y. K. & Park, K. G. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp. Mol. Med. 55, 706\u2013715 (2023).","journal-title":"Exp. Mol. Med."},{"key":"2141_CR77","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbcan.2018.04.009","volume":"1870","author":"AK Kaushik","year":"2018","unstructured":"Kaushik, A. K. & DeBerardinis, R. J. Applications of metabolomics to study cancer metabolism. Biochim. Biophys. Acta Rev. Cancer 1870, 2\u201314 (2018).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"2141_CR78","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/CIRCRESAHA.120.315898","volume":"126","author":"ZZ Chen","year":"2020","unstructured":"Chen, Z. Z. & Gerszten, R. E. Metabolomics and Proteomics in Type 2 Diabetes. Circ. Res. 126, 1613\u20131627 (2020).","journal-title":"Circ. Res."},{"key":"2141_CR79","first-page":"619","volume":"622","author":"X Li","year":"2023","unstructured":"Li, X. et al. Inhibition of fatty acid oxidation enables heart regeneration in adult mice. Nature 622, 619\u2013626 (2023).","journal-title":"Nature"},{"key":"2141_CR80","doi-asserted-by":"crossref","unstructured":"Chandel, N. S. Glycolysis. Cold Spring Harb Perspect Biol. 13, a040535 (2021).","DOI":"10.1101\/cshperspect.a040535"},{"key":"2141_CR81","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1016\/0014-5793(80)80564-3","volume":"117","author":"HA Krebs","year":"1980","unstructured":"Krebs, H. A. & Johnson, W. A. The role of citric acid in intermediate metabolism in animal tissues. FEBS Lett. 117, K1\u2013K10 (1980).","journal-title":"FEBS Lett."},{"key":"2141_CR82","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fonc.2017.00306","volume":"7","author":"M Scalise","year":"2017","unstructured":"Scalise, M. et al. Glutamine transport and mitochondrial metabolism in cancer cell growth. Front. Oncol. 7, 306 (2017).","journal-title":"Front. Oncol."},{"key":"2141_CR83","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.celrep.2014.04.037","volume":"7","author":"AR Mullen","year":"2014","unstructured":"Mullen, A. R. et al. Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects. Cell Rep. 7, 1679\u20131690 (2014).","journal-title":"Cell Rep."},{"key":"2141_CR84","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang, L., Venneti, S. & Nagrath, D. Glutaminolysis: a hallmark of cancer metabolism. Annu. Rev. Biomed. Eng. 19, 163\u2013194 (2017).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"2141_CR85","doi-asserted-by":"crossref","unstructured":"de Carvalho, C. & Caramujo, M. J. The various roles of fatty acids. Molecules. 23, 2583 (2018).","DOI":"10.3390\/molecules23102583"},{"key":"2141_CR86","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1089\/ars.2017.7120","volume":"28","author":"JP Fessel","year":"2018","unstructured":"Fessel, J. P. & Oldham, W. M. Pyridine Dinucleotides from molecules to man. Antioxid. Redox Signal. 28, 180\u2013212 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"2141_CR87","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska, P. & Crawford, P. A. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 25, 262\u2013284 (2017).","journal-title":"Cell Metab."},{"key":"2141_CR88","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s12276-020-0415-z","volume":"52","author":"YM Han","year":"2020","unstructured":"Han, Y. M., Ramprasath, T. & Zou, M. H. beta-hydroxybutyrate and its metabolic effects on age-associated pathology. Exp. Mol. Med. 52, 548\u2013555 (2020).","journal-title":"Exp. Mol. Med."},{"key":"2141_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02185-0","volume":"19","author":"H Kolb","year":"2021","unstructured":"Kolb, H. et al. Ketone bodies: from enemy to friend and guardian angel. BMC Med. 19, 313 (2021).","journal-title":"BMC Med."},{"key":"2141_CR90","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.14336\/AD.2021.1217","volume":"13","author":"Z Jiang","year":"2022","unstructured":"Jiang, Z. et al. Effects of ketogenic diet on neuroinflammation in neurodegenerative diseases. Aging Dis. 13, 1146\u20131165 (2022).","journal-title":"Aging Dis."},{"key":"2141_CR91","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.amjmed.2020.03.030","volume":"133","author":"TA Dong","year":"2020","unstructured":"Dong, T. A. et al. Intermittent fasting: a heart healthy dietary pattern? Am. J. Med. 133, 901\u2013907 (2020).","journal-title":"Am. J. Med."},{"key":"2141_CR92","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm, Y. H. et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21, 263\u2013269 (2015).","journal-title":"Nat. Med."},{"key":"2141_CR93","doi-asserted-by":"publisher","first-page":"e124079","DOI":"10.1172\/jci.insight.124079","volume":"4","author":"JL Horton","year":"2019","unstructured":"Horton, J. L. et al. The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. JCI Insight. 4, e124079 (2019).","journal-title":"JCI Insight."},{"key":"2141_CR94","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.immuni.2023.07.002","volume":"56","author":"KM Luda","year":"2023","unstructured":"Luda, K. M. et al. Ketolysis drives CD8(+) T cell effector function through effects on histone acetylation. Immunity 56, 2021\u20132035 e2028 (2023).","journal-title":"Immunity"},{"key":"2141_CR95","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110466","volume":"41","author":"V Gouirand","year":"2022","unstructured":"Gouirand, V. et al. Ketogenic HMG-CoA lyase and its product beta-hydroxybutyrate promote pancreatic cancer progression. EMBO J. 41, e110466 (2022).","journal-title":"EMBO J."},{"key":"2141_CR96","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41556-022-00925-9","volume":"24","author":"GE Thomas","year":"2022","unstructured":"Thomas, G. E. et al. The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness. Nat. Cell Biol. 24, 872\u2013884 (2022).","journal-title":"Nat. Cell Biol."},{"key":"2141_CR97","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.15252\/embj.201490379","volume":"34","author":"E Enzo","year":"2015","unstructured":"Enzo, E. et al. Aerobic glycolysis tunes YAP\/TAZ transcriptional activity. EMBO J. 34, 1349\u20131370 (2015).","journal-title":"EMBO J."},{"key":"2141_CR98","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molcel.2018.03.018","volume":"70","author":"JH Lee","year":"2018","unstructured":"Lee, J. H. et al. EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation. Mol. Cell. 70, 197\u2013210.e197 (2018).","journal-title":"Mol. Cell."},{"key":"2141_CR99","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13578-019-0317-8","volume":"9","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. PKM2, function and expression and regulation. Cell Biosci. 9, 52 (2019).","journal-title":"Cell Biosci."},{"key":"2141_CR100","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1158\/1541-7786.MCR-19-0842","volume":"18","author":"C Lu","year":"2020","unstructured":"Lu, C. et al. A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer. Mol. Cancer Res. 18, 787\u2013796 (2020).","journal-title":"Mol. Cancer Res."},{"key":"2141_CR101","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2019.10.012","volume":"31","author":"P Huangyang","year":"2020","unstructured":"Huangyang, P. et al. Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis. Cell Metab. 31, 174\u2013188.e177 (2020).","journal-title":"Cell Metab."},{"key":"2141_CR102","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1158\/0008-5472.CAN-18-2575","volume":"79","author":"T Chen","year":"2019","unstructured":"Chen, T. et al. PAK4 phosphorylates fumarase and blocks TGFbeta-induced cell growth arrest in lung cancer cells. Cancer Res. 79, 1383\u20131397 (2019).","journal-title":"Cancer Res."},{"key":"2141_CR103","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","volume":"580","author":"D Xu","year":"2020","unstructured":"Xu, D. et al. The gluconeogenic enzyme PCK1 phosphorylates INSIG1\/2 for lipogenesis. Nature 580, 530\u2013535 (2020).","journal-title":"Nature"},{"key":"2141_CR104","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s42255-020-00330-2","volume":"3","author":"W Li","year":"2021","unstructured":"Li, W. et al. NADPH levels affect cellular epigenetic state by inhibiting HDAC3-Ncor complex. Nat. Met. ab 3, 75\u201389 (2021).","journal-title":"Nat. Met. ab"},{"key":"2141_CR105","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.molcel.2023.12.033","volume":"84","author":"M Russo","year":"2024","unstructured":"Russo, M. et al. Acetyl-CoA production by Mediator-bound 2-ketoacid dehydrogenases boosts de novo histone acetylation and is regulated by nitric oxide. Mol. Cell. 84, 967\u2013980.e910 (2024).","journal-title":"Mol. Cell."},{"key":"2141_CR106","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.molcel.2018.09.007","volume":"72","author":"X Li","year":"2018","unstructured":"Li, X. et al. Nuclear PGK1 Alleviates ADP-Dependent Inhibition of CDC7 to Promote DNA Replication. Mol. Cell. 72, 650\u2013660.e658 (2018).","journal-title":"Mol. Cell."},{"key":"2141_CR107","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.molcel.2017.06.008","volume":"67","author":"S Sivanand","year":"2017","unstructured":"Sivanand, S. et al. Nuclear Acetyl-CoA Production by ACLY promotes homologous recombination. Mol. Cell. 67, 252\u2013265.e256 (2017).","journal-title":"Mol. Cell."},{"key":"2141_CR108","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1096\/fj.201902904RR","volume":"34","author":"S Ci","year":"2020","unstructured":"Ci, S. et al. Src-mediated phosphorylation of GAPDH regulates its nuclear localization and cellular response to DNA damage. FASEB J. 34, 10443\u201310461 (2020).","journal-title":"FASEB J."},{"key":"2141_CR109","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/ncb3209","volume":"17","author":"Y Jiang","year":"2015","unstructured":"Jiang, Y. et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nat. Cell Biol. 17, 1158\u20131168 (2015).","journal-title":"Nat. Cell Biol."},{"key":"2141_CR110","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-020-2363-0","volume":"582","author":"PL Sulkowski","year":"2020","unstructured":"Sulkowski, P. L. et al. Oncometabolites suppress DNA repair by disrupting local chromatin signalling. Nature 582, 586\u2013591 (2020).","journal-title":"Nature"},{"key":"2141_CR111","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.aaf6284","volume":"354","author":"M Peng","year":"2016","unstructured":"Peng, M. et al. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354, 481\u2013484 (2016).","journal-title":"Science"},{"key":"2141_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06841-7","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Nuclear lactate dehydrogenase A senses ROS to produce alpha-hydroxybutyrate for HPV-induced cervical tumor growth. Nat. Commun. 9, 4429 (2018).","journal-title":"Nat. Commun."},{"key":"2141_CR113","doi-asserted-by":"publisher","first-page":"6210","DOI":"10.7150\/ijbs.75434","volume":"18","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Lactylation of PKM2 suppresses inflammatory metabolic adaptation in pro-inflammatory macrophages. Int. J. Biol. Sci. 18, 6210\u20136225 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"2141_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu, J. et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-beta signaling in regulatory T cells. Cell Rep. 39, 110986 (2022).","journal-title":"Cell Rep."},{"key":"2141_CR115","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCRESAHA.122.320488","volume":"131","author":"N Wang","year":"2022","unstructured":"Wang, N. et al. Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ. Res. 131, 893\u2013908 (2022).","journal-title":"Circ. Res."},{"key":"2141_CR116","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41418-021-00841-9","volume":"29","author":"K Yang","year":"2022","unstructured":"Yang, K. et al. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ. 29, 133\u2013146 (2022).","journal-title":"Cell Death Differ."},{"key":"2141_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32521-8","volume":"13","author":"Q Feng","year":"2022","unstructured":"Feng, Q. et al. Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity. Nat. Commun. 13, 4981 (2022).","journal-title":"Nat. Commun."},{"key":"2141_CR118","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/263914","volume":"2010","author":"C Brigati","year":"2010","unstructured":"Brigati, C. et al. Inflammation, HIF-1, and the epigenetics that follows. Mediators Inflamm. 2010, 263914 (2010).","journal-title":"Mediators Inflamm."},{"key":"2141_CR119","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","volume":"24","author":"RJ Arts","year":"2016","unstructured":"Arts, R. J. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24, 807\u2013819 (2016).","journal-title":"Cell Metab."},{"key":"2141_CR120","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.molcel.2022.01.029","volume":"82","author":"X Ge","year":"2022","unstructured":"Ge, X. et al. Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma. Mol. Cell. 82, 1249\u20131260.e1247 (2022).","journal-title":"Mol. Cell."},{"key":"2141_CR121","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.molcel.2013.09.004","volume":"52","author":"L Lv","year":"2013","unstructured":"Lv, L. et al. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization. Mol. Cell. 52, 340\u2013352 (2013).","journal-title":"Mol. Cell."},{"key":"2141_CR122","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.molcel.2019.08.006","volume":"76","author":"X Qian","year":"2019","unstructured":"Qian, X. et al. PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1. Mol. Cell. 76, 516\u2013527.e517 (2019).","journal-title":"Mol. Cell."},{"key":"2141_CR123","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41589-023-01267-9","volume":"19","author":"W Yu","year":"2023","unstructured":"Yu, W. et al. Histone tyrosine sulfation by SULT1B1 regulates H4R3me2a and gene transcription. Nat. Chem. Biol. 19, 855\u2013864 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"2141_CR124","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-022-01014-x","volume":"7","author":"SR Li","year":"2022","unstructured":"Li, S. R., Bu, L. L. & Cai, L. Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal. Transduct. Target Ther. 7, 158 (2022).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2141_CR125","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen, W., Zhao, H. & Li, Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal. Transduct. Target Ther. 8, 333 (2023).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2141_CR126","doi-asserted-by":"publisher","first-page":"155142","DOI":"10.1016\/j.metabol.2022.155142","volume":"129","author":"L Norton","year":"2022","unstructured":"Norton, L., Shannon, C., Gastaldelli, A. & DeFronzo, R. A. Insulin: the master regulator of glucose metabolism. Metabolism 129, 155142 (2022).","journal-title":"Metabolism"},{"key":"2141_CR127","doi-asserted-by":"publisher","first-page":"e142241","DOI":"10.1172\/JCI142241","volume":"131","author":"AR Saltiel","year":"2021","unstructured":"Saltiel, A. R. Insulin signaling in health and disease. J. Clin. Investig. 131, e142241 (2021).","journal-title":"J. Clin. Investig."},{"key":"2141_CR128","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1152\/physiol.00034.2021","volume":"37","author":"DH Wasserman","year":"2022","unstructured":"Wasserman, D. H. Insulin, muscle glucose uptake, and hexokinase: revisiting the road not taken. Physiology 37, 115\u2013127 (2022).","journal-title":"Physiology"},{"key":"2141_CR129","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s42255-019-0148-2","volume":"1","author":"GM Noguchi","year":"2019","unstructured":"Noguchi, G. M. & Huising, M. O. Integrating the inputs that shape pancreatic islet hormone release. Nat. Metab. 1, 1189\u20131201 (2019).","journal-title":"Nat. Metab."},{"key":"2141_CR130","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrn.2018.7","volume":"19","author":"A Caron","year":"2018","unstructured":"Caron, A., Lee, S., Elmquist, J. K. & Gautron, L. Leptin and brain-adipose crosstalks. Nat. Rev. Neurosci. 19, 153\u2013165 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"2141_CR131","doi-asserted-by":"publisher","first-page":"T25","DOI":"10.1530\/JOE-14-0404","volume":"223","author":"MB Allison","year":"2014","unstructured":"Allison, M. B. & Myers, M. G. Jr. 20 years of leptin: connecting leptin signaling to biological function. J. Endocrinol. 223, T25\u2013T35 (2014).","journal-title":"J. Endocrinol."},{"key":"2141_CR132","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121\u2013135 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2141_CR133","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg, G. R. & Hardie, D. G. New insights into activation and function of the AMPK. Nat. Rev. Mol. Cell Biol. 24, 255\u2013272 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2141_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.81","volume":"48","author":"SM Jeon","year":"2016","unstructured":"Jeon, S. M. Regulation and function of AMPK in physiology and diseases. Exp. Mol. Med. 48, e245 (2016).","journal-title":"Exp. Mol. Med."},{"key":"2141_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/1475-4924-2-28","volume":"2","author":"SA Hawley","year":"2003","unstructured":"Hawley, S. A. et al. Complexes between the LKB1 tumor suppressor, STRAD alpha\/beta and MO25 alpha\/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28 (2003).","journal-title":"J. Biol."},{"key":"2141_CR136","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1073\/pnas.0308061100","volume":"101","author":"RJ Shaw","year":"2004","unstructured":"Shaw, R. J. et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl Acad. Sci. USA 101, 3329\u20133335 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR137","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.cub.2003.10.031","volume":"13","author":"A Woods","year":"2003","unstructured":"Woods, A. et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004\u20132008 (2003).","journal-title":"Curr. Biol."},{"key":"2141_CR138","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cmet.2013.08.019","volume":"18","author":"GJ Gowans","year":"2013","unstructured":"Gowans, G. J., Hawley, S. A., Ross, F. A. & Hardie, D. G. AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. Cell Metab. 18, 556\u2013566 (2013).","journal-title":"Cell Metab."},{"key":"2141_CR139","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1126\/science.1200094","volume":"332","author":"JS Oakhill","year":"2011","unstructured":"Oakhill, J. S. et al. AMPK is a direct adenylate charge-regulated protein kinase. Science 332, 1433\u20131435 (2011).","journal-title":"Science"},{"key":"2141_CR140","doi-asserted-by":"publisher","first-page":"32207","DOI":"10.1074\/jbc.M606357200","volume":"281","author":"M Suter","year":"2006","unstructured":"Suter, M. et al. Dissecting the role of 5\u2019-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem. 281, 32207\u201332216 (2006).","journal-title":"J. Biol. Chem."},{"key":"2141_CR141","first-page":"5080","volume":"24","author":"L Garcia-Haro","year":"2010","unstructured":"Garcia-Haro, L. et al. The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells. FASEB J. 24, 5080\u20135091 (2010).","journal-title":"FASEB J."},{"key":"2141_CR142","doi-asserted-by":"publisher","first-page":"10588","DOI":"10.1074\/jbc.M114.626259","volume":"290","author":"BK Joseph","year":"2015","unstructured":"Joseph, B. K. et al. Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d. J. Biol. Chem. 290, 10588\u201310598 (2015).","journal-title":"J. Biol. Chem."},{"key":"2141_CR143","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2005.05.009","volume":"2","author":"SA Hawley","year":"2005","unstructured":"Hawley, S. A. et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9\u201319 (2005).","journal-title":"Cell Metab."},{"key":"2141_CR144","doi-asserted-by":"publisher","first-page":"29060","DOI":"10.1074\/jbc.M503824200","volume":"280","author":"RL Hurley","year":"2005","unstructured":"Hurley, R. L. et al. The Ca2+\/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280, 29060\u201329066 (2005).","journal-title":"J. Biol. Chem."},{"key":"2141_CR145","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2005.06.005","volume":"2","author":"A Woods","year":"2005","unstructured":"Woods, A. et al. Ca2+\/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21\u201333 (2005).","journal-title":"Cell Metab."},{"key":"2141_CR146","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature23275","volume":"548","author":"CS Zhang","year":"2017","unstructured":"Zhang, C. S. et al. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature 548, 112\u2013116 (2017).","journal-title":"Nature"},{"key":"2141_CR147","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41422-019-0163-6","volume":"29","author":"Y Zong","year":"2019","unstructured":"Zong, Y. et al. Hierarchical activation of compartmentalized pools of AMPK depends on severity of nutrient or energy stress. Cell Res. 29, 460\u2013473 (2019).","journal-title":"Cell Res."},{"key":"2141_CR148","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell. 30, 214\u2013226 (2008).","journal-title":"Mol. Cell."},{"key":"2141_CR149","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","volume":"26","author":"DG Hardie","year":"2016","unstructured":"Hardie, D. G., Schaffer, B. E. & Brunet, A. AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol. 26, 190\u2013201 (2016).","journal-title":"Trends Cell Biol."},{"key":"2141_CR150","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.molcel.2011.11.005","volume":"44","author":"MR Banko","year":"2011","unstructured":"Banko, M. R. et al. Chemical genetic screen for AMPKalpha2 substrates uncovers a network of proteins involved in mitosis. Mol. Cell. 44, 878\u2013892 (2011).","journal-title":"Mol. Cell."},{"key":"2141_CR151","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cmet.2015.09.001","volume":"22","author":"NJ Hoffman","year":"2015","unstructured":"Hoffman, N. J. et al. Global phosphoproteomic analysis of human skeletal muscle reveals a network of exercise-regulated kinases and AMPK substrates. Cell Metab. 22, 922\u2013935 (2015).","journal-title":"Cell Metab."},{"key":"2141_CR152","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cmet.2015.09.009","volume":"22","author":"BE Schaffer","year":"2015","unstructured":"Schaffer, B. E. et al. Identification of AMPK phosphorylation sites reveals a network of proteins involved in cell invasion and facilitates large-scale substrate prediction. Cell Metab. 22, 907\u2013921 (2015).","journal-title":"Cell Metab."},{"key":"2141_CR153","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmet.2014.03.027","volume":"20","author":"L Mouchiroud","year":"2014","unstructured":"Mouchiroud, L., Eichner, L. J., Shaw, R. J. & Auwerx, J. Transcriptional coregulators: fine-tuning metabolism. Cell Metab. 20, 26\u201340 (2014).","journal-title":"Cell Metab."},{"key":"2141_CR154","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.2337\/db13-0368","volume":"62","author":"DG Hardie","year":"2013","unstructured":"Hardie, D. G. AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62, 2164\u20132172 (2013).","journal-title":"Diabetes"},{"key":"2141_CR155","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.molcel.2013.01.035","volume":"49","author":"N Wu","year":"2013","unstructured":"Wu, N. et al. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol. Cell 49, 1167\u20131175 (2013).","journal-title":"Mol. Cell"},{"key":"2141_CR156","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2011.05.002","volume":"13","author":"M Ahmadian","year":"2011","unstructured":"Ahmadian, M. et al. Desnutrin\/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab. 13, 739\u2013748 (2011).","journal-title":"Cell Metab."},{"key":"2141_CR157","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature03967","volume":"437","author":"SH Koo","year":"2005","unstructured":"Koo, S. H. et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109\u20131111 (2005).","journal-title":"Nature"},{"key":"2141_CR158","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","volume":"145","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova, M. M. et al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145, 607\u2013621 (2011).","journal-title":"Cell"},{"key":"2141_CR159","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376\u2013388 (2011).","journal-title":"Cell Metab."},{"key":"2141_CR160","doi-asserted-by":"publisher","first-page":"27495","DOI":"10.1074\/jbc.M304112200","volume":"278","author":"YH Hong","year":"2003","unstructured":"Hong, Y. H., Varanasi, U. S., Yang, W. & Leff, T. AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J. Biol. Chem. 278, 27495\u201327501 (2003).","journal-title":"J. Biol. Chem."},{"key":"2141_CR161","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1074\/jbc.M107895200","volume":"277","author":"T Kawaguchi","year":"2002","unstructured":"Kawaguchi, T. et al. Mechanism for fatty acid \u201csparing\u201d effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J. Biol. Chem. 277, 3829\u20133835 (2002).","journal-title":"J. Biol. Chem."},{"key":"2141_CR162","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Zhu, T. & Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577\u2013590 (2003).","journal-title":"Cell"},{"key":"2141_CR163","doi-asserted-by":"publisher","first-page":"17781","DOI":"10.1073\/pnas.0909873106","volume":"106","author":"S Hoppe","year":"2009","unstructured":"Hoppe, S. et al. AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc. Natl Acad. Sci. USA 106, 17781\u201317786 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR164","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2013.04.055","volume":"153","author":"G Leprivier","year":"2013","unstructured":"Leprivier, G. et al. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 153, 1064\u20131079 (2013).","journal-title":"Cell"},{"key":"2141_CR165","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature13896","volume":"517","author":"WJ Faller","year":"2015","unstructured":"Faller, W. J. et al. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Nature 517, 497\u2013500 (2015).","journal-title":"Nature"},{"key":"2141_CR166","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan, D. F. et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456\u2013461 (2011).","journal-title":"Science"},{"key":"2141_CR167","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"2141_CR168","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.4161\/auto.20586","volume":"8","author":"HI Mack","year":"2012","unstructured":"Mack, H. I., Zheng, B., Asara, J. M. & Thomas, S. M. AMPK-dependent phosphorylation of ULK1 regulates ATG9 localization. Autophagy 8, 1197\u20131214 (2012).","journal-title":"Autophagy"},{"key":"2141_CR169","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2012.12.016","volume":"152","author":"J Kim","year":"2013","unstructured":"Kim, J. et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152, 290\u2013303 (2013).","journal-title":"Cell"},{"key":"2141_CR170","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1128\/MCB.00740-14","volume":"34","author":"VK Weerasekara","year":"2014","unstructured":"Weerasekara, V. K. et al. Metabolic-stress-induced rearrangement of the 14-3-3zeta interactome promotes autophagy via a ULK1- and AMPK-regulated 14-3-3zeta interaction with phosphorylated Atg9. Mol. Cell Biol. 34, 4379\u20134388 (2014).","journal-title":"Mol. Cell Biol."},{"key":"2141_CR171","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/cr.2016.146","volume":"27","author":"C Zhou","year":"2017","unstructured":"Zhou, C. et al. Regulation of mATG9 trafficking by Src- and ULK1-mediated phosphorylation in basal and starvation-induced autophagy. Cell Res. 27, 184\u2013201 (2017).","journal-title":"Cell Res."},{"key":"2141_CR172","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"2141_CR173","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed, A., Kim, E. & Jacinto, E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol. Rev. 101, 1371\u20131426 (2021).","journal-title":"Physiol. Rev."},{"key":"2141_CR174","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41580-023-00641-8","volume":"24","author":"C Goul","year":"2023","unstructured":"Goul, C., Peruzzo, R. & Zoncu, R. The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Nat. Rev. Mol. Cell Biol. 24, 857\u2013875 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2141_CR175","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296\u20131302 (2004).","journal-title":"Curr. Biol."},{"key":"2141_CR176","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"E Jacinto","year":"2004","unstructured":"Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122\u20131128 (2004).","journal-title":"Nat. Cell Biol."},{"key":"2141_CR177","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1083\/jcb.201205030","volume":"201","author":"V Thomanetz","year":"2013","unstructured":"Thomanetz, V. et al. Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. J. Cell Biol. 201, 293\u2013308 (2013).","journal-title":"J. Cell Biol."},{"key":"2141_CR178","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010611-134537","volume":"52","author":"K Inoki","year":"2012","unstructured":"Inoki, K., Kim, J. & Guan, K. L. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu. Rev. Pharmacol. Toxicol. 52, 381\u2013400 (2012).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2141_CR179","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s42255-022-00732-4","volume":"5","author":"X Dai","year":"2023","unstructured":"Dai, X. et al. AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation. Nat. Metab. 5, 265\u2013276 (2023).","journal-title":"Nat. Metab."},{"key":"2141_CR180","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1158\/0008-5472.CAN-21-4403","volume":"82","author":"S Yue","year":"2022","unstructured":"Yue, S., Li, G., He, S. & Li, T. The central role of mTORC1 in amino acid sensing. Cancer Res. 82, 2964\u20132974 (2022).","journal-title":"Cancer Res."},{"key":"2141_CR181","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/ncb1753","volume":"10","author":"E Kim","year":"2008","unstructured":"Kim, E. et al. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10, 935\u2013945 (2008).","journal-title":"Nat. Cell Biol."},{"key":"2141_CR182","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nature11745","volume":"493","author":"A Efeyan","year":"2013","unstructured":"Efeyan, A. et al. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival. Nature 493, 679\u2013683 (2013).","journal-title":"Nature"},{"key":"2141_CR183","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender, A. et al. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab. 11, 390\u2013401 (2010).","journal-title":"Cell Metab."},{"key":"2141_CR184","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4161\/sgtp.2.4.16703","volume":"2","author":"MD Lacher","year":"2011","unstructured":"Lacher, M. D., Pincheira, R. J. & Castro, A. F. Consequences of interrupted Rheb-to-AMPK feedback signaling in tuberous sclerosis complex and cancer. Small GTPases 2, 211\u2013216 (2011).","journal-title":"Small GTPases"},{"key":"2141_CR185","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3892\/ijo.2020.5152","volume":"58","author":"H Fan","year":"2021","unstructured":"Fan, H. et al. Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review). Int. J. Oncol. 58, 9\u201319 (2021).","journal-title":"Int. J. Oncol."},{"key":"2141_CR186","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-10-4158","volume":"71","author":"JL Yecies","year":"2011","unstructured":"Yecies, J. L. & Manning, B. D. Transcriptional control of cellular metabolism by mTOR signaling. Cancer Res. 71, 2815\u20132820 (2011).","journal-title":"Cancer Res."},{"key":"2141_CR187","doi-asserted-by":"crossref","unstructured":"Magaway, C., Kim, E. & Jacinto, E. Targeting mTOR and metabolism in cancer: lessons and innovations. Cells. 8, 1584 (2019).","DOI":"10.3390\/cells8121584"},{"key":"2141_CR188","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"K Duvel","year":"2010","unstructured":"Duvel, K. et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171\u2013183 (2010).","journal-title":"Mol. Cell"},{"key":"2141_CR189","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu, Q. J. et al. The sirtuin family in health and disease. Signal. Transduct. Target Ther. 7, 402 (2022).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2141_CR190","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrm3293","volume":"13","author":"RH Houtkooper","year":"2012","unstructured":"Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225\u2013238 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2141_CR191","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrendo.2011.225","volume":"8","author":"A Chalkiadaki","year":"2012","unstructured":"Chalkiadaki, A. & Guarente, L. Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat. Rev. Endocrinol. 8, 287\u2013296 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2141_CR192","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers, J. T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113\u2013118 (2005).","journal-title":"Nature"},{"key":"2141_CR193","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1101\/gad.1650608","volume":"22","author":"D Chen","year":"2008","unstructured":"Chen, D. et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 22, 1753\u20131757 (2008).","journal-title":"Genes Dev."},{"key":"2141_CR194","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cmet.2010.02.006","volume":"11","author":"C Canto","year":"2010","unstructured":"Canto, C. et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11, 213\u2013219 (2010).","journal-title":"Cell Metab."},{"key":"2141_CR195","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Canto","year":"2009","unstructured":"Canto, C. et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056\u20131060 (2009).","journal-title":"Nature"},{"key":"2141_CR196","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jgg.2021.11.005","volume":"49","author":"Z Ji","year":"2022","unstructured":"Ji, Z., Liu, G. H. & Qu, J. Mitochondrial sirtuins, metabolism, and aging. J. Genet Genom. 49, 287\u2013298 (2022).","journal-title":"J. Genet Genom."},{"key":"2141_CR197","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","volume":"14","author":"J Yoshino","year":"2011","unstructured":"Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528\u2013536 (2011).","journal-title":"Cell Metab."},{"key":"2141_CR198","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1021\/pr100892r","volume":"10","author":"HJ Kim","year":"2011","unstructured":"Kim, H. J. et al. Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J. Proteome Res. 10, 722\u2013731 (2011).","journal-title":"J. Proteome Res."},{"key":"2141_CR199","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/abbs\/gms108","volume":"45","author":"X Li","year":"2013","unstructured":"Li, X. SIRT1 and energy metabolism. Acta Biochim. Biophys. Sin. 45, 51\u201360 (2013).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"2141_CR200","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tibs.2008.08.001","volume":"33","author":"HS Kwon","year":"2008","unstructured":"Kwon, H. S. & Ott, M. The ups and downs of SIRT1. Trends Biochem. Sci. 33, 517\u2013525 (2008).","journal-title":"Trends Biochem. Sci."},{"key":"2141_CR201","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831168","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Regulation of SIRT1 and its roles in inflammation. Front. Immunol. 13, 831168 (2022).","journal-title":"Front. Immunol."},{"key":"2141_CR202","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.arr.2019.100961","volume":"55","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. SIRT2: controversy and multiple roles in disease and physiology. Ageing Res. Rev. 55, 100961 (2019).","journal-title":"Ageing Res. Rev."},{"key":"2141_CR203","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.cmet.2020.07.008","volume":"32","author":"I Hamaidi","year":"2020","unstructured":"Hamaidi, I. et al. Sirt2 inhibition enhances metabolic fitness and effector functions of tumor-reactive T Cells. Cell Metab. 32, 420\u2013436.e412 (2020).","journal-title":"Cell Metab."},{"key":"2141_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02537-6","volume":"9","author":"H Watanabe","year":"2018","unstructured":"Watanabe, H. et al. Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein. Nat. Commun. 9, 30 (2018).","journal-title":"Nat. Commun."},{"key":"2141_CR205","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell Proteom. 13, 397\u2013406 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"2141_CR206","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.cell.2010.10.002","volume":"143","author":"S Someya","year":"2010","unstructured":"Someya, S. et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802\u2013812 (2010).","journal-title":"Cell"},{"key":"2141_CR207","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.tips.2017.01.009","volume":"38","author":"Y Jiang","year":"2017","unstructured":"Jiang, Y. et al. Sirtuin inhibition: strategies, inhibitors, and therapeutic potential. Trends Pharmacol. Sci. 38, 459\u2013472 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"2141_CR208","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.cmet.2010.11.003","volume":"12","author":"T Shimazu","year":"2010","unstructured":"Shimazu, T. et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 12, 654\u2013661 (2010).","journal-title":"Cell Metab."},{"key":"2141_CR209","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jmb.2008.07.048","volume":"382","author":"C Schlicker","year":"2008","unstructured":"Schlicker, C. et al. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 382, 790\u2013801 (2008).","journal-title":"J. Mol. Biol."},{"key":"2141_CR210","doi-asserted-by":"publisher","first-page":"835","DOI":"10.18632\/aging.100616","volume":"5","author":"L Ho","year":"2013","unstructured":"Ho, L. et al. SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK. Aging 5, 835\u2013849 (2013).","journal-title":"Aging"},{"key":"2141_CR211","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2018.03.004","volume":"188","author":"H Dai","year":"2018","unstructured":"Dai, H., Sinclair, D. A., Ellis, J. L. & Steegborn, C. Sirtuin activators and inhibitors: promises, achievements, and challenges. Pharmacol. Ther. 188, 140\u2013154 (2018).","journal-title":"Pharmacol. Ther."},{"key":"2141_CR212","first-page":"60","volume":"4","author":"L Garfinkel","year":"1985","unstructured":"Garfinkel, L. & Garfinkel, D. Magnesium regulation of the glycolytic pathway and the enzymes involved. Magnesium 4, 60\u201372 (1985).","journal-title":"Magnesium"},{"key":"2141_CR213","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.ajkd.2019.03.427","volume":"74","author":"BF Palmer","year":"2019","unstructured":"Palmer, B. F. & Clegg, D. J. Physiology and pathophysiology of potassium homeostasis: Core Curriculum 2019. Am. J. Kidney Dis. 74, 682\u2013695 (2019).","journal-title":"Am. J. Kidney Dis."},{"key":"2141_CR214","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41583-021-00535-8","volume":"23","author":"S Li","year":"2022","unstructured":"Li, S. & Sheng, Z. H. Energy matters: presynaptic metabolism and the maintenance of synaptic transmission. Nat. Rev. Neurosci. 23, 4\u201322 (2022).","journal-title":"Nat. Rev. Neurosci."},{"key":"2141_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26180-4","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat. Commun. 12, 5872 (2021).","journal-title":"Nat. Commun."},{"key":"2141_CR216","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao, M. et al. Role of mitochondria in ferroptosis. Mol. Cell. 73, 354\u2013363.e353 (2019).","journal-title":"Mol. Cell."},{"key":"2141_CR217","doi-asserted-by":"crossref","unstructured":"Nassar, Z. D. et al. Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. Elife. 9, e54166 (2020).","DOI":"10.7554\/eLife.54166"},{"key":"2141_CR218","doi-asserted-by":"publisher","first-page":"110098","DOI":"10.1016\/j.cellsig.2021.110098","volume":"87","author":"F Cao","year":"2021","unstructured":"Cao, F., Luo, A. & Yang, C. G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase. Cell. Signal. 87, 110098 (2021).","journal-title":"Cell. Signal."},{"key":"2141_CR219","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688\u2013692 (2019).","journal-title":"Nature"},{"key":"2141_CR220","doi-asserted-by":"crossref","unstructured":"Lin, W. et al. Metabolic heterogeneity protects metastatic mucosal melanomas cells from ferroptosis. Int. J. Mol. Med. 50, 1\u201316 (2022).","DOI":"10.3892\/ijmm.2022.5180"},{"key":"2141_CR221","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat. Cell Biol. 22, 225\u2013234 (2020).","journal-title":"Nat. Cell Biol."},{"key":"2141_CR222","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41556-022-00949-1","volume":"24","author":"M Chen","year":"2022","unstructured":"Chen, M. et al. A p53-phosphoinositide signalosome regulates nuclear AKT activation. Nat. Cell Biol. 24, 1099\u20131113 (2022).","journal-title":"Nat. Cell Biol."},{"key":"2141_CR223","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-018-0062-1","volume":"15","author":"TMZ Waise","year":"2018","unstructured":"Waise, T. M. Z., Dranse, H. J. & Lam, T. K. T. The metabolic role of vagal afferent innervation. Nat. Rev. Gastroenterol. Hepatol. 15, 625\u2013636 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2141_CR224","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10684-1","volume":"10","author":"MT Hackl","year":"2019","unstructured":"Hackl, M. T. et al. Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis. Nat. Commun. 10, 2717 (2019).","journal-title":"Nat. Commun."},{"key":"2141_CR225","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41392-023-01673-4","volume":"8","author":"M Yan","year":"2023","unstructured":"Yan, M. et al. Gut liver brain axis in diseases: the implications for therapeutic interventions. Signal. Transduct. Target Ther. 8, 443 (2023).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2141_CR226","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.4254\/wjh.v13.i11.1512","volume":"13","author":"Y Ma","year":"2021","unstructured":"Ma, Y. et al. Fatty acid metabolism and acyl-CoA synthetases in the liver-gut axis. World J. Hepatol. 13, 1512\u20131533 (2021).","journal-title":"World J. Hepatol."},{"key":"2141_CR227","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jnutbio.2018.03.009","volume":"57","author":"C Goswami","year":"2018","unstructured":"Goswami, C., Iwasaki, Y. & Yada, T. Short-chain fatty acids suppress food intake by activating vagal afferent neurons. J. Nutr. Biochem. 57, 130\u2013135 (2018).","journal-title":"J. Nutr. Biochem."},{"key":"2141_CR228","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-021-00398-4","volume":"3","author":"A Perino","year":"2021","unstructured":"Perino, A. et al. Central anorexigenic actions of bile acids are mediated by TGR5. Nat. Metab. 3, 595\u2013603 (2021).","journal-title":"Nat. Metab."},{"key":"2141_CR229","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","volume":"13","author":"MJ Potthoff","year":"2011","unstructured":"Potthoff, M. J. et al. FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway. Cell Metab. 13, 729\u2013738 (2011).","journal-title":"Cell Metab."},{"key":"2141_CR230","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3316","volume":"4","author":"Y Izumida","year":"2013","unstructured":"Izumida, Y. et al. Glycogen shortage during fasting triggers liver-brain-adipose neurocircuitry to facilitate fat utilization. Nat. Commun. 4, 2316 (2013).","journal-title":"Nat. Commun."},{"key":"2141_CR231","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","volume":"81","author":"E Trefts","year":"2021","unstructured":"Trefts, E. & Shaw, R. J. AMPK: restoring metabolic homeostasis over space and time. Mol. Cell. 81, 3677\u20133690 (2021).","journal-title":"Mol. Cell."},{"key":"2141_CR232","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","volume":"244","author":"JD McGarry","year":"1997","unstructured":"McGarry, J. D. & Brown, N. F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244, 1\u201314 (1997).","journal-title":"Eur. J. Biochem."},{"key":"2141_CR233","doi-asserted-by":"publisher","first-page":"148276","DOI":"10.1016\/j.bbabio.2020.148276","volume":"1861","author":"M Rigoulet","year":"2020","unstructured":"Rigoulet, M. et al. Cell energy metabolism: an update. Biochim. Biophys. Acta Bioenerg. 1861, 148276 (2020).","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"2141_CR234","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s42255-020-0251-4","volume":"2","author":"M Hargreaves","year":"2020","unstructured":"Hargreaves, M. & Spriet, L. L. Skeletal muscle energy metabolism during exercise. Nat. Metab. 2, 817\u2013828 (2020).","journal-title":"Nat. Metab."},{"key":"2141_CR235","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cmet.2012.12.012","volume":"17","author":"B Egan","year":"2013","unstructured":"Egan, B. & Zierath, J. R. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 17, 162\u2013184 (2013).","journal-title":"Cell Metab."},{"key":"2141_CR236","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev-physiol-060721-095517","volume":"84","author":"HR Spaulding","year":"2022","unstructured":"Spaulding, H. R. & Yan, Z. AMPK and the adaptation to exercise. Annu. Rev. Physiol. 84, 209\u2013227 (2022).","journal-title":"Annu. Rev. Physiol."},{"key":"2141_CR237","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s13105-017-0576-y","volume":"73","author":"A Thirupathi","year":"2017","unstructured":"Thirupathi, A. & de Souza, C. T. Multi-regulatory network of ROS: the interconnection of ROS, PGC-1 alpha, and AMPK-SIRT1 during exercise. J. Physiol. Biochem. 73, 487\u2013494 (2017).","journal-title":"J. Physiol. Biochem."},{"key":"2141_CR238","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/10408398.2010.500245","volume":"52","author":"J Xu","year":"2012","unstructured":"Xu, J., Ji, J. & Yan, X. H. Cross-talk between AMPK and mTOR in regulating energy balance. Crit. Rev. Food Sci. Nutr. 52, 373\u2013381 (2012).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"2141_CR239","doi-asserted-by":"publisher","first-page":"e12978","DOI":"10.1111\/obr.12978","volume":"21","author":"K McInnis","year":"2020","unstructured":"McInnis, K., Haman, F. & Doucet, E. Humans in the cold: regulating energy balance. Obes. Rev. 21, e12978 (2020).","journal-title":"Obes. Rev."},{"key":"2141_CR240","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.redox.2017.04.011","volume":"12","author":"C Scheele","year":"2017","unstructured":"Scheele, C. & Nielsen, S. Metabolic regulation and the anti-obesity perspectives of human brown fat. Redox Biol. 12, 770\u2013775 (2017).","journal-title":"Redox Biol."},{"key":"2141_CR241","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/nm.4429","volume":"23","author":"K Ikeda","year":"2017","unstructured":"Ikeda, K. et al. UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis. Nat. Med. 23, 1454\u20131465 (2017).","journal-title":"Nat. Med."},{"key":"2141_CR242","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fendo.2011.00102","volume":"2","author":"S Collins","year":"2011","unstructured":"Collins, S. beta-Adrenoceptor signaling networks in adipocytes for recruiting stored fat and energy expenditure. Front. Endocrinol. 2, 102 (2011).","journal-title":"Front. Endocrinol."},{"key":"2141_CR243","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1096\/fj.00-0536fje","volume":"15","author":"V Golozoubova","year":"2001","unstructured":"Golozoubova, V. et al. Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold. FASEB J. 15, 2048\u20132050 (2001).","journal-title":"FASEB J."},{"key":"2141_CR244","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/B978-0-444-63912-7.00010-2","volume":"156","author":"DP Blondin","year":"2018","unstructured":"Blondin, D. P. & Haman, F. Shivering and nonshivering thermogenesis in skeletal muscles. Handb. Clin. Neurol. 156, 153\u2013173 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"2141_CR245","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","volume":"19","author":"VD Longo","year":"2014","unstructured":"Longo, V. D. & Mattson, M. P. Fasting: molecular mechanisms and clinical applications. Cell Metab. 19, 181\u2013192 (2014).","journal-title":"Cell Metab."},{"key":"2141_CR246","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/nature09584","volume":"468","author":"S Sengupta","year":"2010","unstructured":"Sengupta, S. et al. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468, 1100\u20131104 (2010).","journal-title":"Nature"},{"key":"2141_CR247","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ecl.2016.04.012","volume":"45","author":"GA Triantafyllou","year":"2016","unstructured":"Triantafyllou, G. A., Paschou, S. A. & Mantzoros, C. S. Leptin and hormones: energy homeostasis. Endocrinol. Metab. Clin. North Am. 45, 633\u2013645 (2016).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"2141_CR248","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","volume":"42","author":"S Ramamoorthy","year":"2016","unstructured":"Ramamoorthy, S. & Cidlowski, J. A. Corticosteroids: mechanisms of action in health and disease. Rheum. Dis. Clin. North Am. 42, 15\u201331 (2016).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"2141_CR249","doi-asserted-by":"publisher","first-page":"155768","DOI":"10.1016\/j.metabol.2023.155768","volume":"152","author":"KL Storoschuk","year":"2024","unstructured":"Storoschuk, K. L. et al. Impact of fasting on the AMPK and PGC-1alpha axis in rodent and human skeletal muscle: a systematic review. Metabolism 152, 155768 (2024).","journal-title":"Metabolism"},{"key":"2141_CR250","doi-asserted-by":"publisher","first-page":"1238528","DOI":"10.3389\/fnins.2023.1238528","volume":"17","author":"Z Liu","year":"2023","unstructured":"Liu, Z., Xiao, T. & Liu, H. Leptin signaling and its central role in energy homeostasis. Front. Neurosci. 17, 1238528 (2023).","journal-title":"Front. Neurosci."},{"key":"2141_CR251","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/jmcb\/mjz112","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Zhang, W. & Liu, C. Integration of peripheral circadian clock and energy metabolism in metabolic tissues. J. Mol. Cell. Biol. 12, 481\u2013485 (2020).","journal-title":"J. Mol. Cell. Biol."},{"key":"2141_CR252","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20624","volume":"58","author":"MF Beal","year":"2005","unstructured":"Beal, M. F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58, 495\u2013505 (2005).","journal-title":"Ann. Neurol."},{"key":"2141_CR253","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","volume":"257","author":"K Sas","year":"2007","unstructured":"Sas, K., Robotka, H., Toldi, J. & Vecsei, L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J. Neurol. Sci. 257, 221\u2013239 (2007).","journal-title":"J. Neurol. Sci."},{"key":"2141_CR254","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-3-319-57193-5_16","volume":"15","author":"J Fan","year":"2017","unstructured":"Fan, J., Dawson, T. M. & Dawson, V. L. Cell death mechanisms of neurodegeneration. Adv. Neurobiol. 15, 403\u2013425 (2017).","journal-title":"Adv. Neurobiol."},{"key":"2141_CR255","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev-physiol-022516-034110","volume":"79","author":"C Toda","year":"2017","unstructured":"Toda, C., Santoro, A., Kim, J. D. & Diano, S. POMC neurons: from birth to death. Annu. Rev. Physiol. 79, 209\u2013236 (2017).","journal-title":"Annu. Rev. Physiol."},{"key":"2141_CR256","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1515\/hsz-2019-0140","volume":"400","author":"S Zulfiqar","year":"2019","unstructured":"Zulfiqar, S., Garg, P. & Nieweg, K. Contribution of astrocytes to metabolic dysfunction in the Alzheimer\u2019s disease brain. Biol. Chem. 400, 1113\u20131127 (2019).","journal-title":"Biol. Chem."},{"key":"2141_CR257","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/acn3.530","volume":"5","author":"R Mullins","year":"2018","unstructured":"Mullins, R., Reiter, D. & Kapogiannis, D. Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer\u2019s brain. Ann. Clin. Transl. Neurol. 5, 262\u2013272 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"2141_CR258","doi-asserted-by":"publisher","first-page":"eabm6131","DOI":"10.1126\/science.abm6131","volume":"385","author":"PS Minhas","year":"2024","unstructured":"Minhas, P. S. et al. Restoring hippocampal glucose metabolism rescues cognition across Alzheimer\u2019s disease pathologies. Science. 385, eabm6131 (2024).","journal-title":"Science."},{"key":"2141_CR259","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","volume":"36","author":"L Mosconi","year":"2009","unstructured":"Mosconi, L. et al. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease. Eur. J. Nucl. Med. Mol. Imaging 36, 811\u2013822 (2009).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2141_CR260","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13195-020-00621-6","volume":"12","author":"MS Tan","year":"2020","unstructured":"Tan, M. S. et al. Longitudinal trajectories of Alzheimer\u2019s ATN biomarkers in elderly persons without dementia. Alzheimers Res. Ther. 12, 55 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"2141_CR261","doi-asserted-by":"publisher","first-page":"17757","DOI":"10.1073\/pnas.1010459107","volume":"107","author":"SN Vaishnavi","year":"2010","unstructured":"Vaishnavi, S. N. et al. Regional aerobic glycolysis in the human brain. Proc. Natl Acad. Sci. USA 107, 17757\u201317762 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR262","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40478-015-0187-1","volume":"3","author":"T Arendt","year":"2015","unstructured":"Arendt, T. et al. Early neurone loss in Alzheimer\u2019s disease: cortical or subcortical? Acta Neuropathol. Commun. 3, 10 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"2141_CR263","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnmol.2018.00148","volume":"11","author":"N Vardjan","year":"2018","unstructured":"Vardjan, N. et al. Enhancement of astroglial aerobic glycolysis by extracellular lactate-mediated increase in cAMP. Front. Mol. Neurosci. 11, 148 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"2141_CR264","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079977","volume":"8","author":"F Ding","year":"2013","unstructured":"Ding, F. et al. Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer\u2019s mouse brain: implication for bioenergetic intervention. PLoS ONE 8, e79977 (2013).","journal-title":"PLoS ONE"},{"key":"2141_CR265","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ana.20899","volume":"60","author":"KJ Bough","year":"2006","unstructured":"Bough, K. J. et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 60, 223\u2013235 (2006).","journal-title":"Ann. Neurol."},{"key":"2141_CR266","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.exger.2017.07.004","volume":"107","author":"E Croteau","year":"2018","unstructured":"Croteau, E. et al. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer\u2019s disease. Exp. Gerontol. 107, 18\u201326 (2018).","journal-title":"Exp. Gerontol."},{"key":"2141_CR267","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.ebiom.2015.11.002","volume":"2","author":"LP Klosinski","year":"2015","unstructured":"Klosinski, L. P. et al. White matter lipids as a ketogenic fuel supply in aging female brain: implications for Alzheimer\u2019s disease. EBioMedicine 2, 1888\u20131904 (2015).","journal-title":"EBioMedicine"},{"key":"2141_CR268","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","volume":"16","author":"KA Vossel","year":"2017","unstructured":"Vossel, K. A. et al. Epileptic activity in Alzheimer\u2019s disease: causes and clinical relevance. Lancet Neurol. 16, 311\u2013322 (2017).","journal-title":"Lancet Neurol."},{"key":"2141_CR269","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073813487598","volume":"28","author":"NN Danial","year":"2013","unstructured":"Danial, N. N., Hartman, A. L., Stafstrom, C. E. & Thio, L. L. How does the ketogenic diet work? Four potential mechanisms. J. Child Neurol. 28, 1027\u20131033 (2013).","journal-title":"J. Child Neurol."},{"key":"2141_CR270","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.nbd.2009.06.014","volume":"36","author":"PM Ullner","year":"2009","unstructured":"Ullner, P. M. et al. Murine Glut-1 transporter haploinsufficiency: postnatal deceleration of brain weight and reactive astrocytosis. Neurobiol. Dis. 36, 60\u201369 (2009).","journal-title":"Neurobiol. Dis."},{"key":"2141_CR271","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne, A. et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85, 296\u2013302 (2015).","journal-title":"Neuron"},{"key":"2141_CR272","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield, D. A. & Halliwell, B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 20, 148\u2013160 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"2141_CR273","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","volume":"14","author":"Y An","year":"2018","unstructured":"An, Y. et al. Evidence for brain glucose dysregulation in Alzheimer\u2019s disease. Alzheimers Dement 14, 318\u2013329 (2018).","journal-title":"Alzheimers Dement"},{"key":"2141_CR274","doi-asserted-by":"crossref","unstructured":"Folch, J. et al. The Implication of the Brain Insulin Receptor in Late Onset Alzheimer\u2019s Disease Dementia. Pharmaceuticals 11, 11 (2018).","DOI":"10.3390\/ph11010011"},{"key":"2141_CR275","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1007\/s12035-021-02297-x","volume":"58","author":"S Cho","year":"2021","unstructured":"Cho, S., Lee, H. & Seo, J. Impact of genetic risk factors for Alzheimer\u2019s disease on brain glucose metabolism. Mol. Neurobiol. 58, 2608\u20132619 (2021).","journal-title":"Mol. Neurobiol."},{"key":"2141_CR276","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1080\/15548627.2016.1159375","volume":"12","author":"SM Son","year":"2016","unstructured":"Son, S. M. et al. Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease. Autophagy 12, 784\u2013800 (2016).","journal-title":"Autophagy"},{"key":"2141_CR277","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1471-4159.2008.05858.x","volume":"108","author":"M Guglielmotto","year":"2009","unstructured":"Guglielmotto, M. et al. The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha. J. Neurochem. 108, 1045\u20131056 (2009).","journal-title":"J. Neurochem."},{"key":"2141_CR278","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.immuni.2023.12.002","volume":"57","author":"E Tagliatti","year":"2024","unstructured":"Tagliatti, E. et al. Trem2 expression in microglia is required to maintain normal neuronal bioenergetics during development. Immunity 57, 86\u2013105.e109 (2024).","journal-title":"Immunity"},{"key":"2141_CR279","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02318-5","volume":"18","author":"G Luo","year":"2021","unstructured":"Luo, G. et al. Metabolic reprogramming mediates hippocampal microglial M1 polarization in response to surgical trauma causing perioperative neurocognitive disorders. J. Neuroinflamm. 18, 267 (2021).","journal-title":"J. Neuroinflamm."},{"key":"2141_CR280","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/jnr.23356","volume":"92","author":"J Gimeno-Bayon","year":"2014","unstructured":"Gimeno-Bayon, J., Lopez-Lopez, A., Rodriguez, M. J. & Mahy, N. Glucose pathways adaptation supports acquisition of activated microglia phenotype. J. Neurosci. Res. 92, 723\u2013731 (2014).","journal-title":"J. Neurosci. Res."},{"key":"2141_CR281","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell, H. Glucose transporters in brain in health and disease. Pflug. Arch. 472, 1299\u20131343 (2020).","journal-title":"Pflug. Arch."},{"key":"2141_CR282","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.apsb.2019.12.006","volume":"10","author":"W Song","year":"2020","unstructured":"Song, W. et al. Solute carrier transporters: the metabolic gatekeepers of immune cells. Acta Pharm. Sin. B 10, 61\u201378 (2020).","journal-title":"Acta Pharm. Sin. B"},{"key":"2141_CR283","doi-asserted-by":"publisher","first-page":"947","DOI":"10.5650\/jos.ess21069","volume":"70","author":"T Tsukahara","year":"2021","unstructured":"Tsukahara, T., Hara, H., Haniu, H. & Matsuda, Y. The combined effects of Lysophospholipids against Lipopolysaccharide-induced inflammation and oxidative stress in microglial cells. J. Oleo Sci. 70, 947\u2013954 (2021).","journal-title":"J. Oleo Sci."},{"key":"2141_CR284","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fimmu.2020.00493","volume":"11","author":"C Lauro","year":"2020","unstructured":"Lauro, C. & Limatola, C. Metabolic reprograming of microglia in the regulation of the innate inflammatory response. Front. Immunol. 11, 493 (2020).","journal-title":"Front. Immunol."},{"key":"2141_CR285","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tem.2021.12.001","volume":"33","author":"K Monsorno","year":"2022","unstructured":"Monsorno, K., Buckinx, A. & Paolicelli, R. C. Microglial metabolic flexibility: emerging roles for lactate. Trends Endocrinol. Metab. 33, 186\u2013195 (2022).","journal-title":"Trends Endocrinol. Metab."},{"key":"2141_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2023.114453","volume":"276","author":"SCA Silva","year":"2024","unstructured":"Silva, S. C. A. et al. Overweight during development dysregulates cellular metabolism and critical genes that control food intake in the prefrontal cortex. Physiol. Behav. 276, 114453 (2024).","journal-title":"Physiol. Behav."},{"key":"2141_CR287","doi-asserted-by":"crossref","unstructured":"Versele, R. et al. TNF-alpha and IL-1beta modulate blood-brain barrier permeability and decrease amyloid-beta peptide efflux in a human blood-brain barrier model. Int. J. Mol. Sci. 23, 10235 (2022).","DOI":"10.3390\/ijms231810235"},{"key":"2141_CR288","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1196\/annals.1372.039","volume":"1084","author":"K Alexandraki","year":"2006","unstructured":"Alexandraki, K. et al. Inflammatory process in type 2 diabetes: the role of cytokines. Ann. N. Y. Acad. Sci. 1084, 89\u2013117 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2141_CR289","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"QL Ma","year":"2009","unstructured":"Ma, Q. L. et al. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J. Neurosci. 29, 9078\u20139089 (2009).","journal-title":"J. Neurosci."},{"key":"2141_CR290","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland, T. K. et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170, 649\u2013663.e613 (2017).","journal-title":"Cell"},{"key":"2141_CR291","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1096\/fj.201902447R","volume":"34","author":"TM Piers","year":"2020","unstructured":"Piers, T. M. et al. A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia. FASEB J. 34, 2436\u20132450 (2020).","journal-title":"FASEB J."},{"key":"2141_CR292","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","volume":"30","author":"SH Baik","year":"2019","unstructured":"Baik, S. H. et al. A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer\u2019s disease. Cell Metab. 30, 493\u2013507.e496 (2019).","journal-title":"Cell Metab."},{"key":"2141_CR293","doi-asserted-by":"publisher","first-page":"e131355","DOI":"10.1172\/jci.insight.131355","volume":"4","author":"W Cai","year":"2019","unstructured":"Cai, W. et al. STAT6\/Arg1 promotes microglia\/macrophage efferocytosis and inflammation resolution in stroke mice. JCI Insight. 4, e131355 (2019).","journal-title":"JCI Insight."},{"key":"2141_CR294","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-020-00333-8","volume":"6","author":"T Gaojian","year":"2020","unstructured":"Gaojian, T. et al. Parthenolide promotes the repair of spinal cord injury by modulating M1\/M2 polarization via the NF-kappaB and STAT 1\/3 signaling pathway. Cell Death Discov. 6, 97 (2020).","journal-title":"Cell Death Discov."},{"key":"2141_CR295","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.expneurol.2015.10.009","volume":"275","author":"CL Lin","year":"2016","unstructured":"Lin, C. L. et al. Amyloid-beta suppresses AMP-activated protein kinase (AMPK) signaling and contributes to alpha-synuclein-induced cytotoxicity. Exp. Neurol. 275, 84\u201398 (2016).","journal-title":"Exp. Neurol."},{"key":"2141_CR296","doi-asserted-by":"publisher","first-page":"113043","DOI":"10.1016\/j.bbr.2020.113043","volume":"400","author":"M Chen","year":"2021","unstructured":"Chen, M. et al. AMPK: a bridge between diabetes mellitus and Alzheimer\u2019s disease. Behav. Brain Res. 400, 113043 (2021).","journal-title":"Behav. Brain Res."},{"key":"2141_CR297","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.2174\/1567205013666160401114751","volume":"13","author":"L Qin","year":"2016","unstructured":"Qin, L., Chong, T., Rodriguez, R. & Pugazhenthi, S. Glucagon-Like Peptide-1-Mediated modulation of inflammatory pathways in the diabetic brain: relevance to Alzheimer\u2019s Disease. Curr. Alzheimer Res 13, 1346\u20131355 (2016).","journal-title":"Curr. Alzheimer Res"},{"key":"2141_CR298","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.nlm.2010.02.002","volume":"93","author":"EC McNay","year":"2010","unstructured":"McNay, E. C. et al. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol. Learn. Mem. 93, 546\u2013553 (2010).","journal-title":"Neurobiol. Learn. Mem."},{"key":"2141_CR299","doi-asserted-by":"publisher","first-page":"e21594","DOI":"10.1371\/journal.pone.0021594","volume":"6","author":"M Heni","year":"2011","unstructured":"Heni, M. et al. Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS ONE 6, e21594 (2011).","journal-title":"PLoS ONE"},{"key":"2141_CR300","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","volume":"560","author":"BD Hopkins","year":"2018","unstructured":"Hopkins, B. D. et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560, 499\u2013503 (2018).","journal-title":"Nature"},{"key":"2141_CR301","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"L Yang","year":"2018","unstructured":"Yang, L., Wang, H., Liu, L. & Xie, A. The role of Insulin\/IGF-1\/PI3K\/Akt\/GSK3beta Signaling in Parkinson\u2019s disease dementia. Front. Neurosci. 12, 73 (2018).","journal-title":"Front. Neurosci."},{"key":"2141_CR302","doi-asserted-by":"publisher","first-page":"18227","DOI":"10.1523\/JNEUROSCI.3266-12.2012","volume":"32","author":"WJ Jagust","year":"2012","unstructured":"Jagust, W. J. & Landau, S. M. Alzheimer\u2019s Disease Neuroimaging, I. Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging. J. Neurosci. 32, 18227\u201318233 (2012).","journal-title":"J. Neurosci."},{"key":"2141_CR303","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-150348","volume":"48","author":"JT Keeney","year":"2015","unstructured":"Keeney, J. T., Ibrahimi, S. & Zhao, L. Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer\u2019s disease prevention and early intervention. J. Alzheimers Dis. 48, 411\u2013424 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"2141_CR304","doi-asserted-by":"publisher","first-page":"13653","DOI":"10.1073\/pnas.222538099","volume":"99","author":"P Onyango","year":"2002","unstructured":"Onyango, P. et al. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl Acad. Sci. USA 99, 13653\u201313658 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR305","doi-asserted-by":"crossref","unstructured":"Lee, J. et al. SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer\u2019s disease. Aging Cell. 17, e12679 (2018).","DOI":"10.1111\/acel.12679"},{"key":"2141_CR306","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","volume":"100","author":"F Yin","year":"2016","unstructured":"Yin, F., Sancheti, H., Patil, I. & Cadenas, E. Energy metabolism and inflammation in brain aging and Alzheimer\u2019s disease. Free Radic. Biol. Med. 100, 108\u2013122 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"2141_CR307","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen, D. V., Hanson, J. E. & Sheng, M. Microglia in Alzheimer\u2019s disease. J. Cell Biol. 217, 459\u2013472 (2018).","journal-title":"J. Cell Biol."},{"key":"2141_CR308","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/ars.2020.8070","volume":"34","author":"Y Mi","year":"2021","unstructured":"Mi, Y., Qi, G., Brinton, R. D. & Yin, F. Mitochondria-targeted therapeutics for Alzheimer\u2019s disease: the good, the bad, the potential. Antioxid. Redox Signal. 34, 611\u2013630 (2021).","journal-title":"Antioxid. Redox Signal."},{"key":"2141_CR309","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s00259-016-3417-2","volume":"43","author":"C Liguori","year":"2016","unstructured":"Liguori, C. et al. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer\u2019s disease. Eur. J. Nucl. Med. Mol. Imaging 43, 2040\u20132049 (2016).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2141_CR310","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","volume":"19","author":"T Ashleigh","year":"2023","unstructured":"Ashleigh, T., Swerdlow, R. H. & Beal, M. F. The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis. Alzheimers Dement 19, 333\u2013342 (2023).","journal-title":"Alzheimers Dement"},{"key":"2141_CR311","doi-asserted-by":"crossref","unstructured":"Chausse, B. et al. Distinct metabolic patterns during microglial remodeling by oleate and palmitate. Biosci. Rep. 39, BSR20190072 (2019).","DOI":"10.1042\/BSR20190072"},{"key":"2141_CR312","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fendo.2019.00294","volume":"10","author":"G Vial","year":"2019","unstructured":"Vial, G., Detaille, D. & Guigas, B. Role of Mitochondria in the Mechanism(s) of Action of Metformin. Front. Endocrinol. 10, 294 (2019).","journal-title":"Front. Endocrinol."},{"key":"2141_CR313","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbabio.2006.03.010","volume":"1757","author":"J Rydstrom","year":"2006","unstructured":"Rydstrom, J. Mitochondrial NADPH, transhydrogenase and disease. Biochim. Biophys. Acta 1757, 721\u2013726 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"2141_CR314","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/acel.12216","volume":"13","author":"D Ghosh","year":"2014","unstructured":"Ghosh, D., Levault, K. R. & Brewer, G. J. Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons. Aging Cell 13, 631\u2013640 (2014).","journal-title":"Aging Cell"},{"key":"2141_CR315","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1021\/bi027370f","volume":"42","author":"AC Nulton-Persson","year":"2003","unstructured":"Nulton-Persson, A. C., Starke, D. W., Mieyal, J. J. & Szweda, L. I. Reversible inactivation of alpha-ketoglutarate dehydrogenase in response to alterations in the mitochondrial glutathione status. Biochemistry 42, 4235\u20134242 (2003).","journal-title":"Biochemistry"},{"key":"2141_CR316","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2007.12.007","volume":"30","author":"T Reed","year":"2008","unstructured":"Reed, T. et al. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer\u2019s disease. Neurobiol. Dis. 30, 107\u2013120 (2008).","journal-title":"Neurobiol. Dis."},{"key":"2141_CR317","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2015.07.008","volume":"22","author":"AG Nickel","year":"2015","unstructured":"Nickel, A. G. et al. Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure. Cell Metab. 22, 472\u2013484 (2015).","journal-title":"Cell Metab."},{"key":"2141_CR318","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12264-013-1424-x","volume":"30","author":"DJ Bonda","year":"2014","unstructured":"Bonda, D. J. et al. Neuronal failure in Alzheimer\u2019s disease: a view through the oxidative stress looking-glass. Neurosci. Bull. 30, 243\u2013252 (2014).","journal-title":"Neurosci. Bull."},{"key":"2141_CR319","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","volume":"1842","author":"DA Butterfield","year":"2014","unstructured":"Butterfield, D. A., Di Domenico, F. & Barone, E. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim. Biophys. Acta 1842, 1693\u20131706 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"2141_CR320","doi-asserted-by":"crossref","unstructured":"Zhao, Y. et al. Abeta and Tau regulate microglia metabolism via exosomes in Alzheimer\u2019s disease. Biomedicines. 10, 1800 (2022).","DOI":"10.3390\/biomedicines10081800"},{"key":"2141_CR321","doi-asserted-by":"publisher","first-page":"746631","DOI":"10.3389\/fncel.2021.746631","volume":"15","author":"KKM Fernando","year":"2021","unstructured":"Fernando, K. K. M. & Wijayasinghe, Y. S. Sirtuins as potential therapeutic targets for mitigating neuroinflammation associated with Alzheimer\u2019s disease. Front. Cell. Neurosci. 15, 746631 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"2141_CR322","doi-asserted-by":"crossref","unstructured":"Cianciulli, A. et al. Microglia mediated neuroinflammation: focus on PI3K modulation. Biomolecules. 10, 137 (2020).","DOI":"10.3390\/biom10010137"},{"key":"2141_CR323","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s12192-021-01231-3","volume":"26","author":"E Razani","year":"2021","unstructured":"Razani, E. et al. The PI3K\/Akt signaling axis in Alzheimer\u2019s disease: a valuable target to stimulate or suppress? Cell Stress Chaperones 26, 871\u2013887 (2021).","journal-title":"Cell Stress Chaperones"},{"key":"2141_CR324","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnmol.2018.00010","volume":"11","author":"TJ Tracey","year":"2018","unstructured":"Tracey, T. J., Steyn, F. J., Wolvetang, E. J. & Ngo, S. T. Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease. Front. Mol. Neurosci. 11, 10 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"2141_CR325","doi-asserted-by":"publisher","first-page":"101648","DOI":"10.1016\/j.redox.2020.101648","volume":"36","author":"G Ates","year":"2020","unstructured":"Ates, G., Goldberg, J., Currais, A. & Maher, P. CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer\u2019s disease. Redox Biol. 36, 101648 (2020).","journal-title":"Redox Biol."},{"key":"2141_CR326","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13195-017-0277-3","volume":"9","author":"D Daugherty","year":"2017","unstructured":"Daugherty, D. et al. A novel Alzheimer\u2019s disease drug candidate targeting inflammation and fatty acid metabolism. Alzheimers Res. Ther. 9, 50 (2017).","journal-title":"Alzheimers Res. Ther."},{"key":"2141_CR327","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuint.2017.03.018","volume":"109","author":"P Schonfeld","year":"2017","unstructured":"Schonfeld, P. & Reiser, G. Brain energy metabolism spurns fatty acids as fuel due to their inherent mitotoxicity and potential capacity to unleash neurodegeneration. Neurochem. Int. 109, 68\u201377 (2017).","journal-title":"Neurochem. Int."},{"key":"2141_CR328","doi-asserted-by":"publisher","first-page":"105050","DOI":"10.1016\/j.neuint.2021.105050","volume":"148","author":"P Schonfeld","year":"2021","unstructured":"Schonfeld, P. & Reiser, G. How the brain fights fatty acids\u2019 toxicity. Neurochem. Int. 148, 105050 (2021).","journal-title":"Neurochem. Int."},{"key":"2141_CR329","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JAD-190408","volume":"71","author":"Y Dong","year":"2019","unstructured":"Dong, Y. & Brewer, G. J. Global metabolic shifts in age and Alzheimer\u2019s disease mouse brains Pivot at NAD+\/NADH Redox Sites. J. Alzheimers Dis. 71, 119\u2013140 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"2141_CR330","doi-asserted-by":"publisher","first-page":"E756","DOI":"10.1152\/ajpendo.00362.2014","volume":"308","author":"MI Malandrino","year":"2015","unstructured":"Malandrino, M. I. et al. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. Am. J. Physiol. Endocrinol. Metab. 308, E756\u2013E769 (2015).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2141_CR331","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00125-014-3173-4","volume":"57","author":"D Namgaladze","year":"2014","unstructured":"Namgaladze, D. et al. Inhibition of macrophage fatty acid beta-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses. Diabetologia 57, 1067\u20131077 (2014).","journal-title":"Diabetologia"},{"key":"2141_CR332","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","volume":"177","author":"MS Ioannou","year":"2019","unstructured":"Ioannou, M. S. et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell 177, 1522\u20131535.e1514 (2019).","journal-title":"Cell"},{"key":"2141_CR333","doi-asserted-by":"publisher","first-page":"108572","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi, G. et al. ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism. Cell Rep. 34, 108572 (2021).","journal-title":"Cell Rep."},{"key":"2141_CR334","doi-asserted-by":"crossref","unstructured":"Moulton, M. J. et al. Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer\u2019s disease-associated genes. Proc. Natl Acad. Sci. USA 118, e2112095118 (2021).","DOI":"10.1073\/pnas.2112095118"},{"key":"2141_CR335","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","volume":"289","author":"JC Bruning","year":"2000","unstructured":"Bruning, J. C. et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122\u20132125 (2000).","journal-title":"Science"},{"key":"2141_CR336","first-page":"187","volume":"580","author":"R Mauerer","year":"2009","unstructured":"Mauerer, R., Walczak, Y. & Langmann, T. Comprehensive mRNA profiling of lipid-related genes in microglia and macrophages using taqman arrays. Methods Mol. Biol. 580, 187\u2013201 (2009).","journal-title":"Methods Mol. Biol."},{"key":"2141_CR337","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnins.2018.00612","volume":"12","author":"FN Emamzadeh","year":"2018","unstructured":"Emamzadeh, F. N. & Surguchov, A. Parkinson\u2019s disease: biomarkers, treatment, and risk factors. Front. Neurosci. 12, 612 (2018).","journal-title":"Front. Neurosci."},{"key":"2141_CR338","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.14336\/AD.2021.0422","volume":"12","author":"M Liu","year":"2021","unstructured":"Liu, M. et al. Potential crosstalk between parkinson\u2019s disease and energy metabolism. Aging Dis. 12, 2003\u20132015 (2021).","journal-title":"Aging Dis."},{"key":"2141_CR339","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/cns.12264","volume":"20","author":"A Camilleri","year":"2014","unstructured":"Camilleri, A. & Vassallo, N. The centrality of mitochondria in the pathogenesis and treatment of Parkinson\u2019s disease. CNS Neurosci. Ther. 20, 591\u2013602 (2014).","journal-title":"CNS Neurosci. Ther."},{"key":"2141_CR340","doi-asserted-by":"publisher","first-page":"e1654","DOI":"10.1212\/WNL.0000000000005475","volume":"90","author":"G Pagano","year":"2018","unstructured":"Pagano, G. et al. Diabetes mellitus and Parkinson disease. Neurology 90, e1654\u2013e1662 (2018).","journal-title":"Neurology"},{"key":"2141_CR341","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2013.11.020","volume":"19","author":"MS Goyal","year":"2014","unstructured":"Goyal, M. S. et al. Aerobic glycolysis in the human brain is associated with development and neotenous gene expression. Cell Metab. 19, 49\u201357 (2014).","journal-title":"Cell Metab."},{"key":"2141_CR342","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/npp.2012.255","volume":"38","author":"P Edison","year":"2013","unstructured":"Edison, P. et al. Microglia, amyloid, and glucose metabolism in Parkinson\u2019s disease with and without dementia. Neuropsychopharmacology 38, 938\u2013949 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"2141_CR343","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI129987","volume":"129","author":"R Cai","year":"2019","unstructured":"Cai, R. et al. Enhancing glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases. J. Clin. Investig. 129, 4539\u20134549 (2019).","journal-title":"J. Clin. Investig."},{"key":"2141_CR344","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105290","volume":"152","author":"S Yang","year":"2021","unstructured":"Yang, S. et al. Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system. Neurobiol. Dis. 152, 105290 (2021).","journal-title":"Neurobiol. Dis."},{"key":"2141_CR345","doi-asserted-by":"crossref","unstructured":"Pajares, M. et al. Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells. 9, 1687 (2020).","DOI":"10.3390\/cells9071687"},{"key":"2141_CR346","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ijbiomac.2019.02.029","volume":"129","author":"H Qiao","year":"2019","unstructured":"Qiao, H. et al. Alpha-synuclein induces microglial migration via PKM2-dependent glycolysis. Int. J. Biol. Macromol. 129, 601\u2013607 (2019).","journal-title":"Int. J. Biol. Macromol."},{"key":"2141_CR347","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02484-0","volume":"19","author":"J Lu","year":"2022","unstructured":"Lu, J. et al. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of alpha-synuclein in a mouse model of Parkinson\u2019s disease. J. Neuroinflamm. 19, 113 (2022).","journal-title":"J. Neuroinflamm."},{"key":"2141_CR348","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2016.10.018","volume":"60","author":"R Gu","year":"2017","unstructured":"Gu, R. et al. Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming. Brain. Behav. Immun. 60, 206\u2013219 (2017).","journal-title":"Brain. Behav. Immun."},{"key":"2141_CR349","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113087","volume":"142","author":"J Li","year":"2024","unstructured":"Li, J. et al. NR1H4 ameliorates Parkinson\u2019s disease via inhibiting astrocyte activation and neuroinflammation in a CEBPbeta\/NF-kappaB dependent manner. Int. Immunopharmacol. 142, 113087 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"2141_CR350","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj, A. & Galea, I. The blood-brain barrier in systemic inflammation. Brain. Behav. Immun. 60, 1\u201312 (2017).","journal-title":"Brain. Behav. Immun."},{"key":"2141_CR351","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.nbd.2009.11.018","volume":"37","author":"AL De Lella Ezcurra","year":"2010","unstructured":"De Lella Ezcurra, A. L. et al. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia\/macrophage activation. Neurobiol. Dis. 37, 630\u2013640 (2010).","journal-title":"Neurobiol. Dis."},{"key":"2141_CR352","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03210-8","volume":"21","author":"H Hong","year":"2024","unstructured":"Hong, H. et al. Suppression of the JAK\/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson\u2019s disease. J. Neuroinflamm. 21, 216 (2024).","journal-title":"J. Neuroinflamm."},{"key":"2141_CR353","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2019.03.015","volume":"703","author":"S Burks","year":"2019","unstructured":"Burks, S. et al. Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson\u2019s disease mouse model: endothelial and microglial effects. Neurosci. Lett. 703, 86\u201395 (2019).","journal-title":"Neurosci. Lett."},{"key":"2141_CR354","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1007\/s12035-016-9906-2","volume":"54","author":"A Anandhan","year":"2017","unstructured":"Anandhan, A. et al. Glucose metabolism and AMPK signaling regulate dopaminergic cell death induced by Gene (alpha-Synuclein)-Environment (Paraquat) Interactions. Mol. Neurobiol. 54, 3825\u20133842 (2017).","journal-title":"Mol. Neurobiol."},{"key":"2141_CR355","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41531-017-0014-4","volume":"3","author":"S Sakaue","year":"2017","unstructured":"Sakaue, S. et al. Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism? NPJ Parkinsons Dis. 3, 13 (2017).","journal-title":"NPJ Parkinsons Dis."},{"key":"2141_CR356","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1002\/jnr.22357","volume":"88","author":"JC Corona","year":"2010","unstructured":"Corona, J. C., Gimenez-Cassina, A., Lim, F. & Diaz-Nido, J. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson\u2019s disease. J. Neurosci. Res. 88, 1943\u20131950 (2010).","journal-title":"J. Neurosci. Res."},{"key":"2141_CR357","doi-asserted-by":"publisher","DOI":"10.1038\/srep25344","volume":"6","author":"CT Hong","year":"2016","unstructured":"Hong, C. T., Chau, K. Y. & Schapira, A. H. Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models. Sci. Rep. 6, 25344 (2016).","journal-title":"Sci. Rep."},{"key":"2141_CR358","doi-asserted-by":"crossref","unstructured":"Heremans, I. P. et al. Parkinson\u2019s disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite. Proc. Natl. Acad. Sci. USA. 119, e2111338119 (2022).","DOI":"10.1073\/pnas.2111338119"},{"key":"2141_CR359","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lfs.2016.06.024","volume":"158","author":"R Libro","year":"2016","unstructured":"Libro, R., Bramanti, P. & Mazzon, E. The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sci. 158, 78\u201388 (2016).","journal-title":"Life Sci."},{"key":"2141_CR360","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nrm2717","volume":"10","author":"S Angers","year":"2009","unstructured":"Angers, S. & Moon, R. T. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 10, 468\u2013477 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2141_CR361","doi-asserted-by":"publisher","first-page":"e0134087","DOI":"10.1371\/journal.pone.0134087","volume":"10","author":"X Su","year":"2015","unstructured":"Su, X. et al. PGC-1alpha Promoter Methylation in Parkinson\u2019s Disease. PLoS ONE 10, e0134087 (2015).","journal-title":"PLoS ONE"},{"key":"2141_CR362","doi-asserted-by":"publisher","first-page":"105344","DOI":"10.1016\/j.neuint.2022.105344","volume":"157","author":"MZ Ali","year":"2022","unstructured":"Ali, M. Z. & Dholaniya, P. S. Oxidative phosphorylation mediated pathogenesis of Parkinson\u2019s disease and its implication via Akt signaling. Neurochem. Int. 157, 105344 (2022).","journal-title":"Neurochem. Int."},{"key":"2141_CR363","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","volume":"42","author":"ME Johnson","year":"2019","unstructured":"Johnson, M. E. et al. Triggers, facilitators, and aggravators: redefining parkinson\u2019s disease pathogenesis. Trends Neurosci. 42, 4\u201313 (2019).","journal-title":"Trends Neurosci."},{"key":"2141_CR364","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-016-0065-1","volume":"5","author":"B Wang","year":"2016","unstructured":"Wang, B., Abraham, N., Gao, G. & Yang, Q. Dysregulation of autophagy and mitochondrial function in Parkinson\u2019s disease. Transl. Neurodegener. 5, 19 (2016).","journal-title":"Transl. Neurodegener."},{"key":"2141_CR365","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.927682","volume":"16","author":"F Zhang","year":"2022","unstructured":"Zhang, F. et al. The roles of ATP13A2 gene mutations leading to abnormal aggregation of alpha-Synuclein in Parkinson\u2019s disease. Front. Cell. Neurosci. 16, 927682 (2022).","journal-title":"Front. Cell. Neurosci."},{"key":"2141_CR366","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mito.2019.09.010","volume":"50","author":"L Rani","year":"2020","unstructured":"Rani, L. & Mondal, A. C. Emerging concepts of mitochondrial dysfunction in Parkinson\u2019s disease progression: pathogenic and therapeutic implications. Mitochondrion 50, 25\u201334 (2020).","journal-title":"Mitochondrion"},{"key":"2141_CR367","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tins.2021.10.014","volume":"45","author":"E Merlini","year":"2022","unstructured":"Merlini, E., Coleman, M. P. & Loreto, A. Mitochondrial dysfunction as a trigger of programmed axon death. Trends Neurosci. 45, 53\u201363 (2022).","journal-title":"Trends Neurosci."},{"key":"2141_CR368","doi-asserted-by":"publisher","first-page":"101578","DOI":"10.1016\/j.arr.2022.101578","volume":"76","author":"A Manini","year":"2022","unstructured":"Manini, A. et al. Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction: a trembling balance. Ageing Res. Rev. 76, 101578 (2022).","journal-title":"Ageing Res. Rev."},{"key":"2141_CR369","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L. & Kukreti, S. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules. 24, 1583 (2019).","DOI":"10.3390\/molecules24081583"},{"key":"2141_CR370","doi-asserted-by":"crossref","unstructured":"Behl, T. et al. Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: pathophysiological and therapeutic perspectives. Int. J. Mol. Sci. 22, 1413 (2021).","DOI":"10.3390\/ijms22031413"},{"key":"2141_CR371","doi-asserted-by":"crossref","unstructured":"Bhattacharya, T. et al. Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Materials (Basel). 15, 804 (2022).","DOI":"10.3390\/ma15030804"},{"key":"2141_CR372","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","volume":"48","author":"S Moradi Vastegani","year":"2023","unstructured":"Moradi Vastegani, S. et al. Mitochondrial dysfunction and parkinson\u2019s disease: pathogenesis and therapeutic strategies. Neurochem. Res. 48, 2285\u20132308 (2023).","journal-title":"Neurochem. Res."},{"key":"2141_CR373","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04422-2","volume":"9","author":"MHR Ludtmann","year":"2018","unstructured":"Ludtmann, M. H. R. et al. alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease. Nat. Commun. 9, 2293 (2018).","journal-title":"Nat. Commun."},{"key":"2141_CR374","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/brain\/awad388","volume":"147","author":"Y Chu","year":"2024","unstructured":"Chu, Y. et al. Nigrostriatal tau pathology in parkinsonism and Parkinson\u2019s disease. Brain 147, 444\u2013457 (2024).","journal-title":"Brain"},{"key":"2141_CR375","doi-asserted-by":"publisher","first-page":"110657","DOI":"10.1016\/j.isci.2024.110657","volume":"27","author":"V Secco","year":"2024","unstructured":"Secco, V. et al. HSPB6: a lipid-dependent molecular chaperone inhibits alpha-synuclein aggregation. iScience 27, 110657 (2024).","journal-title":"iScience"},{"key":"2141_CR376","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12035-020-02128-5","volume":"58","author":"W Yang","year":"2021","unstructured":"Yang, W. et al. Molecular regulatory mechanism and toxicology of neurodegenerative processes in MPTP\/Probenecid-induced progressive parkinson\u2019s disease mice model revealed by transcriptome. Mol. Neurobiol. 58, 603\u2013616 (2021).","journal-title":"Mol. Neurobiol."},{"key":"2141_CR377","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1021\/acs.chemrestox.0c00522","volume":"34","author":"J Innos","year":"2021","unstructured":"Innos, J. & Hickey, M. A. Using rotenone to model Parkinson\u2019s disease in mice: a review of the role of pharmacokinetics. Chem. Res. Toxicol. 34, 1223\u20131239 (2021).","journal-title":"Chem. Res. Toxicol."},{"key":"2141_CR378","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.drudis.2018.08.001","volume":"23","author":"K Kalani","year":"2018","unstructured":"Kalani, K., Yan, S. F. & Yan, S. S. Mitochondrial permeability transition pore: a potential drug target for neurodegeneration. Drug Discov. Today 23, 1983\u20131989 (2018).","journal-title":"Drug Discov. Today"},{"key":"2141_CR379","doi-asserted-by":"publisher","first-page":"114811","DOI":"10.1016\/j.bbr.2023.114811","volume":"459","author":"MF Yao","year":"2024","unstructured":"Yao, M. F. et al. Mitochondrial homeostasis regulation: a promising therapeutic target for Parkinson\u2019s disease. Behav. Brain Res. 459, 114811 (2024).","journal-title":"Behav. Brain Res."},{"key":"2141_CR380","doi-asserted-by":"crossref","unstructured":"Piccinin, E. et al. PGC-1s in the spotlight with Parkinson\u2019s disease. Int. J. Mol. Sci. 22, 3487 (2021).","DOI":"10.3390\/ijms22073487"},{"key":"2141_CR381","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.arr.2018.03.006","volume":"44","author":"S Lin","year":"2018","unstructured":"Lin, S. et al. Sirtuins in mitochondrial stress: indispensable helpers behind the scenes. Ageing Res. Rev. 44, 22\u201332 (2018).","journal-title":"Ageing Res. Rev."},{"key":"2141_CR382","doi-asserted-by":"publisher","first-page":"106014","DOI":"10.1016\/j.phrs.2021.106014","volume":"175","author":"MP Jalgaonkar","year":"2022","unstructured":"Jalgaonkar, M. P., Parmar, U. M., Kulkarni, Y. A. & Oza, M. J. SIRT1-FOXOs activity regulates diabetic complications. Pharmacol. Res. 175, 106014 (2022).","journal-title":"Pharmacol. Res."},{"key":"2141_CR383","doi-asserted-by":"crossref","unstructured":"Calabrese, V. et al. Hydrogen Sulfide and carnosine: modulation of oxidative stress and inflammation in kidney and brain axis. Antioxidants 9, 1303 (2020).","DOI":"10.3390\/antiox9121303"},{"key":"2141_CR384","doi-asserted-by":"crossref","unstructured":"Jhuo, C. F. et al. Teaghrelin protects SH-SY5Y Cells against MPP(+)-Induced neurotoxicity through activation of AMPK\/SIRT1\/PGC-1alpha and ERK1\/2 Pathways. Nutrients 12, 3665 (2020).","DOI":"10.3390\/nu12123665"},{"key":"2141_CR385","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s11064-022-03560-w","volume":"47","author":"L He","year":"2022","unstructured":"He, L. et al. Mitochondrial Sirtuins in Parkinson\u2019s Disease. Neurochem. Res. 47, 1491\u20131502 (2022).","journal-title":"Neurochem. Res."},{"key":"2141_CR386","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ajpath.2014.10.022","volume":"185","author":"JG Hoekstra","year":"2015","unstructured":"Hoekstra, J. G. et al. Astrocytic dynamin-like protein 1 regulates neuronal protection against excitotoxicity in Parkinson disease. Am. J. Pathol. 185, 536\u2013549 (2015).","journal-title":"Am. J. Pathol."},{"key":"2141_CR387","unstructured":"Liao, S. C. et al. CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism. Preprint at http:\/\/biorxiv.org\/content\/early\/2024\/09\/01\/2024.08.30.610586 (2024)."},{"key":"2141_CR388","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00401-020-02177-z","volume":"141","author":"S Fanning","year":"2021","unstructured":"Fanning, S., Selkoe, D. & Dettmer, U. Vesicle trafficking and lipid metabolism in synucleinopathy. Acta Neuropathol. 141, 491\u2013510 (2021).","journal-title":"Acta Neuropathol."},{"key":"2141_CR389","doi-asserted-by":"publisher","first-page":"788695","DOI":"10.3389\/fnmol.2021.788695","volume":"14","author":"RE Estes","year":"2021","unstructured":"Estes, R. E., Lin, B., Khera, A. & Davis, M. Y. Lipid metabolism influence on neurodegenerative disease progression: is the vehicle as important as the Cargo? Front. Mol. Neurosci. 14, 788695 (2021).","journal-title":"Mol. Neurosci."},{"key":"2141_CR390","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s11033-018-4551-7","volume":"46","author":"BA Jana","year":"2019","unstructured":"Jana, B. A. et al. Cytosolic lipid excess-induced mitochondrial dysfunction is the cause or effect of high fat diet-induced skeletal muscle insulin resistance: a molecular insight. Mol. Biol. Rep. 46, 957\u2013963 (2019).","journal-title":"Mol. Biol. Rep."},{"key":"2141_CR391","doi-asserted-by":"crossref","unstructured":"Sarchione, A., Marchand, A., Taymans, J. M. & Chartier-Harlin, M. C. Alpha-Synuclein and Lipids: the elephant in the room? Cells. 10, 2452 (2021).","DOI":"10.3390\/cells10092452"},{"key":"2141_CR392","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","volume":"18","author":"MV Lourenco","year":"2013","unstructured":"Lourenco, M. V. et al. TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s beta-amyloid oligomers in mice and monkeys. Cell Metab. 18, 831\u2013843 (2013).","journal-title":"Cell Metab."},{"key":"2141_CR393","doi-asserted-by":"publisher","first-page":"6420","DOI":"10.18632\/aging.202755","volume":"13","author":"D Stein","year":"2021","unstructured":"Stein, D. et al. Aging and pathological aging signatures of the brain: through the focusing lens of SIRT6. Aging 13, 6420\u20136441 (2021).","journal-title":"Aging"},{"key":"2141_CR394","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05542-w","volume":"14","author":"D Smirnov","year":"2023","unstructured":"Smirnov, D. et al. SIRT6 is a key regulator of mitochondrial function in the brain. Cell Death Dis. 14, 35 (2023).","journal-title":"Cell Death Dis."},{"key":"2141_CR395","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s13311-023-01382-4","volume":"20","author":"F Tang","year":"2023","unstructured":"Tang, F. et al. Inhibition of ACSL4 Alleviates Parkinsonism phenotypes by reduction of lipid reactive oxygen species. Neurotherapeutics 20, 1154\u20131166 (2023).","journal-title":"Neurotherapeutics"},{"key":"2141_CR396","doi-asserted-by":"crossref","unstructured":"Dong, C. et al. Plasma Metabolite Signature Classifies Male LRRK2 Parkinson\u2019s Disease Patients. Metabolites. 12, 149 (2022).","DOI":"10.3390\/metabo12020149"},{"key":"2141_CR397","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"M Barichella","year":"2019","unstructured":"Barichella, M. et al. Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism. Mov. Disord. 34, 396\u2013405 (2019).","journal-title":"Mov. Disord."},{"key":"2141_CR398","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41586-021-03185-z","volume":"591","author":"J Wie","year":"2021","unstructured":"Wie, J. et al. A growth-factor-activated lysosomal K(+) channel regulates Parkinson\u2019s pathology. Nature 591, 431\u2013437 (2021).","journal-title":"Nature"},{"key":"2141_CR399","doi-asserted-by":"crossref","unstructured":"Yamanaka, R., Shindo, Y. & Oka, K. Magnesium is a key player in neuronal maturation and neuropathology. Int. J. Mol. Sci. 20, 3439 (2019).","DOI":"10.3390\/ijms20143439"},{"key":"2141_CR400","doi-asserted-by":"publisher","first-page":"115271","DOI":"10.1016\/j.biopha.2023.115271","volume":"165","author":"Q Li","year":"2023","unstructured":"Li, Q. et al. Energy metabolism: a critical target of cardiovascular injury. Biomed. Pharmacother. 165, 115271 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"2141_CR401","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","volume":"5","author":"QG Karwi","year":"2018","unstructured":"Karwi, Q. G., Uddin, G. M., Ho, K. L. & Lopaschuk, G. D. Loss of metabolic flexibility in the failing heart. Front. Cardiovasc. Med. 5, 68 (2018).","journal-title":"Front. Cardiovasc. Med."},{"key":"2141_CR402","doi-asserted-by":"publisher","first-page":"e99239","DOI":"10.1172\/jci.insight.99239","volume":"3","author":"A Fukushima","year":"2018","unstructured":"Fukushima, A. et al. Acetylation contributes to hypertrophy-caused maturational delay of cardiac energy metabolism. JCI Insight. 3, e99239 (2018).","journal-title":"JCI Insight."},{"key":"2141_CR403","doi-asserted-by":"crossref","unstructured":"Tryphena, K. P. et al. Mitochondrial Complex I as a pathologic and therapeutic target for Parkinson\u2019s Disease. ACS Chem. Neurosci. 14, 1356\u20131368 (2023).","DOI":"10.1021\/acschemneuro.2c00819"},{"key":"2141_CR404","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1002\/ehf2.13634","volume":"8","author":"S Takahara","year":"2021","unstructured":"Takahara, S. et al. Chronic exogenous ketone supplementation blunts the decline of cardiac function in the failing heart. ESC Heart Fail 8, 5606\u20135612 (2021).","journal-title":"ESC Heart Fail"},{"key":"2141_CR405","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","volume":"139","author":"R Nielsen","year":"2019","unstructured":"Nielsen, R. et al. Cardiovascular effects of treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart failure patients. Circulation 139, 2129\u20132141 (2019).","journal-title":"Circulation"},{"key":"2141_CR406","doi-asserted-by":"publisher","first-page":"101119","DOI":"10.1016\/j.redox.2019.101119","volume":"23","author":"E Gianazza","year":"2019","unstructured":"Gianazza, E., Brioschi, M., Fernandez, A. M. & Banfi, C. Lipoxidation in cardiovascular diseases. Redox Biol. 23, 101119 (2019).","journal-title":"Redox Biol."},{"key":"2141_CR407","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.freeradbiomed.2016.08.030","volume":"99","author":"J Park","year":"2016","unstructured":"Park, J. et al. Peroxiredoxin 5 (Prx5) decreases LPS-induced microglial activation through regulation of Ca(2+)\/calcineurin-Drp1-dependent mitochondrial fission. Free Radic. Biol. Med. 99, 392\u2013404 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"2141_CR408","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2348","volume":"32","author":"YL Arancibia-Hernandez","year":"2022","unstructured":"Arancibia-Hernandez, Y. L., Aranda-Rivera, A. K., Cruz-Gregorio, A. & Pedraza-Chaverri, J. Antioxidant\/anti-inflammatory effect of Mg(2+) in coronavirus disease 2019 (COVID-19). Rev. Med. Virol. 32, e2348 (2022).","journal-title":"Rev. Med. Virol."},{"key":"2141_CR409","doi-asserted-by":"publisher","unstructured":"Roslan, A. et al. Slack K+ channels confer protection against myocardial ischemia\/reperfusion injury. Preprint at https:\/\/doi.org\/10.1093\/cvr\/cvae155 (2024).","DOI":"10.1093\/cvr\/cvae155"},{"key":"2141_CR410","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41591-020-1126-7","volume":"27","author":"T Becher","year":"2021","unstructured":"Becher, T. et al. Brown adipose tissue is associated with cardiometabolic health. Nat. Med. 27, 58\u201365 (2021).","journal-title":"Nat. Med."},{"key":"2141_CR411","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2019.05.005","volume":"30","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. A PRDM16-Driven metabolic signal from adipocytes regulates precursor cell fate. Cell Metab. 30, 174\u2013189.e175 (2019).","journal-title":"Cell Metab."},{"key":"2141_CR412","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jmri.25594","volume":"46","author":"BT Franssens","year":"2017","unstructured":"Franssens, B. T. et al. Relation between brown adipose tissue and measures of obesity and metabolic dysfunction in patients with cardiovascular disease. J. Magn. Reson. Imaging 46, 497\u2013504 (2017).","journal-title":"J. Magn. Reson. Imaging"},{"key":"2141_CR413","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvq376","volume":"90","author":"A Planavila","year":"2011","unstructured":"Planavila, A., Iglesias, R., Giralt, M. & Villarroya, F. Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc. Res. 90, 276\u2013284 (2011).","journal-title":"Cardiovasc. Res."},{"key":"2141_CR414","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s42255-022-00671-0","volume":"4","author":"L Shi","year":"2022","unstructured":"Shi, L. et al. Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and atherosclerosis in male mice. Nat. Metab. 4, 1573\u20131590 (2022).","journal-title":"Nat. Metab."},{"key":"2141_CR415","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/CIRCRESAHA.122.322337","volume":"133","author":"I Marti-Pamies","year":"2023","unstructured":"Marti-Pamies, I. et al. Brown adipose tissue and BMP3b decrease injury in cardiac ischemia-reperfusion. Circ. Res. 133, 353\u2013365 (2023).","journal-title":"Circ. Res."},{"key":"2141_CR416","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.cell.2024.03.030","volume":"187","author":"ARP Verkerke","year":"2024","unstructured":"Verkerke, A. R. P. et al. BCAA-nitrogen flux in brown fat controls metabolic health independent of thermogenesis. Cell 187, 2359\u20132374.e2318 (2024).","journal-title":"Cell"},{"key":"2141_CR417","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biochi.2021.01.015","volume":"184","author":"B Ahmad","year":"2021","unstructured":"Ahmad, B. et al. Brown\/Beige adipose tissues and the emerging role of their secretory factors in improving metabolic health: the batokines. Biochimie 184, 26\u201339 (2021).","journal-title":"Biochimie"},{"key":"2141_CR418","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.cmet.2016.08.002","volume":"24","author":"S Altshuler-Keylin","year":"2016","unstructured":"Altshuler-Keylin, S. et al. Beige adipocyte maintenance is regulated by autophagy-induced mitochondrial clearance. Cell Metab. 24, 402\u2013419 (2016).","journal-title":"Cell Metab."},{"key":"2141_CR419","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7420196","volume":"2019","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Thyroxine alleviates energy failure, prevents myocardial cell apoptosis, and protects against doxorubicin-induced cardiac injury and cardiac dysfunction via the LKB1\/AMPK\/mTOR Axis in Mice. Dis. Markers 2019, 7420196 (2019).","journal-title":"Dis. Markers"},{"key":"2141_CR420","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109487","volume":"120","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARalpha pathway. Biomed. Pharmacother. 120, 109487 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"2141_CR421","first-page":"3347","volume":"18","author":"L He","year":"2019","unstructured":"He, L. et al. Puerarin inhibits apoptosis and inflammation in myocardial cells via PPARalpha expression in rats with chronic heart failure. Exp. Ther. Med. 18, 3347\u20133356 (2019).","journal-title":"Exp. Ther. Med."},{"key":"2141_CR422","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1111\/bph.14781","volume":"176","author":"CC Hsieh","year":"2019","unstructured":"Hsieh, C. C. et al. Mitochondrial protection by simvastatin against angiotensin II-mediated heart failure. Br. J. Pharmacol. 176, 3791\u20133804 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"2141_CR423","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152845","volume":"61","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Epigallocatechin gallate prevents mitochondrial impairment and cell apoptosis by regulating miR-30a\/p53 axis. Phytomedicine 61, 152845 (2019).","journal-title":"Phytomedicine"},{"key":"2141_CR424","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.molmed.2019.05.010","volume":"25","author":"B Aryal","year":"2019","unstructured":"Aryal, B., Price, N. L., Suarez, Y. & Fernandez-Hernando, C. ANGPTL4 in metabolic and cardiovascular disease. Trends Mol. Med. 25, 723\u2013734 (2019).","journal-title":"Trends Mol. Med."},{"key":"2141_CR425","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1002\/jcp.27329","volume":"234","author":"Y Zheng","year":"2019","unstructured":"Zheng, Y. et al. The novel relationship between Sirt3 and autophagy in myocardial ischemia-reperfusion. J. Cell. Physiol. 234, 5488\u20135495 (2019).","journal-title":"J. Cell. Physiol."},{"key":"2141_CR426","doi-asserted-by":"publisher","first-page":"850340","DOI":"10.3389\/fcvm.2022.850340","volume":"9","author":"K Murugasamy","year":"2022","unstructured":"Murugasamy, K., Munjal, A. & Sundaresan, N. R. Emerging roles of SIRT3 in cardiac metabolism. Front. Cardiovasc. Med. 9, 850340 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"2141_CR427","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41401-020-0490-7","volume":"42","author":"S Song","year":"2021","unstructured":"Song, S. et al. Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation. Acta Pharmacol. Sin. 42, 230\u2013241 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"2141_CR428","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13105-018-0648-7","volume":"75","author":"J Diao","year":"2019","unstructured":"Diao, J. et al. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats. J. Physiol. Biochem. 75, 39\u201351 (2019).","journal-title":"J. Physiol. Biochem."},{"key":"2141_CR429","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/FJC.0000000000000640","volume":"73","author":"XW Liu","year":"2019","unstructured":"Liu, X. W. et al. Panax notoginseng saponins attenuate myocardial ischemia-reperfusion injury through the HIF-1alpha\/BNIP3 pathway of autophagy. J. Cardiovasc. Pharmacol. 73, 92\u201399 (2019).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2141_CR430","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jacbts.2019.02.003","volume":"4","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Malonyl CoA decarboxylase inhibition improves cardiac function Post-Myocardial infarction. JACC Basic Transl. Sci. 4, 385\u2013400 (2019).","journal-title":"JACC Basic Transl. Sci."},{"key":"2141_CR431","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G. D. et al. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90, 207\u2013258 (2010).","journal-title":"Physiol. Rev."},{"key":"2141_CR432","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","volume":"1813","author":"JS Jaswal","year":"2011","unstructured":"Jaswal, J. S. et al. Targeting fatty acid and carbohydrate oxidation\u2013a novel therapeutic intervention in the ischemic and failing heart. Biochim. Biophys. Acta 1813, 1333\u20131350 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2141_CR433","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12265-023-10432-3","volume":"17","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Cardiac metabolism, reprogramming, and diseases. J. Cardiovasc. Transl. Res. 17, 71\u201384 (2024).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"2141_CR434","doi-asserted-by":"publisher","first-page":"3712500","DOI":"10.1155\/2022\/3712500","volume":"2022","author":"J Zhao","year":"2022","unstructured":"Zhao, J. et al. An energy metabolism study on the efficacy of naoxintong capsules against myocardial infarction in a rat model. Oxid. Med. Cell. Longev. 2022, 3712500 (2022).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2141_CR435","doi-asserted-by":"publisher","first-page":"8430733","DOI":"10.1155\/2022\/8430733","volume":"2022","author":"X Wang","year":"2022","unstructured":"Wang, X., Yan, K., Wen, C. & Wang, J. Simvastatin combined with resistance training improves outcomes in patients with chronic heart failure by modulating mitochondrial membrane potential and the Janus Kinase\/Signal transducer and activator of Transcription 3 signaling pathways. Cardiovasc. Ther. 2022, 8430733 (2022).","journal-title":"Cardiovasc. Ther."},{"key":"2141_CR436","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108599","volume":"112","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs\/mTOR-dependent autophagy pathway. Biomed. Pharmacother. 112, 108599 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"2141_CR437","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cmet.2018.10.013","volume":"29","author":"MD Neinast","year":"2019","unstructured":"Neinast, M. D. et al. Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab. 29, 417\u2013429.e414 (2019).","journal-title":"Cell Metab."},{"key":"2141_CR438","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7670854","volume":"2019","author":"LM Yu","year":"2019","unstructured":"Yu, L. M. et al. Naringenin ATTENUATES MYOCARDIAL ISCHEMIA-REPERFUSION INJUry via cGMP-PKGIalpha SIGNALING AND IN VIVO AND IN VITRO STUdies. Oxid. Med. Cell. Longev. 2019, 7670854 (2019).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2141_CR439","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1039\/C9FO00001A","volume":"10","author":"LM Yu","year":"2019","unstructured":"Yu, L. M. et al. Naringenin improves mitochondrial function and reduces cardiac damage following ischemia-reperfusion injury: the role of the AMPK-SIRT3 signaling pathway. Food Funct. 10, 2752\u20132765 (2019).","journal-title":"Food Funct."},{"key":"2141_CR440","first-page":"169","volume":"17","author":"R Gao","year":"2024","unstructured":"Gao, R. et al. Remote Ischemic conditioning mediates cardio-protection after myocardial ischemia\/reperfusion injury by reduCing 4-HNE levels and regulating autophagy via the ALDH2\/SIRT3\/HIF1alpha signaling pathway. J. Cardiovasc. Transl. Res. 17, 169\u2013182 (2024).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"2141_CR441","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/HJH.0000000000001651","volume":"36","author":"L Castiglioni","year":"2018","unstructured":"Castiglioni, L. et al. Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection. J. Hypertens. 36, 1129\u20131146 (2018).","journal-title":"J. Hypertens."},{"key":"2141_CR442","doi-asserted-by":"publisher","first-page":"H839","DOI":"10.1152\/ajpheart.00409.2017","volume":"314","author":"DS Matasic","year":"2018","unstructured":"Matasic, D. S., Brenner, C. & London, B. Emerging potential benefits of modulating NAD(+) metabolism in cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 314, H839\u2013H852 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2141_CR443","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/dna.2019.5097","volume":"39","author":"W Li","year":"2020","unstructured":"Li, W. et al. Ferroptosis is involved in diabetes myocardial ischemia\/reperfusion injury through endoplasmic reticulum stress. DNA Cell Biol. 39, 210\u2013225 (2020).","journal-title":"DNA Cell Biol."},{"key":"2141_CR444","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1172\/JCI126428","volume":"129","author":"W Li","year":"2019","unstructured":"Li, W. et al. Ferroptotic cell death and TLR4\/Trif signaling initiate neutrophil recruitment after heart transplantation. J. Clin. Investig. 129, 2293\u20132304 (2019).","journal-title":"J. Clin. Investig."},{"key":"2141_CR445","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2020.10.307","volume":"162","author":"LJ Tang","year":"2021","unstructured":"Tang, L. J. et al. Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53\/TfR1 pathway in the rat hearts after ischemia\/reperfusion. Free Radic. Biol. Med. 162, 339\u2013352 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"2141_CR446","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12933-018-0790-0","volume":"17","author":"A Durak","year":"2018","unstructured":"Durak, A. et al. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats. Cardiovasc. Diabetol. 17, 144 (2018).","journal-title":"Cardiovasc. Diabetol."},{"key":"2141_CR447","doi-asserted-by":"publisher","first-page":"E1046","DOI":"10.1152\/ajpendo.00097.2018","volume":"315","author":"N Fillmore","year":"2018","unstructured":"Fillmore, N. et al. Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart. Am. J. Physiol. Endocrinol. Metab. 315, E1046\u2013E1052 (2018).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2141_CR448","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10557-012-6376-2","volume":"26","author":"SJ Somers","year":"2012","unstructured":"Somers, S. J. et al. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc. Drugs Ther. 26, 227\u2013237 (2012).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"2141_CR449","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.02.003","volume":"228","author":"MA Frias","year":"2013","unstructured":"Frias, M. A. et al. HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity. Atherosclerosis 228, 110\u2013116 (2013).","journal-title":"Atherosclerosis"},{"key":"2141_CR450","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer, S. The failing heart\u2013an engine out of fuel. N. Engl. J. Med. 356, 1140\u20131151 (2007).","journal-title":"N. Engl. J. Med."},{"key":"2141_CR451","volume":"2018","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Multitarget effects of Danqi Pill on global gene expression changes in Myocardial Ischemia. Int. J. Genom. 2018, 9469670 (2018).","journal-title":"Int. J. Genom."},{"key":"2141_CR452","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","volume":"109","author":"LR Peterson","year":"2004","unstructured":"Peterson, L. R. et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109, 2191\u20132196 (2004).","journal-title":"Circulation"},{"key":"2141_CR453","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jchf.2017.07.009","volume":"5","author":"DE Lanfear","year":"2017","unstructured":"Lanfear, D. E. et al. Targeted metabolomic profiling of plasma and survival in heart failure patients. JACC Heart Fail 5, 823\u2013832 (2017).","journal-title":"JACC Heart Fail"},{"key":"2141_CR454","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten, S. M., Violante, S., Ventura, F. V. & Wanders, R. J. The biochemistry and physiology of mitochondrial fatty acid beta-oxidation and its genetic disorders. Annu Rev. Physiol. 78, 23\u201344 (2016).","journal-title":"Annu Rev. Physiol."},{"key":"2141_CR455","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcvm.2020.00002","volume":"7","author":"SI Oka","year":"2020","unstructured":"Oka, S. I., Sabry, A. D., Cawley, K. M. & Warren, J. S. Multiple levels of PGC-1alpha dysregulation in heart failure. Front. Cardiovasc. Med. 7, 2 (2020).","journal-title":"Front. Cardiovasc. Med."},{"key":"2141_CR456","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang, X. et al. Ferroptosis as a target for protection against cardiomyopathy. Proc. Natl Acad. Sci. USA 116, 2672\u20132680 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR457","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","volume":"15","author":"IJ Goldberg","year":"2012","unstructured":"Goldberg, I. J., Trent, C. M. & Schulze, P. C. Lipid metabolism and toxicity in the heart. Cell Metab. 15, 805\u2013812 (2012).","journal-title":"Cell Metab."},{"key":"2141_CR458","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02360-5","volume":"7","author":"Z Dong","year":"2017","unstructured":"Dong, Z. et al. Astragaloside IV alleviates heart failure via activating PPARalpha to switch glycolysis to fatty acid beta-oxidation. Sci. Rep. 7, 2691 (2017).","journal-title":"Sci. Rep."},{"key":"2141_CR459","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/cvr\/cvx045","volume":"113","author":"LS Mansor","year":"2017","unstructured":"Mansor, L. S. et al. Inhibition of sarcolemmal FAT\/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia\/reoxygenation. Cardiovasc. Res. 113, 737\u2013748 (2017).","journal-title":"Cardiovasc. Res."},{"key":"2141_CR460","doi-asserted-by":"crossref","unstructured":"Chu, Y., Zhang, C. & Xie, M. Beta-Hydroxybutyrate, friend or foe for stressed hearts. Front Aging. 2, 681513 (2021).","DOI":"10.3389\/fragi.2021.681513"},{"key":"2141_CR461","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.121.054885","volume":"144","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. PKM1 exerts critical roles in cardiac remodeling under pressure overload in the heart. Circulation 144, 712\u2013727 (2021).","journal-title":"Circulation"},{"key":"2141_CR462","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jtbi.2017.02.019","volume":"419","author":"HI Sano","year":"2017","unstructured":"Sano, H. I., Toki, T., Naito, Y. & Tomita, M. Developmental changes in the balance of glycolytic ATP production and oxidative phosphorylation in ventricular cells: a simulation study. J. Theor. Biol. 419, 269\u2013277 (2017).","journal-title":"J. Theor. Biol."},{"key":"2141_CR463","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21775\/cimb.028.029","volume":"28","author":"W Di","year":"2018","unstructured":"Di, W. et al. PGC-1: the energetic regulator in cardiac metabolism. Curr. Issues Mol. Biol. 28, 29\u201346 (2018).","journal-title":"Curr. Issues Mol. Biol."},{"key":"2141_CR464","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/nm1137","volume":"10","author":"R Shibata","year":"2004","unstructured":"Shibata, R. et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 10, 1384\u20131389 (2004).","journal-title":"Nat. Med."},{"key":"2141_CR465","doi-asserted-by":"crossref","unstructured":"Li, X. et al. AMPK: a therapeutic target of heart failure-not only metabolism regulation. Biosci. Rep. 39, BSR20181767 (2019).","DOI":"10.1042\/BSR20181767"},{"key":"2141_CR466","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1113\/jphysiol.2006.109389","volume":"574","author":"JR Dyck","year":"2006","unstructured":"Dyck, J. R. & Lopaschuk, G. D. AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol. 574, 95\u2013112 (2006).","journal-title":"J. Physiol."},{"key":"2141_CR467","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1210\/er.2006-0037","volume":"27","author":"C Handschin","year":"2006","unstructured":"Handschin, C. & Spiegelman, B. M. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 27, 728\u2013735 (2006).","journal-title":"Endocr. Rev."},{"key":"2141_CR468","doi-asserted-by":"publisher","first-page":"884S","DOI":"10.3945\/ajcn.110.001917","volume":"93","author":"PJ Fernandez-Marcos","year":"2011","unstructured":"Fernandez-Marcos, P. J. & Auwerx, J. Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr. 93, 884S\u2013890S (2011).","journal-title":"Am. J. Clin. Nutr."},{"key":"2141_CR469","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.117.030486","volume":"137","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. MicroRNA-195 regulates metabolism in failing Myocardium Via Alterations in Sirtuin 3 expression and mitochondrial protein acetylation. Circulation 137, 2052\u20132067 (2018).","journal-title":"Circulation"},{"key":"2141_CR470","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/s41401-020-00563-7","volume":"42","author":"YQ Ding","year":"2021","unstructured":"Ding, Y. Q. et al. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction. Acta Pharmacol. Sin. 42, 1422\u20131436 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"2141_CR471","doi-asserted-by":"publisher","first-page":"8057","DOI":"10.1111\/jcmm.15437","volume":"24","author":"H Su","year":"2020","unstructured":"Su, H., Zeng, H., Liu, B. & Chen, J. X. Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition. J. Cell. Mol. Med. 24, 8057\u20138068 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"2141_CR472","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.722530","volume":"12","author":"J Pan","year":"2021","unstructured":"Pan, J. et al. Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-beta\/Smad Pathway. Front. Pharmacol. 12, 722530 (2021).","journal-title":"Front. Pharmacol."},{"key":"2141_CR473","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","volume":"292","author":"HH Hu","year":"2018","unstructured":"Hu, H. H. et al. New insights into TGF-beta\/Smad signaling in tissue fibrosis. Chem. Biol. Interact. 292, 76\u201383 (2018).","journal-title":"Chem. Biol. Interact."},{"key":"2141_CR474","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10741-023-10295-5","volume":"28","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Changes of energy metabolism in failing heart and its regulation by SIRT3. Heart Fail. Rev. 28, 977\u2013992 (2023).","journal-title":"Heart Fail. Rev."},{"key":"2141_CR475","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/01.CIR.0000137836.95625.D4","volume":"110","author":"K Okada","year":"2004","unstructured":"Okada, K. et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110, 705\u2013712 (2004).","journal-title":"Circulation"},{"key":"2141_CR476","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.redox.2017.12.016","volume":"15","author":"Y Xin","year":"2018","unstructured":"Xin, Y. et al. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt\/GSK-3ss\/Fyn pathway. Redox Biol. 15, 405\u2013417 (2018).","journal-title":"Redox Biol."},{"key":"2141_CR477","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nchembio.2172","volume":"12","author":"YJ Chen","year":"2016","unstructured":"Chen, Y. J. et al. Lactate metabolism is associated with mammalian mitochondria. Nat. Chem. Biol. 12, 937\u2013943 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"2141_CR478","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/cvr\/cvv279","volume":"109","author":"L Valls-Lacalle","year":"2016","unstructured":"Valls-Lacalle, L. et al. Succinate dehydrogenase inhibition with malonate during reperfusion reduces infarct size by preventing mitochondrial permeability transition. Cardiovasc. Res. 109, 374\u2013384 (2016).","journal-title":"Cardiovasc. Res."},{"key":"2141_CR479","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s42255-024-01036-5","volume":"6","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy. Nat. Metab. 6, 1161\u20131177 (2024).","journal-title":"Nat. Metab."},{"key":"2141_CR480","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1042\/BCJ20160164","volume":"473","author":"E Liepinsh","year":"2016","unstructured":"Liepinsh, E. et al. Long-chain acylcarnitines determine ischaemia\/reperfusion-induced damage in heart mitochondria. Biochem. J. 473, 1191\u20131202 (2016).","journal-title":"Biochem. J."},{"key":"2141_CR481","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","volume":"20","author":"RW McGarrah","year":"2023","unstructured":"McGarrah, R. W. & White, P. J. Branched-chain amino acids in cardiovascular disease. Nat. Rev. Cardiol. 20, 77\u201389 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"2141_CR482","doi-asserted-by":"publisher","first-page":"38029","DOI":"10.1074\/jbc.M509039200","volume":"280","author":"M Yamamoto","year":"2005","unstructured":"Yamamoto, M. et al. Regulation of oxidative stress by the anti-aging hormone klotho. J. Biol. Chem. 280, 38029\u201338034 (2005).","journal-title":"J. Biol. Chem."},{"key":"2141_CR483","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12872-020-01400-9","volume":"20","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. Recombinant Klotho protein enhances cholesterol efflux of THP-1 macrophage-derived foam cells via suppressing Wnt\/beta-catenin signaling pathway. BMC Cardiovasc. Disord. 20, 120 (2020).","journal-title":"BMC Cardiovasc. Disord."},{"key":"2141_CR484","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mito.2013.01.006","volume":"13","author":"T Wenz","year":"2013","unstructured":"Wenz, T. Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress. Mitochondrion 13, 134\u2013142 (2013).","journal-title":"Mitochondrion"},{"key":"2141_CR485","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2009.03.011","volume":"10","author":"RT Brookheart","year":"2009","unstructured":"Brookheart, R. T., Michel, C. I. & Schaffer, J. E. As a matter of fat. Cell Metab. 10, 9\u201312 (2009).","journal-title":"Cell Metab."},{"key":"2141_CR486","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2010.01.039","volume":"320","author":"CL Gao","year":"2010","unstructured":"Gao, C. L. et al. Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes. Mol. Cell. Endocrinol. 320, 25\u201333 (2010).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2141_CR487","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/oby.21135","volume":"23","author":"M Alcala","year":"2015","unstructured":"Alcala, M. et al. Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity. Obesity 23, 1598\u20131606 (2015).","journal-title":"Obesity"},{"key":"2141_CR488","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa, S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 114, 1752\u20131761 (2004).","journal-title":"J. Clin. Investig."},{"key":"2141_CR489","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.metabol.2014.01.009","volume":"63","author":"A Jankovic","year":"2014","unstructured":"Jankovic, A. et al. Differences in the redox status of human visceral and subcutaneous adipose tissues\u2013relationships to obesity and metabolic risk. Metabolism 63, 661\u2013671 (2014).","journal-title":"Metabolism"},{"key":"2141_CR490","doi-asserted-by":"crossref","unstructured":"Kobayashi, M., Deguchi, Y., Nozaki, Y. & Higami, Y. Contribution of PGC-1alpha to obesity- and caloric restriction-related physiological changes in white adipose tissue. Int. J. Mol. Sci. 22, 6025 (2021).","DOI":"10.3390\/ijms22116025"},{"key":"2141_CR491","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nm1195-1155","volume":"1","author":"M Maffei","year":"1995","unstructured":"Maffei, M. et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155\u20131161 (1995).","journal-title":"Nat. Med."},{"key":"2141_CR492","doi-asserted-by":"publisher","first-page":"11848","DOI":"10.1073\/pnas.182420899","volume":"99","author":"Y Lee","year":"2002","unstructured":"Lee, Y. et al. PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc. Natl Acad. Sci. USA 99, 11848\u201311853 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR493","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/415339a","volume":"415","author":"Y Minokoshi","year":"2002","unstructured":"Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339\u2013343 (2002).","journal-title":"Nature"},{"key":"2141_CR494","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0026-0495(77)90085-3","volume":"26","author":"AA Rossini","year":"1977","unstructured":"Rossini, A. A. et al. Metabolic and endocrine studies in a case of lipoatrophic diabetes. Metabolism 26, 637\u2013650 (1977).","journal-title":"Metabolism"},{"key":"2141_CR495","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2337\/diab.46.3.513","volume":"46","author":"XS Wu-Peng","year":"1997","unstructured":"Wu-Peng, X. S. et al. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes 46, 513\u2013518 (1997).","journal-title":"Diabetes"},{"key":"2141_CR496","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2337\/db08-0585","volume":"58","author":"G Mantovani","year":"2009","unstructured":"Mantovani, G. et al. Protein kinase A regulatory subunits in human adipose tissue: decreased R2B expression and activity in adipocytes from obese subjects. Diabetes 58, 620\u2013626 (2009).","journal-title":"Diabetes"},{"key":"2141_CR497","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/JOE-20-0035","volume":"246","author":"E London","year":"2020","unstructured":"London, E., Bloyd, M. & Stratakis, C. A. PKA functions in metabolism and resistance to obesity: lessons from mouse and human studies. J. Endocrinol. 246, R51\u2013R64 (2020).","journal-title":"J. Endocrinol."},{"key":"2141_CR498","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cellsig.2017.10.005","volume":"42","author":"M Chattopadhyay","year":"2018","unstructured":"Chattopadhyay, M. et al. Impairment of energy sensors, SIRT1 and AMPK, in lipid induced inflamed adipocyte is regulated by Fetuin A. Cell. Signal. 42, 67\u201376 (2018).","journal-title":"Cell. Signal."},{"key":"2141_CR499","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.166050","volume":"1867","author":"S Das","year":"2021","unstructured":"Das, S. et al. Increase in PPARgamma inhibitory phosphorylation by Fetuin-A through the activation of Ras-MEK-ERK pathway causes insulin resistance. Biochim. Biophys. Acta Mol. Basis Dis. 1867, 166050 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"2141_CR500","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bbrc.2014.08.135","volume":"452","author":"GJ Prud\u2019homme","year":"2014","unstructured":"Prud\u2019homme, G. J. et al. GABA protects pancreatic beta cells against apoptosis by increasing SIRT1 expression and activity. Biochem. Biophys. Res. Commun. 452, 649\u2013654 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2141_CR501","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"CN Lumeng","year":"2007","unstructured":"Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Investig. 117, 175\u2013184 (2007).","journal-title":"J. Clin. Investig."},{"key":"2141_CR502","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm.2627","volume":"18","author":"O Osborn","year":"2012","unstructured":"Osborn, O. & Olefsky, J. M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18, 363\u2013374 (2012).","journal-title":"Nat. Med."},{"key":"2141_CR503","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1096\/fj.201701586R","volume":"33","author":"AD Lieber","year":"2019","unstructured":"Lieber, A. D. et al. Loss of HDAC6 alters gut microbiota and worsens obesity. FASEB J. 33, 1098\u20131109 (2019).","journal-title":"FASEB J."},{"key":"2141_CR504","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1530\/JME-14-0066","volume":"53","author":"X Jiang","year":"2014","unstructured":"Jiang, X. et al. Inhibition of HDAC3 promotes ligand-independent PPARgamma activation by protein acetylation. J. Mol. Endocrinol. 53, 191\u2013200 (2014).","journal-title":"J. Mol. Endocrinol."},{"key":"2141_CR505","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1159\/000447858","volume":"39","author":"HY Jia","year":"2016","unstructured":"Jia, H. Y., Li, Q. Z. & Lv, L. F. HDAC5 inhibits hepatic lipogenic genes expression by attenuating the transcriptional activity of liver X receptor. Cell. Physiol. Biochem. 39, 1561\u20131567 (2016).","journal-title":"Cell. Physiol. Biochem."},{"key":"2141_CR506","doi-asserted-by":"publisher","first-page":"e120159","DOI":"10.1172\/jci.insight.120159","volume":"3","author":"RA Bagchi","year":"2018","unstructured":"Bagchi, R. A. et al. HDAC11 suppresses the thermogenic program of adipose tissue via BRD2. JCI Insight. 3, e120159 (2018).","journal-title":"JCI Insight."},{"key":"2141_CR507","doi-asserted-by":"crossref","unstructured":"Contreras, R. E. et al. HDAC5 controls a hypothalamic STAT5b-TH axis, the sympathetic activation of ATP-consuming futile cycles and adult-onset obesity in male mice. Mol. Metab. 90, 102033 (2024).","DOI":"10.1016\/j.molmet.2024.102033"},{"key":"2141_CR508","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110875","volume":"111","author":"D Tian","year":"2023","unstructured":"Tian, D. et al. HDAC1 inhibits beige adipocyte-mediated thermogenesis through histone crotonylation of Pgc1a\/Ucp1. Cell. Signal. 111, 110875 (2023).","journal-title":"Cell. Signal."},{"key":"2141_CR509","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202300149","volume":"67","author":"H Yang","year":"2023","unstructured":"Yang, H. et al. Sulforaphane mitigates high-fat diet-induced obesity by enhancing mitochondrial biogenesis in skeletal muscle via the HDAC8-PGC1alpha Axis. Mol. Nutr. Food Res. 67, e2300149 (2023).","journal-title":"Mol. Nutr. Food Res."},{"key":"2141_CR510","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108517","volume":"26","author":"M Farhadipour","year":"2023","unstructured":"Farhadipour, M. et al. SCFAs switch stem cell fate through HDAC inhibition to improve barrier integrity in 3D intestinal organoids from patients with obesity. iScience 26, 108517 (2023).","journal-title":"iScience"},{"key":"2141_CR511","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.705827","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Maternal high-fat diet disturbs the DNA methylation profile in the brown adipose tissue of offspring mice. Front. Endocrinol. 12, 705827 (2021).","journal-title":"Front. Endocrinol."},{"key":"2141_CR512","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13059","volume":"19","author":"Q Tian","year":"2020","unstructured":"Tian, Q. et al. Dietary alpha-ketoglutarate promotes beige adipogenesis and prevents obesity in middle-aged mice. Aging Cell 19, e13059 (2020).","journal-title":"Aging Cell"},{"key":"2141_CR513","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41575-021-00452-2","volume":"18","author":"H Choi","year":"2021","unstructured":"Choi, H., Rao, M. C. & Chang, E. B. Gut microbiota as a transducer of dietary cues to regulate host circadian rhythms and metabolism. Nat. Rev. Gastroenterol. Hepatol. 18, 679\u2013689 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2141_CR514","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cmet.2018.01.005","volume":"27","author":"A Mardinoglu","year":"2018","unstructured":"Mardinoglu, A. et al. An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans. Cell Metab. 27, 559\u2013571.e555 (2018).","journal-title":"Cell Metab."},{"key":"2141_CR515","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/09637486.2023.2235899","volume":"74","author":"Y Dong","year":"2023","unstructured":"Dong, Y. et al. Normal diet ameliorates obesity more safely and effectively than ketogenic diet does in high-fat diet-induced obesity mouse based on gut microbiota and lipid metabolism. Int. J. Food Sci. Nutr. 74, 589\u2013605 (2023).","journal-title":"Int. J. Food Sci. Nutr."},{"key":"2141_CR516","doi-asserted-by":"crossref","unstructured":"Manca, C. et al. Oral Capsaicinoid administration alters the plasma endocannabinoidome and fecal microbiota of reproductive-aged women living with overweight and obesity. Biomedicines. 9, 1246 (2021).","DOI":"10.3390\/biomedicines9091246"},{"key":"2141_CR517","doi-asserted-by":"crossref","unstructured":"Stanek, A. et al. The role of intermittent energy restriction diet on metabolic profile and weight loss among obese adults. Nutrients 14, 1509 (2022).","DOI":"10.3390\/nu14071509"},{"key":"2141_CR518","doi-asserted-by":"publisher","first-page":"5","DOI":"10.31083\/j.fbs1601005","volume":"16","author":"A Blagov","year":"2024","unstructured":"Blagov, A. et al. Mitochondrial dysfunction as a factor of energy metabolism disorders in Type 2 Diabetes Mellitus. Front. Biosci. 16, 5 (2024).","journal-title":"Front. Biosci."},{"key":"2141_CR519","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1172\/JCI7535","volume":"105","author":"K Cusi","year":"2000","unstructured":"Cusi, K. et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Investig. 105, 311\u2013320 (2000).","journal-title":"J. Clin. Investig."},{"key":"2141_CR520","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1073\/pnas.92.4.983","volume":"92","author":"DL Rothman","year":"1995","unstructured":"Rothman, D. L. et al. Decreased muscle glucose transport\/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc. Natl Acad. Sci. USA 92, 983\u2013987 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR521","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2337\/diabetes.51.4.921","volume":"51","author":"M Gaster","year":"2002","unstructured":"Gaster, M. et al. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51, 921\u2013927 (2002).","journal-title":"Diabetes"},{"key":"2141_CR522","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/BF02658504","volume":"39","author":"JR Zierath","year":"1996","unstructured":"Zierath, J. R. et al. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39, 1180\u20131189 (1996).","journal-title":"Diabetologia"},{"key":"2141_CR523","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1073\/pnas.1332551100","volume":"100","author":"CS Stump","year":"2003","unstructured":"Stump, C. S. et al. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc. Natl Acad. Sci. USA 100, 7996\u20138001 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR524","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"2141_CR525","doi-asserted-by":"publisher","first-page":"8466","DOI":"10.1073\/pnas.1032913100","volume":"100","author":"ME Patti","year":"2003","unstructured":"Patti, M. E. et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA 100, 8466\u20138471 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR526","doi-asserted-by":"publisher","first-page":"27320","DOI":"10.1074\/jbc.273.42.27320","volume":"273","author":"J Liao","year":"1998","unstructured":"Liao, J., Barthel, A., Nakatani, K. & Roth, R. A. Activation of protein kinase B\/Akt is sufficient to repress the glucocorticoid and cAMP induction of phosphoenolpyruvate carboxykinase gene. J. Biol. Chem. 273, 27320\u201327324 (1998).","journal-title":"J. Biol. Chem."},{"key":"2141_CR527","doi-asserted-by":"publisher","first-page":"30169","DOI":"10.1074\/jbc.M004898200","volume":"275","author":"RK Hall","year":"2000","unstructured":"Hall, R. K. et al. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin: the role winged helix\/forkhead proteins.J. Biol. Chem. 275, 30169\u201330175 (2000).","journal-title":"J. Biol. Chem."},{"key":"2141_CR528","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ng.288","volume":"41","author":"V Lyssenko","year":"2009","unstructured":"Lyssenko, V. et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat. Genet. 41, 82\u201388 (2009).","journal-title":"Nat. Genet."},{"key":"2141_CR529","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ng.277","volume":"41","author":"N Bouatia-Naji","year":"2009","unstructured":"Bouatia-Naji, N. et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat. Genet. 41, 89\u201394 (2009).","journal-title":"Nat. Genet."},{"key":"2141_CR530","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2337\/db14-0874","volume":"64","author":"K Sharma","year":"2015","unstructured":"Sharma, K. Mitochondrial hormesis and diabetic complications. Diabetes 64, 663\u2013672 (2015).","journal-title":"Diabetes"},{"key":"2141_CR531","first-page":"1","volume":"50","author":"TW Jung","year":"2018","unstructured":"Jung, T. W. et al. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARdelta-dependent pathways in skeletal muscle of mice. Exp. Mol. Med. 50, 1\u201311 (2018).","journal-title":"Exp. Mol. Med."},{"key":"2141_CR532","doi-asserted-by":"publisher","first-page":"627147","DOI":"10.3389\/fphar.2021.627147","volume":"12","author":"W Hu","year":"2021","unstructured":"Hu, W., Wang, R. & Sun, B. Meteorin-Like Ameliorates beta Cell Function by Inhibiting beta Cell Apoptosis of and Promoting beta Cell Proliferation via Activating the WNT\/beta-Catenin Pathway. Front. Pharmacol. 12, 627147 (2021).","journal-title":"Front. Pharmacol."},{"key":"2141_CR533","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/febs.15301","volume":"287","author":"JO Lee","year":"2020","unstructured":"Lee, J. O. et al. The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKalpha2. FEBS J. 287, 2087\u20132104 (2020).","journal-title":"FEBS J."},{"key":"2141_CR534","doi-asserted-by":"publisher","first-page":"761834","DOI":"10.3389\/fendo.2021.761834","volume":"12","author":"T Arora","year":"2021","unstructured":"Arora, T. & Tremaroli, V. Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes. Front. Endocrinol. (Lausanne) 12, 761834 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2141_CR535","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0293-3","volume":"8","author":"C Sathishkumar","year":"2016","unstructured":"Sathishkumar, C. et al. Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes. Clin. Epigenetics. 8, 125 (2016).","journal-title":"Clin. Epigenetics."},{"key":"2141_CR536","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00215-1","volume":"8","author":"K Kim","year":"2017","unstructured":"Kim, K. et al. RORalpha controls hepatic lipid homeostasis via negative regulation of PPARgamma transcriptional network. Nat. Commun. 8, 162 (2017).","journal-title":"Nat. Commun."},{"key":"2141_CR537","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/0260106014537160","volume":"22","author":"SH House","year":"2013","unstructured":"House, S. H. Epigenetics in adaptive evolution and development: the interplay between evolving species and epigenetic mechanisms: extract from Trygve Tollefsbol (ed.) (2011) Handbook of epigenetics\u2013the new molecular and medical genetics. Chapter 26. Amsterdam, USA: Elsevier, pp. 423-446. Nutr. Health 22, 105\u2013131 (2013).","journal-title":"Nutr. Health"},{"key":"2141_CR538","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/sj.emboj.7600106","volume":"23","author":"L Zeng","year":"2004","unstructured":"Zeng, L. et al. ATF6 modulates SREBP2-mediated lipogenesis. EMBO J. 23, 950\u2013958 (2004).","journal-title":"EMBO J."},{"key":"2141_CR539","doi-asserted-by":"publisher","first-page":"860","DOI":"10.2337\/db07-0843","volume":"57","author":"SL McGee","year":"2008","unstructured":"McGee, S. L. et al. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57, 860\u2013867 (2008).","journal-title":"Diabetes"},{"key":"2141_CR540","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3920\/BM2013.006","volume":"5","author":"M Remely","year":"2014","unstructured":"Remely, M. et al. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Benef. Microbes 5, 33\u201343 (2014).","journal-title":"Benef. Microbes"},{"key":"2141_CR541","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1210\/endrev\/bnab025","volume":"43","author":"A Jais","year":"2022","unstructured":"Jais, A. & Bruning, J. C. Arcuate nucleus-dependent regulation of metabolism-pathways to obesity and Diabetes Mellitus. Endocr. Rev. 43, 314\u2013328 (2022).","journal-title":"Endocr. Rev."},{"key":"2141_CR542","doi-asserted-by":"publisher","first-page":"114108","DOI":"10.1016\/j.physbeh.2023.114108","volume":"263","author":"R Dali","year":"2023","unstructured":"Dali, R., Estrada-Meza, J. & Langlet, F. Tanycyte, the neuron whisperer. Physiol. Behav. 263, 114108 (2023).","journal-title":"Physiol. Behav."},{"key":"2141_CR543","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cell.2016.07.028","volume":"166","author":"C Garcia-Caceres","year":"2016","unstructured":"Garcia-Caceres, C. et al. Astrocytic insulin signaling couples brain glucose uptake with nutrient availability. Cell 166, 867\u2013880 (2016).","journal-title":"Cell"},{"key":"2141_CR544","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/nn.3725","volume":"17","author":"JG Kim","year":"2014","unstructured":"Kim, J. G. et al. Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding. Nat. Neurosci. 17, 908\u2013910 (2014).","journal-title":"Nat. Neurosci."},{"key":"2141_CR545","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nn.2167","volume":"11","author":"Q Tong","year":"2008","unstructured":"Tong, Q. et al. Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat. Neurosci. 11, 998\u20131000 (2008).","journal-title":"Nat. Neurosci."},{"key":"2141_CR546","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41593-021-00854-0","volume":"24","author":"N Biglari","year":"2021","unstructured":"Biglari, N. et al. Functionally distinct POMC-expressing neuron subpopulations in hypothalamus revealed by intersectional targeting. Nat. Neurosci. 24, 913\u2013929 (2021).","journal-title":"Nat. Neurosci."},{"key":"2141_CR547","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/bies.201500167","volume":"38","author":"Y Chen","year":"2016","unstructured":"Chen, Y. & Knight, Z. A. Making sense of the sensory regulation of hunger neurons. Bioessays 38, 316\u2013324 (2016).","journal-title":"Bioessays"},{"key":"2141_CR548","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.neuron.2017.06.014","volume":"95","author":"ML Andermann","year":"2017","unstructured":"Andermann, M. L. & Lowell, B. B. Toward a wiring diagram understanding of appetite control. Neuron 95, 757\u2013778 (2017).","journal-title":"Neuron"},{"key":"2141_CR549","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2015.02.028","volume":"160","author":"RJ Seeley","year":"2015","unstructured":"Seeley, R. J. & Berridge, K. C. The hunger games. Cell 160, 805\u2013806 (2015).","journal-title":"Cell"},{"key":"2141_CR550","doi-asserted-by":"crossref","unstructured":"Mandelblat-Cerf, Y. et al. Arcuate hypothalamic AgRP and putative POMC neurons show opposite changes in spiking across multiple timescales. Elife. 4, e07122 (2015).","DOI":"10.7554\/eLife.07122"},{"key":"2141_CR551","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14656566.2020.1729123","volume":"21","author":"KS Johansson","year":"2020","unstructured":"Johansson, K. S., Bronden, A., Knop, F. K. & Christensen, M. B. Clinical pharmacology of imeglimin for the treatment of type 2 diabetes. Expert Opin. Pharmacother. 21, 871\u2013882 (2020).","journal-title":"Expert Opin. Pharmacother."},{"key":"2141_CR552","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/stem.3134","volume":"38","author":"CL Rackham","year":"2020","unstructured":"Rackham, C. L. et al. Optimizing beta cell function through mesenchymal stromal cell-mediated mitochondria transfer. Stem Cells 38, 574\u2013584 (2020).","journal-title":"Stem Cells"},{"key":"2141_CR553","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.apsb.2022.10.008","volume":"13","author":"TG Zhang","year":"2023","unstructured":"Zhang, T. G. & Miao, C. Y. Mitochondrial transplantation as a promising therapy for mitochondrial diseases. Acta Pharm. Sin. B 13, 1028\u20131035 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"2141_CR554","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/oby.21552","volume":"24","author":"JF Ortega","year":"2016","unstructured":"Ortega, J. F. et al. Dietary supplementation with omega-3 fatty acids and oleate enhances exercise training effects in patients with metabolic syndrome. Obesity 24, 1704\u20131711 (2016).","journal-title":"Obesity"},{"key":"2141_CR555","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aao5774","volume":"359","author":"L Zhao","year":"2018","unstructured":"Zhao, L. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151\u20131156 (2018).","journal-title":"Science"},{"key":"2141_CR556","doi-asserted-by":"crossref","unstructured":"Martin-Pelaez, S., Fito, M. & Castaner, O. Mediterranean diet effects on Type 2 diabetes prevention, disease progression, and related mechanisms. A Review. Nutrients. 12, 2236 (2020).","DOI":"10.3390\/nu12082236"},{"key":"2141_CR557","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/dom.14080","volume":"22","author":"A Rajpal","year":"2020","unstructured":"Rajpal, A. & Ismail-Beigi, F. Intermittent fasting and \u2018metabolic switch\u2019: effects on metabolic syndrome, prediabetes and type 2 diabetes. Diab. Obes. Metab. 22, 1496\u20131510 (2020).","journal-title":"Diab. Obes. Metab."},{"key":"2141_CR558","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00012.2014","volume":"95","author":"JH de Baaij","year":"2015","unstructured":"de Baaij, J. H., Hoenderop, J. G. & Bindels, R. J. Magnesium in man: implications for health and disease. Physiol. Rev. 95, 1\u201346 (2015).","journal-title":"Physiol. Rev."},{"key":"2141_CR559","doi-asserted-by":"crossref","unstructured":"Kostov, K. Effects of magnesium deficiency on mechanisms of insulin resistance in Type 2 diabetes: focusing on the processes of insulin secretion and signaling. Int. J. Mol. Sci. 20, 1351 (2019).","DOI":"10.3390\/ijms20061351"},{"key":"2141_CR560","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.tem.2024.01.005","volume":"35","author":"S Wang","year":"2024","unstructured":"Wang, S., Yang, N. & Zhang, H. Metabolic dysregulation of lymphocytes in autoimmune diseases. Trends Endocrinol. Metab. 35, 624\u2013637 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"2141_CR561","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand, C. M. & Goronzy, J. J. The immunology of rheumatoid arthritis. Nat. Immunol. 22, 10\u201318 (2021).","journal-title":"Nat. Immunol."},{"key":"2141_CR562","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","volume":"19","author":"MF Bustamante","year":"2017","unstructured":"Bustamante, M. F., Garcia-Carbonell, R., Whisenant, K. D. & Guma, M. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res. Ther. 19, 110 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"2141_CR563","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath, M. F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14, 329\u2013342 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"2141_CR564","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2014.01.004","volume":"48-49","author":"C Yu","year":"2014","unstructured":"Yu, C., Gershwin, M. E. & Chang, C. Diagnostic criteria for systemic lupus erythematosus: a critical review. J. Autoimmun. 48-49, 10\u201313 (2014).","journal-title":"J. Autoimmun."},{"key":"2141_CR565","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrrheum.2017.54","volume":"13","author":"JP Rhoads","year":"2017","unstructured":"Rhoads, J. P., Major, A. S. & Rathmell, J. C. Fine tuning of immunometabolism for the treatment of rheumatic diseases. Nat. Rev. Rheumatol. 13, 313\u2013320 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2141_CR566","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3389\/fimmu.2017.01632","volume":"8","author":"L Sun","year":"2017","unstructured":"Sun, L., Fu, J. & Zhou, Y. Metabolism controls the balance of Th17\/T-Regulatory Cells. Front. Immunol. 8, 1632 (2017).","journal-title":"Front. Immunol."},{"key":"2141_CR567","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek, R. D. et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299\u20133303 (2011).","journal-title":"J. Immunol."},{"key":"2141_CR568","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.it.2012.01.010","volume":"33","author":"VA Gerriets","year":"2012","unstructured":"Gerriets, V. A. & Rathmell, J. C. Metabolic pathways in T cell fate and function. Trends Immunol. 33, 168\u2013173 (2012).","journal-title":"Trends Immunol."},{"key":"2141_CR569","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00393-023-01389-4","volume":"82","author":"RH Straub","year":"2023","unstructured":"Straub, R. H., Pongratz, G., Buttgereit, F. & Gaber, T. Energy metabolism of the immune system : Consequences in chronic inflammation. Z. Rheumatol. 82, 479\u2013490 (2023).","journal-title":"Z. Rheumatol."},{"key":"2141_CR570","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tcb.2017.10.009","volume":"28","author":"M Schnoor","year":"2018","unstructured":"Schnoor, M., Stradal, T. E. & Rottner, K. Cortactin: cell functions of a multifaceted actin-binding protein. Trends Cell Biol. 28, 79\u201398 (2018).","journal-title":"Trends Cell Biol."},{"key":"2141_CR571","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04648-0","volume":"9","author":"A Schrepf","year":"2018","unstructured":"Schrepf, A. et al. A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis. Nat. Commun. 9, 2243 (2018).","journal-title":"Nat. Commun."},{"key":"2141_CR572","doi-asserted-by":"publisher","first-page":"6634532","DOI":"10.1155\/2021\/6634532","volume":"2021","author":"F Cai","year":"2021","unstructured":"Cai, F., Jin, S. & Chen, G. The effect of lipid metabolism on CD4(+) T Cells. Mediat. Inflamm. 2021, 6634532 (2021).","journal-title":"Mediat. Inflamm."},{"key":"2141_CR573","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","volume":"175","author":"MO Johnson","year":"2018","unstructured":"Johnson, M. O. et al. Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism. Cell 175, 1780\u20131795.e1719 (2018).","journal-title":"Cell"},{"key":"2141_CR574","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.isci.2018.07.005","volume":"5","author":"LR Waters","year":"2018","unstructured":"Waters, L. R. et al. Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling. iScience 5, 99\u2013109 (2018).","journal-title":"iScience"},{"key":"2141_CR575","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295\u20131306 (2020).","journal-title":"Nat. Med."},{"key":"2141_CR576","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","volume":"10","author":"A Viola","year":"2019","unstructured":"Viola, A. et al. The metabolic signature of macrophage responses. Front. Immunol. 10, 1462 (2019).","journal-title":"Front. Immunol."},{"key":"2141_CR577","first-page":"420","volume":"5","author":"S Galvan-Pena","year":"2014","unstructured":"Galvan-Pena, S. & O\u2019Neill, L. A. Metabolic reprograming in macrophage polarization. Front. Immunol. 5, 420 (2014).","journal-title":"Front. Immunol."},{"key":"2141_CR578","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/art.40785","volume":"71","author":"T Koga","year":"2019","unstructured":"Koga, T. et al. Promotion of Calcium\/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus. Arthritis Rheumatol. 71, 766\u2013772 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"2141_CR579","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2018-213103","volume":"77","author":"MF Bustamante","year":"2018","unstructured":"Bustamante, M. F. et al. Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis. Ann. Rheum. Dis. 77, 1636\u20131643 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"2141_CR580","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3389\/fimmu.2019.01743","volume":"10","author":"PG de Oliveira","year":"2019","unstructured":"de Oliveira, P. G. et al. Fibroblast-Like Synoviocytes Glucose Metabolism as a Therapeutic Target in Rheumatoid Arthritis. Front. Immunol. 10, 1743 (2019).","journal-title":"Front. Immunol."},{"key":"2141_CR581","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","volume":"14","author":"M Diani","year":"2015","unstructured":"Diani, M., Altomare, G. & Reali, E. T cell responses in psoriasis and psoriatic arthritis. Autoimmun. Rev. 14, 286\u2013292 (2015).","journal-title":"Autoimmun. Rev."},{"key":"2141_CR582","doi-asserted-by":"publisher","DOI":"10.1038\/srep42412","volume":"7","author":"T Okano","year":"2017","unstructured":"Okano, T. et al. 3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17\/Treg cell differentiation and suppressing dendritic cell activation. Sci. Rep. 7, 42412 (2017).","journal-title":"Sci. Rep."},{"key":"2141_CR583","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00011-020-01332-2","volume":"69","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Inhibition of glycolysis ameliorate arthritis in adjuvant arthritis rats by inhibiting synoviocyte activation through AMPK\/NF-small ka, CyrillicB pathway. Inflamm. Res. 69, 569\u2013578 (2020).","journal-title":"Inflamm. Res."},{"key":"2141_CR584","doi-asserted-by":"publisher","first-page":"108962","DOI":"10.1016\/j.abb.2021.108962","volume":"708","author":"K Kishimoto","year":"2021","unstructured":"Kishimoto, K. et al. Metabolic changes in synovial cells in early inflammation: involvement of CREB phosphorylation in the anti-inflammatory effect of 2-deoxyglucose. Arch. Biochem. Biophys. 708, 108962 (2021).","journal-title":"Arch. Biochem. Biophys."},{"key":"2141_CR585","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12016-020-08821-6","volume":"60","author":"T Wang","year":"2021","unstructured":"Wang, T., Jiao, Y. & Zhang, X. Immunometabolic pathways and its therapeutic implication in autoimmune diseases. Clin. Rev. Allergy Immunol. 60, 55\u201367 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2141_CR586","doi-asserted-by":"crossref","unstructured":"Chen, Y. & Gaber, T. Hypoxia\/HIF Modulates Immune Responses. Biomedicines. 9, 260 (2021).","DOI":"10.3390\/biomedicines9030260"},{"key":"2141_CR587","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1161\/CIRCRESAHA.116.305420","volume":"116","author":"RB Vega","year":"2015","unstructured":"Vega, R. B., Horton, J. L. & Kelly, D. P. Maintaining ancient organelles: mitochondrial biogenesis and maturation. Circ. Res. 116, 1820\u20131834 (2015).","journal-title":"Circ. Res."},{"key":"2141_CR588","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu, N. et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62\u201368 (2014).","journal-title":"Nat. Med."},{"key":"2141_CR589","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104581","volume":"152","author":"YZ Lee","year":"2020","unstructured":"Lee, Y. Z. et al. Tylophorine-based compounds are therapeutic in rheumatoid arthritis by targeting the caprin-1 ribonucleoprotein complex and inhibiting expression of associated c-Myc and HIF-1alpha. Pharmacol. Res. 152, 104581 (2020).","journal-title":"Pharmacol. Res."},{"key":"2141_CR590","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/eji.201545784","volume":"46","author":"F Hu","year":"2016","unstructured":"Hu, F. et al. Hypoxia-inducible factor-1alpha perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis. Eur. J. Immunol. 46, 742\u2013751 (2016).","journal-title":"Eur. J. Immunol."},{"key":"2141_CR591","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.898","volume":"12","author":"M Barberis","year":"2022","unstructured":"Barberis, M. & Rojas Lopez, A. T cell phenotype switching in autoimmune disorders: clinical significance of targeting metabolism. Clin. Transl. Med 12, e898 (2022).","journal-title":"Clin. Transl. Med"},{"key":"2141_CR592","doi-asserted-by":"publisher","first-page":"331ra338","DOI":"10.1126\/scitranslmed.aad7151","volume":"8","author":"Z Yang","year":"2016","unstructured":"Yang, Z. et al. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci. Transl. Med. 8, 331ra338 (2016).","journal-title":"Sci. Transl. Med."},{"key":"2141_CR593","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.it.2018.04.006","volume":"39","author":"N Huang","year":"2018","unstructured":"Huang, N. & Perl, A. Metabolism as a target for modulation in autoimmune diseases. Trends Immunol. 39, 562\u2013576 (2018).","journal-title":"Trends Immunol."},{"key":"2141_CR594","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/eji.201646477","volume":"47","author":"V Pucino","year":"2017","unstructured":"Pucino, V., Bombardieri, M., Pitzalis, C. & Mauro, C. Lactate at the crossroads of metabolism, inflammation, and autoimmunity. Eur. J. Immunol. 47, 14\u201321 (2017).","journal-title":"Eur. J. Immunol."},{"key":"2141_CR595","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1474","volume":"12","author":"M Certo","year":"2020","unstructured":"Certo, M. et al. Lactate: fueling the fire starter. Wiley Interdiscip. Rev. Syst. Biol. Med. 12, e1474 (2020).","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"2141_CR596","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.cmet.2019.10.004","volume":"30","author":"V Pucino","year":"2019","unstructured":"Pucino, V. et al. Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4(+) T cell metabolic rewiring. Cell Metab. 30, 1055\u20131074.e1058 (2019).","journal-title":"Cell Metab."},{"key":"2141_CR597","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.20150900","volume":"213","author":"T Shirai","year":"2016","unstructured":"Shirai, T. et al. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J. Exp. Med. 213, 337\u2013354 (2016).","journal-title":"J. Exp. Med."},{"key":"2141_CR598","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2018.07.018","volume":"49","author":"D O\u2019Sullivan","year":"2018","unstructured":"O\u2019Sullivan, D. et al. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 49, 375\u2013376 (2018).","journal-title":"Immunity"},{"key":"2141_CR599","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652771","volume":"12","author":"J Qiu","year":"2021","unstructured":"Qiu, J. et al. Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis. Front. Immunol. 12, 652771 (2021).","journal-title":"Front. Immunol."},{"key":"2141_CR600","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.4049\/jimmunol.1600810","volume":"198","author":"L Franchi","year":"2017","unstructured":"Franchi, L. et al. Inhibiting oxidative phosphorylation in vivo restrains Th17 effector responses and ameliorates murine colitis. J. Immunol. 198, 2735\u20132746 (2017).","journal-title":"J. Immunol."},{"key":"2141_CR601","doi-asserted-by":"crossref","unstructured":"Harshan, S., Dey, P. & Raghunathan, S. Altered transcriptional regulation of glycolysis in circulating CD8(+) T cells of rheumatoid arthritis patients. Genes 13, 1216 (2022).","DOI":"10.3390\/genes13071216"},{"key":"2141_CR602","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin, A. et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25, 1282\u20131293.e1287 (2017).","journal-title":"Cell Metab."},{"key":"2141_CR603","doi-asserted-by":"crossref","unstructured":"Vukelic, M., Kono, M. & Tsokos, G. C. T cell Metabolism in Lupus. Immunometabolism. 2, (2020).","DOI":"10.20900\/immunometab20200009"},{"key":"2141_CR604","doi-asserted-by":"publisher","first-page":"e2014681118","DOI":"10.1073\/pnas.2014681118","volume":"118","author":"F Hao","year":"2021","unstructured":"Hao, F. et al. Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation. Proc. Natl. Acad. Sci. USA. 118, e2014681118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2141_CR605","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/imm.13638","volume":"169","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. AhR activation promotes Treg cell generation by enhancing Lkb1-mediated fatty acid oxidation via the Skp2\/K63-ubiquitination pathway. Immunology 169, 412\u2013430 (2023).","journal-title":"Immunology"},{"key":"2141_CR606","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109902","volume":"37","author":"MH Chang","year":"2021","unstructured":"Chang, M. H. et al. Arthritis flares mediated by tissue-resident memory T cells in the joint. Cell Rep. 37, 109902 (2021).","journal-title":"Cell Rep."},{"key":"2141_CR607","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/art.42456","volume":"75","author":"FV Kraus","year":"2023","unstructured":"Kraus, F. V. et al. Reduction of proinflammatory effector functions through remodeling of fatty acid metabolism in CD8+ T cells from rheumatoid arthritis patients. Arthritis Rheumatol. 75, 1098\u20131109 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"2141_CR608","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13075-017-1283-3","volume":"19","author":"S Takahashi","year":"2017","unstructured":"Takahashi, S. et al. Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res. Ther. 19, 76 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"2141_CR609","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","volume":"40","author":"M Nakaya","year":"2014","unstructured":"Nakaya, M. et al. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40, 692\u2013705 (2014).","journal-title":"Immunity"},{"key":"2141_CR610","doi-asserted-by":"publisher","first-page":"ra97","DOI":"10.1126\/scisignal.aab2610","volume":"8","author":"D Klysz","year":"2015","unstructured":"Klysz, D. et al. Glutamine-dependent alpha-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. Sci. Signal. 8, ra97 (2015).","journal-title":"Sci. Signal."},{"key":"2141_CR611","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","volume":"35","author":"R Wang","year":"2011","unstructured":"Wang, R. et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871\u2013882 (2011).","journal-title":"Immunity"},{"key":"2141_CR612","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111516","volume":"41","author":"A Kumar","year":"2022","unstructured":"Kumar, A. et al. NKT cells adopt a glutamine-addicted phenotype to regulate their homeostasis and function. Cell Rep. 41, 111516 (2022).","journal-title":"Cell Rep."},{"key":"2141_CR613","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109133","volume":"112","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR\/P70S6K\/4EBP1 and NLRP3\/caspase-1\/IL-1beta pathways in MRL\/lpr mice. Int. Immunopharmacol. 112, 109133 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"2141_CR614","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14712598.2017.1258399","volume":"17","author":"B Verstockt","year":"2017","unstructured":"Verstockt, B., Van Assche, G., Vermeire, S. & Ferrante, M. Biological therapy targeting the IL-23\/IL-17 axis in inflammatory bowel disease. Expert Opin. Biol. Ther. 17, 31\u201347 (2017).","journal-title":"Expert Opin. Biol. Ther."},{"key":"2141_CR615","doi-asserted-by":"publisher","first-page":"113995","DOI":"10.1016\/j.celrep.2024.113995","volume":"43","author":"Z Zou","year":"2024","unstructured":"Zou, Z. et al. ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4(+) T cells in low arginine condition. Cell Rep. 43, 113995 (2024).","journal-title":"Cell Rep."},{"key":"2141_CR616","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1172\/JCI129269","volume":"130","author":"X Xia","year":"2020","unstructured":"Xia, X. et al. GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis. J. Clin. Investig. 130, 5180\u20135196 (2020).","journal-title":"J. Clin. Investig."},{"key":"2141_CR617","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","volume":"586","author":"M Zhang","year":"2020","unstructured":"Zhang, M. et al. A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis. Nature 586, 434\u2013439 (2020).","journal-title":"Nature"},{"key":"2141_CR618","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao, M. et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326\u20131338 (2012).","journal-title":"Genes Dev."},{"key":"2141_CR619","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature23475","volume":"548","author":"T Xu","year":"2017","unstructured":"Xu, T. et al. Metabolic control of T(H)17 and induced T(reg) cell balance by an epigenetic mechanism. Nature 548, 228\u2013233 (2017).","journal-title":"Nature"},{"key":"2141_CR620","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/gene.2011.74","volume":"13","author":"SY Lin","year":"2012","unstructured":"Lin, S. Y. et al. A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity. Genes Immun. 13, 214\u2013220 (2012).","journal-title":"Genes Immun."},{"key":"2141_CR621","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1136\/annrheumdis-2015-208410","volume":"75","author":"M Zhao","year":"2016","unstructured":"Zhao, M. et al. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann. Rheum. Dis. 75, 1998\u20132006 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"2141_CR622","doi-asserted-by":"publisher","first-page":"J135","DOI":"10.1016\/j.jaut.2011.11.001","volume":"38","author":"FM Strickland","year":"2012","unstructured":"Strickland, F. M. et al. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J. Autoimmun. 38, J135\u2013J143 (2012).","journal-title":"J. Autoimmun."},{"key":"2141_CR623","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13075-015-0748-5","volume":"17","author":"MC de Andres","year":"2015","unstructured":"de Andres, M. C. et al. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate. Arthritis Res. Ther. 17, 233 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"2141_CR624","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/art.38715","volume":"66","author":"AP Cribbs","year":"2014","unstructured":"Cribbs, A. P. et al. Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway. Arthritis Rheumatol. 66, 2344\u20132354 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"2141_CR625","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/08916930903374832","volume":"43","author":"G Gorelik","year":"2010","unstructured":"Gorelik, G. & Richardson, B. Key role of ERK pathway signaling in lupus. Autoimmunity 43, 17\u201322 (2010).","journal-title":"Autoimmunity"},{"key":"2141_CR626","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","volume":"34","author":"SM Hochrein","year":"2022","unstructured":"Hochrein, S. M. et al. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 34, 516\u2013532.e511 (2022).","journal-title":"Cell Metab."},{"key":"2141_CR627","doi-asserted-by":"publisher","first-page":"102913","DOI":"10.1016\/j.ebiom.2020.102913","volume":"58","author":"D Takahashi","year":"2020","unstructured":"Takahashi, D. et al. Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells. EBioMedicine 58, 102913 (2020).","journal-title":"EBioMedicine"},{"key":"2141_CR628","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm1511","volume":"8","author":"J He","year":"2022","unstructured":"He, J. et al. Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis. Sci. Adv. 8, eabm1511 (2022).","journal-title":"Sci. Adv."},{"key":"2141_CR629","doi-asserted-by":"publisher","first-page":"28833","DOI":"10.1074\/jbc.M111.233932","volume":"286","author":"K Yan","year":"2011","unstructured":"Yan, K. et al. Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity. J. Biol. Chem. 286, 28833\u201328843 (2011).","journal-title":"J. Biol. Chem."},{"key":"2141_CR630","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/art.22512","volume":"56","author":"LC Huber","year":"2007","unstructured":"Huber, L. C. et al. Histone deacetylase\/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 56, 1087\u20131093 (2007).","journal-title":"Arthritis Rheum."},{"key":"2141_CR631","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova, N. N., Zhu, J. & Thompson, C. B. The hallmarks of cancer metabolism: still emerging. Cell Metab. 34, 355\u2013377 (2022).","journal-title":"Cell Metab."},{"key":"2141_CR632","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27\u201347 (2016).","journal-title":"Cell Metab."},{"key":"2141_CR633","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-023-01442-3","volume":"8","author":"M You","year":"2023","unstructured":"You, M. et al. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal. Transduct. Target Ther. 8, 196 (2023).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2141_CR634","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","volume":"2","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis, R. J. & Chandel, N. S. We need to talk about the Warburg effect. Nat. Metab. 2, 127\u2013129 (2020).","journal-title":"Nat. Metab."},{"key":"2141_CR635","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.4161\/cc.22137","volume":"11","author":"UE Martinez-Outschoorn","year":"2012","unstructured":"Martinez-Outschoorn, U. E. et al. Ketone body utilization drives tumor growth and metastasis. Cell Cycle 11, 3964\u20133971 (2012).","journal-title":"Cell Cycle"},{"key":"2141_CR636","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bbabio.2010.08.010","volume":"1807","author":"R Diaz-Ruiz","year":"2011","unstructured":"Diaz-Ruiz, R., Rigoulet, M. & Devin, A. The Warburg and Crabtree effects: on the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim. Biophys. Acta 1807, 568\u2013576 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2141_CR637","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41420-021-00508-x","volume":"7","author":"T Zhu","year":"2021","unstructured":"Zhu, T. et al. ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signaling. Cell Death Discov. 7, 126 (2021).","journal-title":"Cell Death Discov."},{"key":"2141_CR638","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/mt.2016.42","volume":"24","author":"V Mamaeva","year":"2016","unstructured":"Mamaeva, V. et al. Inhibiting notch activity in breast cancer stem cells by glucose functionalized nanoparticles carrying gamma-secretase inhibitors. Mol. Ther. 24, 926\u2013936 (2016).","journal-title":"Mol. Ther."},{"key":"2141_CR639","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185085","volume":"12","author":"T Epstein","year":"2017","unstructured":"Epstein, T., Gatenby, R. A. & Brown, J. S. The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand. PLoS ONE 12, e0185085 (2017).","journal-title":"PLoS ONE"},{"key":"2141_CR640","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891\u2013899 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"2141_CR641","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1036502","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Natural products targeting glycolysis in cancer. Front. Pharmacol. 13, 1036502 (2022).","journal-title":"Front. Pharmacol."},{"key":"2141_CR642","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"2141_CR643","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/15384101.2019.1618125","volume":"18","author":"M Ghashghaeinia","year":"2019","unstructured":"Ghashghaeinia, M., Koberle, M., Mrowietz, U. & Bernhardt, I. Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes. Cell Cycle 18, 1316\u20131334 (2019).","journal-title":"Cell Cycle"},{"key":"2141_CR644","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1158\/0008-5472.CAN-18-1604","volume":"79","author":"N Rohani","year":"2019","unstructured":"Rohani, N. et al. Acidification of tumor at stromal boundaries drives transcriptome alterations associated with aggressive phenotypes. Cancer Res. 79, 1952\u20131966 (2019).","journal-title":"Cancer Res."},{"key":"2141_CR645","doi-asserted-by":"publisher","first-page":"86026","DOI":"10.18632\/oncotarget.13323","volume":"7","author":"S Faes","year":"2016","unstructured":"Faes, S. et al. Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies. Oncotarget 7, 86026\u201386038 (2016).","journal-title":"Oncotarget"},{"key":"2141_CR646","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1053\/j.semnuclmed.2014.10.006","volume":"45","author":"JG Rajendran","year":"2015","unstructured":"Rajendran, J. G. & Krohn, K. A. F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy. Semin. Nucl. Med. 45, 151\u2013162 (2015).","journal-title":"Semin. Nucl. Med."},{"key":"2141_CR647","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.12659\/MSM.916886","volume":"25","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Hypoxia-Inducible Factor-1alpha (HIF-1alpha) Promotes Hypoxia-Induced Invasion and metastasis in ovarian cancer by targeting Matrix Metallopeptidase 13 (MMP13). Med. Sci. Monit. 25, 7202\u20137208 (2019).","journal-title":"Med. Sci. Monit."},{"key":"2141_CR648","first-page":"63","volume":"38","author":"S Lu","year":"2018","unstructured":"Lu, S. & Wang, Y. Nonmetabolic functions of metabolic enzymes in cancer development. Cancer Commun. (Lond.) 38, 63 (2018).","journal-title":"Cancer Commun. (Lond.)"},{"key":"2141_CR649","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/cncr.11159","volume":"97","author":"M Kunkel","year":"2003","unstructured":"Kunkel, M. et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97, 1015\u20131024 (2003).","journal-title":"Cancer"},{"key":"2141_CR650","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1158\/2159-8290.CD-13-0565","volume":"3","author":"S Ros","year":"2013","unstructured":"Ros, S. & Schulze, A. Glycolysis back in the limelight: systemic targeting of HK2 blocks tumor growth. Cancer Discov. 3, 1105\u20131107 (2013).","journal-title":"Cancer Discov."},{"key":"2141_CR651","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/cac2.12404","volume":"43","author":"H He","year":"2023","unstructured":"He, H. et al. Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2. Cancer Commun. 43, 387\u2013390 (2023).","journal-title":"Cancer Commun."},{"key":"2141_CR652","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1091\/mbc.E18-09-0606","volume":"30","author":"DJ Kim","year":"2019","unstructured":"Kim, D. J. et al. Tristetraprolin-mediated hexokinase 2 expression regulation contributes to glycolysis in cancer cells. Mol. Biol. Cell. 30, 542\u2013553 (2019).","journal-title":"Mol. Biol. Cell."},{"key":"2141_CR653","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13046-021-02018-1","volume":"40","author":"P Dong","year":"2021","unstructured":"Dong, P. et al. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2\/miR-181a pathway. J. Exp. Clin. Cancer Res. 40, 216 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2141_CR654","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1111\/cas.14524","volume":"111","author":"Y Saito","year":"2020","unstructured":"Saito, Y. et al. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma. Cancer Sci. 111, 3071\u20133081 (2020).","journal-title":"Cancer Sci."},{"key":"2141_CR655","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21535-3","volume":"12","author":"F Zheng","year":"2021","unstructured":"Zheng, F. et al. The HIF-1alpha antisense long non-coding RNA drives a positive feedback loop of HIF-1alpha mediated transactivation and glycolysis. Nat. Commun. 12, 1341 (2021).","journal-title":"Nat. Commun."},{"key":"2141_CR656","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s13238-014-0082-8","volume":"5","author":"P Jiang","year":"2014","unstructured":"Jiang, P., Du, W. & Wu, M. Regulation of the pentose phosphate pathway in cancer. Protein Cell 5, 592\u2013602 (2014).","journal-title":"Protein Cell"},{"key":"2141_CR657","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0490-2","volume":"15","author":"N Azoitei","year":"2016","unstructured":"Azoitei, N. et al. PKM2 promotes tumor angiogenesis by regulating HIF-1alpha through NF-kappaB activation. Mol. Cancer 15, 3 (2016).","journal-title":"Mol. Cancer"},{"key":"2141_CR658","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan, Y. T. et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. 41, 109\u2013120 (2021).","journal-title":"Cancer Commun."},{"key":"2141_CR659","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","volume":"25","author":"B Kelly","year":"2015","unstructured":"Kelly, B. & O\u2019Neill, L. A. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771\u2013784 (2015).","journal-title":"Cell Res."},{"key":"2141_CR660","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-77736-8_1","volume":"1063","author":"S Bose","year":"2018","unstructured":"Bose, S. & Le, A. Glucose metabolism in cancer. Adv. Exp. Med. Biol. 1063, 3\u201312 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2141_CR661","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12094-023-03278-3","volume":"26","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Energy metabolism: a new target for gastric cancer treatment. Clin. Transl. Oncol. 26, 338\u2013351 (2024).","journal-title":"Clin. Transl. Oncol."},{"key":"2141_CR662","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/pros.20594","volume":"67","author":"N Monsef","year":"2007","unstructured":"Monsef, N. et al. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands. Prostate 67, 1219\u20131229 (2007).","journal-title":"Prostate"},{"key":"2141_CR663","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00109-011-0730-x","volume":"89","author":"CV Dang","year":"2011","unstructured":"Dang, C. V. et al. Therapeutic targeting of cancer cell metabolism. J. Mol. Med. 89, 205\u2013212 (2011).","journal-title":"J. Mol. Med."},{"key":"2141_CR664","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110\u20131122 (2014).","journal-title":"Cell"},{"key":"2141_CR665","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.cmet.2019.07.014","volume":"30","author":"CF Labuschagne","year":"2019","unstructured":"Labuschagne, C. F. et al. Cell clustering promotes a metabolic switch that supports metastatic colonization. Cell Metab. 30, 720\u2013734.e725 (2019).","journal-title":"Cell Metab."},{"key":"2141_CR666","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bcp.2018.03.006","volume":"151","author":"C Fumarola","year":"2018","unstructured":"Fumarola, C., Petronini, P. G. & Alfieri, R. Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways. Biochem. Pharmacol. 151, 114\u2013125 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"2141_CR667","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/JP280572","volume":"599","author":"SJ Kierans","year":"2021","unstructured":"Kierans, S. J. & Taylor, C. T. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J. Physiol. 599, 23\u201337 (2021).","journal-title":"J. Physiol."},{"key":"2141_CR668","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1021\/acscombsci.8b00104","volume":"20","author":"W Zhang","year":"2018","unstructured":"Zhang, W. et al. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics. ACS Comb. Sci. 20, 660\u2013671 (2018).","journal-title":"ACS Comb. Sci."},{"key":"2141_CR669","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cmet.2006.02.007","volume":"3","author":"MC Simon","year":"2006","unstructured":"Simon, M. C. Coming up for air: HIF-1 and mitochondrial oxygen consumption. Cell Metab. 3, 150\u2013151 (2006).","journal-title":"Cell Metab."},{"key":"2141_CR670","doi-asserted-by":"crossref","unstructured":"Rodriguez-Enriquez, S. et al. Transcriptional regulation of energy metabolism in cancer cells. Cells. 8, 1225 (2019).","DOI":"10.3390\/cells8101225"},{"key":"2141_CR671","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","volume":"15","author":"F Janku","year":"2018","unstructured":"Janku, F., Yap, T. A. & Meric-Bernstam, F. Targeting the PI3K pathway in cancer: are we making headway? Nat. Rev. Clin. Oncol. 15, 273\u2013291 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2141_CR672","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB signaling: navigating the network. Cell 169, 381\u2013405 (2017).","journal-title":"Cell"},{"key":"2141_CR673","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.celrep.2014.07.053","volume":"8","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth. Cell Rep. 8, 1461\u20131474 (2014).","journal-title":"Cell Rep."},{"key":"2141_CR674","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1111\/jcmm.14378","volume":"23","author":"A Mao","year":"2019","unstructured":"Mao, A. et al. KLF8 is associated with poor prognosis and regulates glycolysis by targeting GLUT4 in gastric cancer. J. Cell. Mol. Med. 23, 5087\u20135097 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"2141_CR675","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/cac2.12141","volume":"41","author":"T Guo","year":"2021","unstructured":"Guo, T. et al. Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4. Cancer Commun. 41, 258\u2013272 (2021).","journal-title":"Cancer Commun."},{"key":"2141_CR676","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01275-y","volume":"20","author":"M Shao","year":"2020","unstructured":"Shao, M. et al. SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis. Cancer Cell Int. 20, 188 (2020).","journal-title":"Cancer Cell Int."},{"key":"2141_CR677","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1128\/MCB.00440-07","volume":"27","author":"JW Kim","year":"2007","unstructured":"Kim, J. W. et al. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol. 27, 7381\u20137393 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"2141_CR678","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1158\/0008-5472.CAN-13-2034","volume":"74","author":"JR Doherty","year":"2014","unstructured":"Doherty, J. R. et al. Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis. Cancer Res. 74, 908\u2013920 (2014).","journal-title":"Cancer Res."},{"key":"2141_CR679","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1158\/0008-5472.CAN-11-2371","volume":"72","author":"MR Doe","year":"2012","unstructured":"Doe, M. R., Ascano, J. M., Kaur, M. & Cole, M. D. Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells. Cancer Res. 72, 949\u2013957 (2012).","journal-title":"Cancer Res."},{"key":"2141_CR680","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2011.145","volume":"22","author":"Y Hu","year":"2012","unstructured":"Hu, Y. et al. K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res. 22, 399\u2013412 (2012).","journal-title":"Cell Res."},{"key":"2141_CR681","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/21541248.2016.1192714","volume":"8","author":"P Storz","year":"2017","unstructured":"Storz, P. KRas, ROS and the initiation of pancreatic cancer. Small GTPases 8, 38\u201342 (2017).","journal-title":"Small GTPases"},{"key":"2141_CR682","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10020-022-00544-y","volume":"28","author":"Q Lu","year":"2022","unstructured":"Lu, Q., Zhang, X., Liang, T. & Bai, X. O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy. Mol. Med. 28, 115 (2022).","journal-title":"Mol. Med."},{"key":"2141_CR683","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1074\/jbc.M111.302547","volume":"287","author":"TP Lynch","year":"2012","unstructured":"Lynch, T. P. et al. Critical role of O-Linked beta-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J. Biol. Chem. 287, 11070\u201311081 (2012).","journal-title":"J. Biol. Chem."},{"key":"2141_CR684","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1111\/cas.14988","volume":"112","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. An AKT\/PRMT5\/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth. Cancer Sci. 112, 3083\u20133098 (2021).","journal-title":"Cancer Sci."},{"key":"2141_CR685","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","volume":"126","author":"K Bensaad","year":"2006","unstructured":"Bensaad, K. et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107\u2013120 (2006).","journal-title":"Cell"},{"key":"2141_CR686","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2017.02.013","volume":"394","author":"RE Gutteridge","year":"2017","unstructured":"Gutteridge, R. E., Singh, C. K., Ndiaye, M. A. & Ahmad, N. Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma. Cancer Lett. 394, 13\u201321 (2017).","journal-title":"Cancer Lett."},{"key":"2141_CR687","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251\u2013262 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2141_CR688","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","volume":"145","author":"W Luo","year":"2011","unstructured":"Luo, W. et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732\u2013744 (2011).","journal-title":"Cell"},{"key":"2141_CR689","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.aao1710","volume":"359","author":"D Pan","year":"2018","unstructured":"Pan, D. et al. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. Science 359, 770\u2013775 (2018).","journal-title":"Science"},{"key":"2141_CR690","doi-asserted-by":"crossref","unstructured":"Kubik, J. et al. Targeting energy metabolism in cancer treatment. Int. J. Mol. Sci. 23, 5572 (2022).","DOI":"10.3390\/ijms23105572"},{"key":"2141_CR691","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s42255-018-0011-x","volume":"1","author":"LP Diebold","year":"2019","unstructured":"Diebold, L. P. et al. Mitochondrial complex III is necessary for endothelial cell proliferation during angiogenesis. Nat. Metab. 1, 158\u2013171 (2019).","journal-title":"Nat. Metab."},{"key":"2141_CR692","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1158\/0008-5472.CAN-17-1751","volume":"78","author":"R Yonashiro","year":"2018","unstructured":"Yonashiro, R. et al. Pyruvate Dehydrogenase PDH-E1beta Controls Tumor Progression by Altering the Metabolic status of cancer cells. Cancer Res. 78, 1592\u20131603 (2018).","journal-title":"Cancer Res."},{"key":"2141_CR693","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79019-1","volume":"10","author":"L Jin","year":"2020","unstructured":"Jin, L. et al. Hemistepsin A suppresses colorectal cancer growth through inhibiting pyruvate dehydrogenase kinase activity. Sci. Rep. 10, 21940 (2020).","journal-title":"Sci. Rep."},{"key":"2141_CR694","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85\u201395 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"2141_CR695","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1042\/BST20160099","volume":"44","author":"G Laurenti","year":"2016","unstructured":"Laurenti, G. & Tennant, D. A. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer? Biochem. Soc. Trans. 44, 1111\u20131116 (2016).","journal-title":"Biochem. Soc. Trans."},{"key":"2141_CR696","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon, N. et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 19, 3011\u20133020 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"2141_CR697","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.bbabio.2011.07.003","volume":"1807","author":"C Bardella","year":"2011","unstructured":"Bardella, C., Pollard, P. J. & Tomlinson, I. SDH mutations in cancer. Biochim. Biophys. Acta 1807, 1432\u20131443 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2141_CR698","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-030-65768-0_2","volume":"1311","author":"T Li","year":"2021","unstructured":"Li, T., Copeland, C. & Le, A. Glutamine metabolism in cancer. Adv. Exp. Med. Biol. 1311, 17\u201338 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2141_CR699","doi-asserted-by":"publisher","first-page":"24691","DOI":"10.1074\/jbc.M114.568162","volume":"289","author":"K Shanmugasundaram","year":"2014","unstructured":"Shanmugasundaram, K. et al. The oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-kappaB signaling. J. Biol. Chem. 289, 24691\u201324699 (2014).","journal-title":"J. Biol. Chem."},{"key":"2141_CR700","first-page":"370","volume":"1826","author":"JQ Chen","year":"2012","unstructured":"Chen, J. Q. & Russo, J. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim. Biophys. Acta 1826, 370\u2013384 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"2141_CR701","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature19353","volume":"537","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli, M. et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 537, 544\u2013547 (2016).","journal-title":"Nature"},{"key":"2141_CR702","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1697","volume":"9","author":"D Shen","year":"2021","unstructured":"Shen, D. et al. Landscape of IDH1\/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis. Mol. Genet Genom. Med. 9, e1697 (2021).","journal-title":"Mol. Genet Genom. Med."},{"key":"2141_CR703","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nature09132","volume":"465","author":"L Dang","year":"2010","unstructured":"Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 465, 966 (2010).","journal-title":"Nature"},{"key":"2141_CR704","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.15252\/embj.201488598","volume":"33","author":"KT Pate","year":"2014","unstructured":"Pate, K. T. et al. Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J. 33, 1454\u20131473 (2014).","journal-title":"EMBO J."},{"key":"2141_CR705","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ajpath.2021.11.007","volume":"192","author":"X Nie","year":"2022","unstructured":"Nie, X. et al. LRP5 promotes gastric cancer via activating Canonical Wnt\/beta-Catenin and glycolysis pathways. Am. J. Pathol. 192, 503\u2013517 (2022).","journal-title":"Am. J. Pathol."},{"key":"2141_CR706","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"JW Kim","year":"2006","unstructured":"Kim, J. W., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177\u2013185 (2006).","journal-title":"Cell Metab."},{"key":"2141_CR707","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1073\/pnas.1001006107","volume":"107","author":"W Hu","year":"2010","unstructured":"Hu, W. et al. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl Acad. Sci. USA 107, 7455\u20137460 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR708","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2013.12.025","volume":"356","author":"J Liu","year":"2015","unstructured":"Liu, J., Zhang, C., Hu, W. & Feng, Z. Tumor suppressor p53 and its mutants in cancer metabolism. Cancer Lett. 356, 197\u2013203 (2015).","journal-title":"Cancer Lett."},{"key":"2141_CR709","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nature13611","volume":"514","author":"A Viale","year":"2014","unstructured":"Viale, A. et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514, 628\u2013632 (2014).","journal-title":"Nature"},{"key":"2141_CR710","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcancer.2024.03.004","volume":"100","author":"M Benej","year":"2024","unstructured":"Benej, M., Papandreou, I. & Denko, N. C. Hypoxic adaptation of mitochondria and its impact on tumor cell function. Semin. Cancer Biol. 100, 28\u201338 (2024).","journal-title":"Semin. Cancer Biol."},{"key":"2141_CR711","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0006-8993(02)04217-8","volume":"966","author":"A Miccheli","year":"2003","unstructured":"Miccheli, A. et al. [1-13C]Glucose entry in neuronal and astrocytic intermediary metabolism of aged rats. A study of the effects of nicergoline treatment by 13C NMR spectroscopy. Brain Res. 966, 116\u2013125 (2003).","journal-title":"Brain Res."},{"key":"2141_CR712","doi-asserted-by":"publisher","first-page":"e45806","DOI":"10.1371\/journal.pone.0045806","volume":"7","author":"CK Goo","year":"2012","unstructured":"Goo, C. K. et al. PTEN\/Akt signaling controls mitochondrial respiratory capacity through 4E-BP1. PLoS ONE 7, e45806 (2012).","journal-title":"PLoS ONE"},{"key":"2141_CR713","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/jcbfm.2014.137","volume":"34","author":"H Sancheti","year":"2014","unstructured":"Sancheti, H. et al. Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer\u2019s disease and the effect of lipoic acid: a 13C-NMR study. J. Cereb. Blood Flow. Metab. 34, 1749\u20131760 (2014).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"2141_CR714","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","volume":"77","author":"JY Wu","year":"2020","unstructured":"Wu, J. Y. et al. Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol. Cell. 77, 213\u2013227.e215 (2020).","journal-title":"Mol. Cell."},{"key":"2141_CR715","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-8-84","volume":"8","author":"TP Storozhevykh","year":"2007","unstructured":"Storozhevykh, T. P. et al. Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons. BMC Neurosci. 8, 84 (2007).","journal-title":"BMC Neurosci."},{"key":"2141_CR716","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.freeradbiomed.2008.06.021","volume":"45","author":"ER Dabkowski","year":"2008","unstructured":"Dabkowski, E. R., Williamson, C. L. & Hollander, J. M. Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia\/reperfusion-associated cardiac dysfunction. Free Radic. Biol. Med. 45, 855\u2013865 (2008).","journal-title":"Free Radic. Biol. Med."},{"key":"2141_CR717","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","volume":"8","author":"G Hatzivassiliou","year":"2005","unstructured":"Hatzivassiliou, G. et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311\u2013321 (2005).","journal-title":"Cancer Cell"},{"key":"2141_CR718","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.humpath.2005.11.022","volume":"37","author":"US Shah","year":"2006","unstructured":"Shah, U. S. et al. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum. Pathol. 37, 401\u2013409 (2006).","journal-title":"Hum. Pathol."},{"key":"2141_CR719","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1158\/2159-8290.CD-12-0107","volume":"2","author":"RA DeFilippis","year":"2012","unstructured":"DeFilippis, R. A. et al. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov. 2, 826\u2013839 (2012).","journal-title":"Cancer Discov."},{"key":"2141_CR720","doi-asserted-by":"crossref","unstructured":"Watt, M. J. et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci. Transl. Med. 11, eaau5758 (2019).","DOI":"10.1126\/scitranslmed.aau5758"},{"key":"2141_CR721","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano, H. & Sato, R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat. Rev. Endocrinol. 13, 710\u2013730 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2141_CR722","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/ijc.33113","volume":"147","author":"MJ Heo","year":"2020","unstructured":"Heo, M. J. et al. UBC12-mediated SREBP-1 neddylation worsens metastatic tumor prognosis. Int. J. Cancer 147, 2550\u20132563 (2020).","journal-title":"Int. J. Cancer"},{"key":"2141_CR723","doi-asserted-by":"publisher","first-page":"110274","DOI":"10.1016\/j.biopha.2020.110274","volume":"128","author":"Q Sun","year":"2020","unstructured":"Sun, Q. et al. Activation of SREBP-1c alters lipogenesis and promotes tumor growth and metastasis in gastric cancer. Biomed. Pharmacother. 128, 110274 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"2141_CR724","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tibs.2018.01.005","volume":"43","author":"RA DeBose-Boyd","year":"2018","unstructured":"DeBose-Boyd, R. A. & Ye, J. SREBPs in lipid metabolism, insulin signaling, and beyond. Trends Biochem. Sci. 43, 358\u2013368 (2018).","journal-title":"Trends Biochem. Sci."},{"key":"2141_CR725","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tem.2008.11.001","volume":"20","author":"X Su","year":"2009","unstructured":"Su, X. & Abumrad, N. A. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol. Metab. 20, 72\u201377 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"2141_CR726","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/excr.2002.5600","volume":"279","author":"YA Yang","year":"2002","unstructured":"Yang, Y. A. et al. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp. Cell Res. 279, 80\u201390 (2002).","journal-title":"Exp. Cell Res."},{"key":"2141_CR727","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI38942","volume":"120","author":"I Samudio","year":"2010","unstructured":"Samudio, I. et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Investig. 120, 142\u2013156 (2010).","journal-title":"J. Clin. Investig."},{"key":"2141_CR728","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","volume":"1807","author":"LS Pike","year":"2011","unstructured":"Pike, L. S. et al. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim. Biophys. Acta 1807, 726\u2013734 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2141_CR729","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova, M. M. & Shaw, R. J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13, 1016\u20131023 (2011).","journal-title":"Nat. Cell Biol."},{"key":"2141_CR730","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature17173","volume":"531","author":"S Beyaz","year":"2016","unstructured":"Beyaz, S. et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 531, 53\u201358 (2016).","journal-title":"Nature"},{"key":"2141_CR731","doi-asserted-by":"crossref","unstructured":"Cruzat, V. et al. Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients 10,1564 (2018).","DOI":"10.3390\/nu10111564"},{"key":"2141_CR732","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1074\/jbc.M115.700534","volume":"291","author":"A Broer","year":"2016","unstructured":"Broer, A., Rahimi, F. & Broer, S. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells. J. Biol. Chem. 291, 13194\u201313205 (2016).","journal-title":"J. Biol. Chem."},{"key":"2141_CR733","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13046-020-01791-9","volume":"40","author":"J Cao","year":"2021","unstructured":"Cao, J. et al. Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2\/beta-catenin pathway. J. Exp. Clin. Cancer Res. 40, 6 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2141_CR734","doi-asserted-by":"publisher","first-page":"994672","DOI":"10.3389\/fonc.2022.994672","volume":"12","author":"T Gong","year":"2022","unstructured":"Gong, T. et al. Glutamine metabolism in cancers: targeting the oxidative homeostasis. Front. Oncol. 12, 994672 (2022).","journal-title":"Front. Oncol."},{"key":"2141_CR735","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2015.447","volume":"35","author":"L Jin","year":"2016","unstructured":"Jin, L., Alesi, G. N. & Kang, S. Glutaminolysis as a target for cancer therapy. Oncogene 35, 3619\u20133625 (2016).","journal-title":"Oncogene"},{"key":"2141_CR736","doi-asserted-by":"publisher","first-page":"E5328","DOI":"10.1073\/pnas.1611406113","volume":"113","author":"A Elgogary","year":"2016","unstructured":"Elgogary, A. et al. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Proc. Natl Acad. Sci. USA 113, E5328\u2013E5336 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR737","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04626-4","volume":"7","author":"JG Ren","year":"2017","unstructured":"Ren, J. G. et al. Citrate suppresses tumor growth in multiple models through inhibition of glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway. Sci. Rep. 7, 4537 (2017).","journal-title":"Sci. Rep."},{"key":"2141_CR738","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/j.celrep.2019.02.037","volume":"26","author":"XH Lowman","year":"2019","unstructured":"Lowman, X. H. et al. p53 promotes cancer cell adaptation to glutamine deprivation by upregulating Slc7a3 to increase arginine uptake. Cell Rep. 26, 3051\u20133060.e3054 (2019).","journal-title":"Cell Rep."},{"key":"2141_CR739","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cmet.2018.07.005","volume":"28","author":"M Tajan","year":"2018","unstructured":"Tajan, M. et al. A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3. Cell Metab. 28, 721\u2013736.e726 (2018).","journal-title":"Cell Metab."},{"key":"2141_CR740","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc.2016.114","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16, 749 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"2141_CR741","doi-asserted-by":"publisher","first-page":"18782","DOI":"10.1073\/pnas.0810199105","volume":"105","author":"DR Wise","year":"2008","unstructured":"Wise, D. R. et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl Acad. Sci. USA 105, 18782\u201318787 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR742","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/toxsci\/kfr183","volume":"123","author":"KC Wu","year":"2011","unstructured":"Wu, K. C., Cui, J. Y. & Klaassen, C. D. Beneficial role of Nrf2 in regulating NADPH generation and consumption. Toxicol. Sci. 123, 590\u2013600 (2011).","journal-title":"Toxicol. Sci."},{"key":"2141_CR743","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cell.2021.12.039","volume":"185","author":"J Lotscher","year":"2022","unstructured":"Lotscher, J. et al. Magnesium sensing via LFA-1 regulates CD8(+) T cell effector function. Cell 185, 585\u2013602.e529 (2022).","journal-title":"Cell"},{"key":"2141_CR744","doi-asserted-by":"publisher","first-page":"102346","DOI":"10.1016\/j.isci.2021.102346","volume":"24","author":"H Bischof","year":"2021","unstructured":"Bischof, H. et al. Potassium ions promote hexokinase-II dependent glycolysis. iScience 24, 102346 (2021).","journal-title":"iScience"},{"key":"2141_CR745","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.cmet.2022.08.016","volume":"34","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1. Cell Metab. 34, 1843\u20131859.e1811 (2022).","journal-title":"Cell Metab."},{"key":"2141_CR746","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature09787","volume":"470","author":"E Sahin","year":"2011","unstructured":"Sahin, E. et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470, 359\u2013365 (2011).","journal-title":"Nature"},{"key":"2141_CR747","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03238-7","volume":"11","author":"M Schank","year":"2020","unstructured":"Schank, M. et al. Telomeric injury by KML001 in human T cells induces mitochondrial dysfunction through the p53-PGC-1alpha pathway. Cell Death Dis. 11, 1030 (2020).","journal-title":"Cell Death Dis."},{"key":"2141_CR748","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112796","volume":"149","author":"H Yuan","year":"2022","unstructured":"Yuan, H. et al. Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma. Biomed. Pharmacother. 149, 112796 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"2141_CR749","doi-asserted-by":"crossref","unstructured":"Yao, P. et al. Abrogation of nuclear entry of TERT by fructose 1,6-bisphosphatase 1-mediated dephosphorylation. Cancer Commun. 44, 1102(2024).","DOI":"10.1002\/cac2.12599"},{"key":"2141_CR750","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111194","volume":"40","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway. Cell Rep. 40, 111194 (2022).","journal-title":"Cell Rep."},{"key":"2141_CR751","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer 11, 726\u2013734 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"2141_CR752","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg, M. V. C. & Bourc\u2019his, D. The diverse roles of DNA methylation in mammalian development and disease. Nat. Rev. Mol. Cell Biol. 20, 590\u2013607 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2141_CR753","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmet.2014.06.004","volume":"20","author":"JV Lee","year":"2014","unstructured":"Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20, 306\u2013319 (2014).","journal-title":"Cell Metab."},{"key":"2141_CR754","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s42255-023-00912-w","volume":"5","author":"X Dou","year":"2023","unstructured":"Dou, X. et al. PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy. Nat. Metab. 5, 1887\u20131910 (2023).","journal-title":"Nat. Metab."},{"key":"2141_CR755","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"2141_CR756","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","volume":"107","author":"E Gottfried","year":"2006","unstructured":"Gottfried, E. et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107, 2013\u20132021 (2006).","journal-title":"Blood"},{"key":"2141_CR757","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader, J. E., Voss, K. & Rathmell, J. C. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol. Cell. 78, 1019\u20131033 (2020).","journal-title":"Mol. Cell."},{"key":"2141_CR758","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41416-021-01385-y","volume":"124","author":"D Jia","year":"2021","unstructured":"Jia, D. et al. Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer. Br. J. Cancer 124, 1902\u20131911 (2021).","journal-title":"Br. J. Cancer"},{"key":"2141_CR759","doi-asserted-by":"crossref","unstructured":"Zuzcak, M. & Trnka, J. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review). Int. J. Oncol. 61, 1\u20136 (2022).","DOI":"10.3892\/ijo.2022.5383"},{"key":"2141_CR760","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3892\/etm.2022.11372","volume":"24","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Erratum: Metformin inhibits the proliferation of A431 cells by modulating the PI3K\/Akt signaling pathway. Exp. Ther. Med. 24, 445 (2022).","journal-title":"Exp. Ther. Med."},{"key":"2141_CR761","doi-asserted-by":"publisher","first-page":"e153470","DOI":"10.1172\/JCI153470","volume":"133","author":"H Hu","year":"2023","unstructured":"Hu, H. et al. Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. J. Clin. Investig. 133, e153470 (2023).","journal-title":"J. Clin. Investig."},{"key":"2141_CR762","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","volume":"28","author":"W Li","year":"2018","unstructured":"Li, W. et al. Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer. Cell Metab. 28, 87\u2013103.e106 (2018).","journal-title":"Cell Metab."},{"key":"2141_CR763","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40425-019-0627-8","volume":"7","author":"KA Marijt","year":"2019","unstructured":"Marijt, K. A. et al. Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNgamma receptor signaling. J. Immunother. Cancer 7, 152 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"2141_CR764","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang, C. H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229\u20131241 (2015).","journal-title":"Cell"},{"key":"2141_CR765","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","volume":"28","author":"J Cong","year":"2018","unstructured":"Cong, J. et al. Dysfunction of natural killer cells by FBP1-Induced inhibition of glycolysis during lung cancer progression. Cell Metab. 28, 243\u2013255.e245 (2018).","journal-title":"Cell Metab."},{"key":"2141_CR766","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2017.06.004","volume":"26","author":"G Andrejeva","year":"2017","unstructured":"Andrejeva, G. & Rathmell, J. C. Similarities and distinctions of cancer and immune metabolism in inflammation and tumors. Cell Metab. 26, 49\u201370 (2017).","journal-title":"Cell Metab."},{"key":"2141_CR767","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang, C. H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239\u20131251 (2013).","journal-title":"Cell"},{"key":"2141_CR768","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","volume":"162","author":"PC Ho","year":"2015","unstructured":"Ho, P. C. et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162, 1217\u20131228 (2015).","journal-title":"Cell"},{"key":"2141_CR769","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia, L. et al. The cancer metabolic reprogramming and immune response. Mol. Cancer 20, 28 (2021).","journal-title":"Mol. Cancer"},{"key":"2141_CR770","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping, N. E. et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45, 374\u2013388 (2016).","journal-title":"Immunity"},{"key":"2141_CR771","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","volume":"6","author":"N Patsoukis","year":"2015","unstructured":"Patsoukis, N. et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun. 6, 6692 (2015).","journal-title":"Nat. Commun."},{"key":"2141_CR772","doi-asserted-by":"publisher","first-page":"19456","DOI":"10.18632\/oncotarget.3318","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer. Oncotarget 6, 19456\u201319468 (2015).","journal-title":"Oncotarget"},{"key":"2141_CR773","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer, K. et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109, 3812\u20133819 (2007).","journal-title":"Blood"},{"key":"2141_CR774","doi-asserted-by":"publisher","first-page":"107451","DOI":"10.1016\/j.pharmthera.2019.107451","volume":"206","author":"TP Brown","year":"2020","unstructured":"Brown, T. P. & Ganapathy, V. Lactate\/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon. Pharmacol. Ther. 206, 107451 (2020).","journal-title":"Pharmacol. Ther."},{"key":"2141_CR775","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","volume":"33","author":"VL Payen","year":"2020","unstructured":"Payen, V. L. et al. Monocarboxylate transporters in cancer. Mol. Metab. 33, 48\u201366 (2020).","journal-title":"Mol. Metab."},{"key":"2141_CR776","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1158\/0008-5472.CAN-17-1307","volume":"78","author":"N Caronni","year":"2018","unstructured":"Caronni, N. et al. Downregulation of membrane trafficking proteins and lactate conditioning determine loss of dendritic cell function in lung cancer. Cancer Res. 78, 1685\u20131699 (2018).","journal-title":"Cancer Res."},{"key":"2141_CR777","doi-asserted-by":"publisher","first-page":"e26383","DOI":"10.4161\/onci.26383","volume":"2","author":"Z Husain","year":"2013","unstructured":"Husain, Z., Seth, P. & Sukhatme, V. P. Tumor-derived lactate and myeloid-derived suppressor cells: linking metabolism to cancer immunology. Oncoimmunology 2, e26383 (2013).","journal-title":"Oncoimmunology"},{"key":"2141_CR778","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo, M. et al. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat. Rev. Immunol. 21, 151\u2013161 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2141_CR779","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645\u2013651 (2021).","journal-title":"Nature"},{"key":"2141_CR780","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.4049\/jimmunol.0902584","volume":"184","author":"K Dietl","year":"2010","unstructured":"Dietl, K. et al. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J. Immunol. 184, 1200\u20131209 (2010).","journal-title":"J. Immunol."},{"key":"2141_CR781","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"2141_CR782","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.tem.2021.04.013","volume":"32","author":"P Icard","year":"2021","unstructured":"Icard, P., Alifano, M., Donnadieu, E. & Simula, L. Fructose-1,6-bisphosphate promotes PI3K and glycolysis in T cells? Trends Endocrinol. Metab. 32, 540\u2013543 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"2141_CR783","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24619-2","volume":"12","author":"J He","year":"2021","unstructured":"He, J. et al. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development. Nat. Commun. 12, 4371 (2021).","journal-title":"Nat. Commun."},{"key":"2141_CR784","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203528","volume":"10","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Nuclear Fructose-1,6-Bisphosphate inhibits tumor growth and sensitizes chemotherapy by targeting HMGB1. Adv. Sci. 10, e2203528 (2023).","journal-title":"Adv. Sci."},{"key":"2141_CR785","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.biopha.2017.01.178","volume":"89","author":"GC Krause","year":"2017","unstructured":"Krause, G. C. et al. Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cells. Biomed. Pharmacother. 89, 358\u2013365 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"2141_CR786","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001\u20131012.e1005 (2021).","journal-title":"Cell Metab."},{"key":"2141_CR787","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors. Immunity 54, 1561\u20131577.e1567 (2021).","journal-title":"Immunity"},{"key":"2141_CR788","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.2172","volume":"16","author":"DL Herber","year":"2010","unstructured":"Herber, D. L. et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat. Med. 16, 880\u2013886 (2010).","journal-title":"Nat. Med."},{"key":"2141_CR789","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat. Immunol. 21, 298\u2013308 (2020).","journal-title":"Nat. Immunol."},{"key":"2141_CR790","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569\u2013573 (2013).","journal-title":"Science"},{"key":"2141_CR791","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2020.06.016","volume":"53","author":"S Kumagai","year":"2020","unstructured":"Kumagai, S. et al. An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells. Immunity 53, 187\u2013203.e188 (2020).","journal-title":"Immunity"},{"key":"2141_CR792","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33349-y","volume":"13","author":"P Yang","year":"2022","unstructured":"Yang, P. et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat. Commun. 13, 5782 (2022).","journal-title":"Nat. Commun."},{"key":"2141_CR793","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.3892\/ijo.2016.3486","volume":"48","author":"D Wang","year":"2016","unstructured":"Wang, D. et al. The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway. Int. J. Oncol. 48, 2303\u20132309 (2016).","journal-title":"Int. J. Oncol."},{"key":"2141_CR794","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41585-018-0118-6","volume":"15","author":"CA Bradley","year":"2018","unstructured":"Bradley, C. A. IL-23 links glutamine addiction and immune function. Nat. Rev. Urol. 15, 725 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"2141_CR795","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4049\/immunohorizons.2000020","volume":"4","author":"SR Presnell","year":"2020","unstructured":"Presnell, S. R. et al. Differential fuel requirements of human NK cells and human CD8 T cells: glutamine regulates glucose uptake in strongly activated CD8 T Cells. Immunohorizons 4, 231\u2013244 (2020).","journal-title":"Immunohorizons"},{"key":"2141_CR796","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-018-0597-x","volume":"562","author":"M Song","year":"2018","unstructured":"Song, M. et al. IRE1alpha-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature 562, 423\u2013428 (2018).","journal-title":"Nature"},{"key":"2141_CR797","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan, Y. et al. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat. Commun. 13, 4554 (2022).","journal-title":"Nat. Commun."},{"key":"2141_CR798","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1016\/j.cell.2024.07.030","volume":"187","author":"DJ Kloosterman","year":"2024","unstructured":"Kloosterman, D. J. et al. Macrophage-mediated myelin recycling fuels brain cancer malignancy. Cell 187, 5336\u20135356.e5330 (2024).","journal-title":"Cell"},{"key":"2141_CR799","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.trecan.2019.11.009","volume":"6","author":"S McGuirk","year":"2020","unstructured":"McGuirk, S., Audet-Delage, Y. & St-Pierre, J. Metabolic fitness and plasticity in cancer progression. Trends Cancer 6, 49\u201361 (2020).","journal-title":"Trends Cancer"},{"key":"2141_CR800","doi-asserted-by":"crossref","unstructured":"Moldogazieva, N. T., Mokhosoev, I. M. & Terentiev, A. A. Metabolic Heterogeneity Of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK. Cancers 12, 862 (2020).","DOI":"10.3390\/cancers12040862"},{"key":"2141_CR801","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni.2386","volume":"13","author":"R Wang","year":"2012","unstructured":"Wang, R. & Green, D. R. Metabolic checkpoints in activated T cells. Nat. Immunol. 13, 907\u2013915 (2012).","journal-title":"Nat. Immunol."},{"key":"2141_CR802","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2021.104556","volume":"83","author":"J Gao","year":"2021","unstructured":"Gao, J. et al. The combination of cinnamaldehyde and kaempferol ameliorates glucose and lipid metabolism disorders by enhancing lipid metabolism via AMPK activation. J. Funct. Foods 83, 104556 (2021).","journal-title":"J. Funct. Foods"},{"key":"2141_CR803","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04942-0","volume":"22","author":"J Dong","year":"2024","unstructured":"Dong, J. et al. ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARalpha- CPT1A axis. J. Transl. Med. 22, 196 (2024).","journal-title":"J. Transl. Med."},{"key":"2141_CR804","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.2337\/db21-0050","volume":"70","author":"L Wu","year":"2021","unstructured":"Wu, L. et al. The Attenuation Of Diabetic Nephropathy by Annexin A1 via Regulation Of Lipid Metabolism Through the AMPK\/PPARalpha\/CPT1b Pathway. Diabetes 70, 2192\u20132203 (2021).","journal-title":"Diabetes"},{"key":"2141_CR805","doi-asserted-by":"crossref","unstructured":"Chu, W. et al. PRMT6 epigenetically drives metabolic switch from fatty acid oxidation toward glycolysis and promotes osteoclast differentiation during osteoporosis. Adv Sci. 11, 2403177 (2024).","DOI":"10.1002\/advs.202403177"},{"key":"2141_CR806","doi-asserted-by":"crossref","unstructured":"Koo, K. M., Kim, C. D. & Kim, T. H. Recent advances in electrochemical detection of cell energy metabolism. Biosensors 14, 46 (2024).","DOI":"10.3390\/bios14010046"},{"key":"2141_CR807","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cell.2012.02.032","volume":"148","author":"RJ DeBerardinis","year":"2012","unstructured":"DeBerardinis, R. J. & Thompson, C. B. Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148, 1132\u20131144 (2012).","journal-title":"Cell"},{"key":"2141_CR808","doi-asserted-by":"publisher","first-page":"111875","DOI":"10.1016\/j.mad.2023.111875","volume":"216","author":"CB Santos-Reboucas","year":"2023","unstructured":"Santos-Reboucas, C. B., Cordovil Cotrin, J. & Dos Santos Junior, G. C. Exploring the interplay between metabolomics and genetics in Parkinson\u2019s disease: insights from ongoing research and future avenues. Mech. Ageing Dev. 216, 111875 (2023).","journal-title":"Mech. Ageing Dev."},{"key":"2141_CR809","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cell.2018.03.055","volume":"173","author":"C Jang","year":"2018","unstructured":"Jang, C., Chen, L. & Rabinowitz, J. D. Metabolomics and isotope tracing. Cell 173, 822\u2013837 (2018).","journal-title":"Cell"},{"key":"2141_CR810","doi-asserted-by":"publisher","first-page":"8248","DOI":"10.1021\/jacs.3c02043","volume":"145","author":"S Uchinomiya","year":"2023","unstructured":"Uchinomiya, S. et al. Fluorescence-based detection of fatty acid beta-oxidation in cells and tissues using quinone methide-releasing probes. J. Am. Chem. Soc. 145, 8248\u20138260 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"2141_CR811","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41551-022-00916-z","volume":"6","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. A wearable electrochemical biosensor for the monitoring of metabolites and nutrients. Nat. Biomed. Eng. 6, 1225\u20131235 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"2141_CR812","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino, T. et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diab. Care 42, 1593\u20131603 (2019).","journal-title":"Diab. Care"},{"key":"2141_CR813","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone, N. J. et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63, 2889\u20132934 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2141_CR814","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(03)12663-3","volume":"361","author":"AD Sniderman","year":"2003","unstructured":"Sniderman, A. D. et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361, 777\u2013780 (2003).","journal-title":"Lancet"},{"key":"2141_CR815","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1002\/jcp.25998","volume":"233","author":"Z Chen","year":"2018","unstructured":"Chen, Z., Liu, M., Li, L. & Chen, L. Involvement of the Warburg effect in non-tumor diseases processes. J. Cell. Physiol. 233, 2839\u20132849 (2018).","journal-title":"J. Cell. Physiol."},{"key":"2141_CR816","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10044-z","volume":"10","author":"S Dabral","year":"2019","unstructured":"Dabral, S. et al. A RASSF1A-HIF1alpha loop drives Warburg effect in cancer and pulmonary hypertension. Nat. Commun. 10, 2130 (2019).","journal-title":"Nat. Commun."},{"key":"2141_CR817","doi-asserted-by":"publisher","first-page":"12-OR","DOI":"10.2337\/db23-12-OR","volume":"72","author":"L Kugathasan","year":"2023","unstructured":"Kugathasan, L. et al. 12-OR: Urine lactate is a disease biomarker for diabetic kidney disease. Diabetes. 72, 12-OR (2023).","journal-title":"Diabetes."},{"key":"2141_CR818","doi-asserted-by":"publisher","first-page":"e3077","DOI":"10.1093\/cid\/ciaa1749","volume":"73","author":"M Abassi","year":"2021","unstructured":"Abassi, M. et al. Cerebrospinal fluid lactate as a prognostic marker of disease severity and mortality in Cryptococcal Meningitis. Clin. Infect. Dis. 73, e3077\u2013e3082 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"2141_CR819","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1021\/ac991021i","volume":"72","author":"N Gajovic","year":"2000","unstructured":"Gajovic, N. et al. Operation of a miniature redox hydrogel-based pyruvate sensor in undiluted deoxygenated calf serum. Anal. Chem. 72, 2963\u20132968 (2000).","journal-title":"Anal. Chem."},{"key":"2141_CR820","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.5740\/jaoacint.13-366","volume":"97","author":"W Shi","year":"2014","unstructured":"Shi, W. et al. Electrochemical determination of catechin, protocatechuic acid, and L-lactic acid based on voltammetric response of ferroceneboronic acid. J. AOAC Int. 97, 1742\u20131745 (2014).","journal-title":"J. AOAC Int."},{"key":"2141_CR821","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ab.2017.10.026","volume":"539","author":"T Larsen","year":"2017","unstructured":"Larsen, T. Fluorometric determination of d-lactate in biological fluids. Anal. Biochem. 539, 152\u2013157 (2017).","journal-title":"Anal. Biochem."},{"key":"2141_CR822","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/jssc.201701283","volume":"41","author":"CL Hsieh","year":"2018","unstructured":"Hsieh, C. L. et al. Enantioselective and simultaneous determination of lactate and 3-hydroxybutyrate in human plasma and urine using a narrow-bore online two-dimensional high-performance liquid chromatography system. J. Sep Sci. 41, 1298\u20131306 (2018).","journal-title":"J. Sep Sci."},{"key":"2141_CR823","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.aca.2016.08.025","volume":"942","author":"M Peng","year":"2016","unstructured":"Peng, M., Cai, Y., Fang, X. & Liu, L. Rapid quantification of metabolic intermediates in blood by liquid chromatography-tandem mass spectrometry to investigate congenital lactic acidosis. Anal. Chim. Acta 942, 50\u201357 (2016).","journal-title":"Anal. Chim. Acta"},{"key":"2141_CR824","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cmet.2022.10.002","volume":"35","author":"X Li","year":"2023","unstructured":"Li, X. et al. Ultrasensitive sensors reveal the spatiotemporal landscape of lactate metabolism in physiology and disease. Cell Metab. 35, 200\u2013211.e209 (2023).","journal-title":"Cell Metab."},{"key":"2141_CR825","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg4993","volume":"9","author":"M Jia","year":"2023","unstructured":"Jia, M. et al. ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation. Sci. Adv. 9, eadg4993 (2023).","journal-title":"Sci. Adv."},{"key":"2141_CR826","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41596-023-00948-y","volume":"19","author":"A Wang","year":"2024","unstructured":"Wang, A. et al. Comprehensive multiscale analysis of lactate metabolic dynamics in vitro and in vivo using highly responsive biosensors. Nat. Protoc. 19, 1311\u20131347 (2024).","journal-title":"Nat. Protoc."},{"key":"2141_CR827","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1077461","volume":"13","author":"DO Kamson","year":"2023","unstructured":"Kamson, D. O. et al. In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders. Front. Oncol. 13, 1077461 (2023).","journal-title":"Front. Oncol."},{"key":"2141_CR828","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.molimm.2015.07.034","volume":"68","author":"RP Donnelly","year":"2015","unstructured":"Donnelly, R. P. & Finlay, D. K. Glucose, glycolysis and lymphocyte responses. Mol. Immunol. 68, 513\u2013519 (2015).","journal-title":"Mol. Immunol."},{"key":"2141_CR829","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bios.2018.06.054","volume":"117","author":"F Alam","year":"2018","unstructured":"Alam, F. et al. Lactate biosensing: The emerging point-of-care and personal health monitoring. Biosens. Bioelectron. 117, 818\u2013829 (2018).","journal-title":"Biosens. Bioelectron."},{"key":"2141_CR830","doi-asserted-by":"crossref","unstructured":"Urbanska, K. & Orzechowski, A. Unappreciated role of LDHA and LDHB to control apoptosis and autophagy in tumor cells. Int. J. Mol. Sci. 20, 2085 (2019).","DOI":"10.3390\/ijms20092085"},{"key":"2141_CR831","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1107\/S1399004714024791","volume":"71","author":"S Kolappan","year":"2015","unstructured":"Kolappan, S. et al. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms. Acta Crystallogr. D. Biol. Crystallogr. 71, 185\u2013195 (2015).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"2141_CR832","doi-asserted-by":"publisher","first-page":"338254","DOI":"10.1016\/j.aca.2021.338254","volume":"1152","author":"E de la Serna","year":"2021","unstructured":"de la Serna, E. et al. Detection of Plasmodium falciparum malaria in 1 h using a simplified enzyme-linked immunosorbent assay. Anal. Chim. Acta 1152, 338254 (2021).","journal-title":"Anal. Chim. Acta"},{"key":"2141_CR833","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40580-020-00223-w","volume":"7","author":"WS Lee","year":"2020","unstructured":"Lee, W. S. et al. Simple, rapid, and accurate malaria diagnostic platform using microfluidic-based immunoassay of Plasmodium falciparum lactate dehydrogenase. Nano Converg. 7, 13 (2020).","journal-title":"Nano Converg."},{"key":"2141_CR834","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bios.2012.03.003","volume":"35","author":"S Lee","year":"2012","unstructured":"Lee, S. et al. A highly sensitive aptasensor towards Plasmodium lactate dehydrogenase for the diagnosis of malaria. Biosens. Bioelectron. 35, 291\u2013296 (2012).","journal-title":"Biosens. Bioelectron."},{"key":"2141_CR835","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92430-6","volume":"11","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases. Sci. Rep. 11, 12997 (2021).","journal-title":"Sci. Rep."},{"key":"2141_CR836","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.semcancer.2022.09.001","volume":"86","author":"A Comandatore","year":"2022","unstructured":"Comandatore, A. et al. Lactate dehydrogenase and its clinical significance in pancreatic and thoracic cancers. Semin. Cancer Biol. 86, 93\u2013100 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2141_CR837","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.751506","volume":"8","author":"Y Ma","year":"2021","unstructured":"Ma, Y. et al. Creation of a Novel Nomogram Based on the Direct Bilirubin-To-Indirect Bilirubin Ratio and Lactate Dehydrogenase Levels in Resectable Colorectal Cancer. Front. Mol. Biosci. 8, 751506 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"2141_CR838","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/cam4.2024","volume":"8","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Cancer Med. 8, 1467\u20131473 (2019).","journal-title":"Cancer Med."},{"key":"2141_CR839","doi-asserted-by":"crossref","unstructured":"Zhang, F. et al. Clinical value of jointly detection serum lactate dehydrogenase\/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion. J. Clin. Lab. Anal. 31, e22106 (2017).","DOI":"10.1002\/jcla.22106"},{"key":"2141_CR840","first-page":"45","volume":"62","author":"BS Aripov","year":"1990","unstructured":"Aripov, B. S. The prevalence of the basic risk factors for ischemic heart disease in Tashkent students. Ter. Arkh. 62, 45\u201347 (1990).","journal-title":"Ter. Arkh."},{"key":"2141_CR841","doi-asserted-by":"publisher","first-page":"11126","DOI":"10.1021\/acsomega.1c07205","volume":"7","author":"VS Siu","year":"2022","unstructured":"Siu, V. S. et al. Toward a Quantitative Colorimeter for Point-of-Care Nitrite Detection. ACS Omega 7, 11126\u201311134 (2022).","journal-title":"ACS Omega"},{"key":"2141_CR842","doi-asserted-by":"publisher","first-page":"e100847","DOI":"10.1371\/journal.pone.0100847","volume":"9","author":"S Lee","year":"2014","unstructured":"Lee, S., Manjunatha, D. H., Jeon, W. & Ban, C. Cationic surfactant-based colorimetric detection of Plasmodium lactate dehydrogenase, a biomarker for malaria, using the specific DNA aptamer. PLoS ONE 9, e100847 (2014).","journal-title":"PLoS ONE"},{"key":"2141_CR843","doi-asserted-by":"publisher","first-page":"9288","DOI":"10.1021\/acs.analchem.5b01923","volume":"87","author":"B Kannan","year":"2015","unstructured":"Kannan, B. et al. Printed paper sensors for serum lactate dehydrogenase using pullulan-based inks to immobilize reagents. Anal. Chem. 87, 9288\u20139293 (2015).","journal-title":"Anal. Chem."},{"key":"2141_CR844","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114513","volume":"215","author":"K Arias-Alpizar","year":"2022","unstructured":"Arias-Alpizar, K. et al. Malaria quantitative POC testing using magnetic particles, a paper microfluidic device and a hand-held fluorescence reader. Biosens. Bioelectron. 215, 114513 (2022).","journal-title":"Biosens. Bioelectron."},{"key":"2141_CR845","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45606-0","volume":"9","author":"CP Halvorsen","year":"2019","unstructured":"Halvorsen, C. P. et al. A rapid smartphone-based lactate dehydrogenase test for neonatal diagnostics at the point of care. Sci. Rep. 9, 9301 (2019).","journal-title":"Sci. Rep."},{"key":"2141_CR846","doi-asserted-by":"publisher","DOI":"10.1186\/s12858-019-0108-1","volume":"20","author":"K Chamchoy","year":"2019","unstructured":"Chamchoy, K. et al. Application of WST-8 based colorimetric NAD(P)H detection for quantitative dehydrogenase assays. BMC Biochem. 20, 4 (2019).","journal-title":"BMC Biochem."},{"key":"2141_CR847","doi-asserted-by":"publisher","first-page":"114989","DOI":"10.1016\/j.jelechem.2021.114989","volume":"882","author":"HO Kaya","year":"2021","unstructured":"Kaya, H. O., Cetin, A. E., Azimzadeh, M. & Topkaya, S. N. Pathogen detection with electrochemical biosensors: Advantages, challenges and future perspectives. J. Electroanal. Chem. 882, 114989 (2021).","journal-title":"J. Electroanal. Chem."},{"key":"2141_CR848","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.aca.2020.03.034","volume":"1111","author":"IS Kucherenko","year":"2020","unstructured":"Kucherenko, I. S., Soldatkin, O. O., Dzyadevych, S. V. & Soldatkin, A. P. Electrochemical biosensors based on multienzyme systems: main groups, advantages and limitations - A review. Anal. Chim. Acta 1111, 114\u2013131 (2020).","journal-title":"Anal. Chim. Acta"},{"key":"2141_CR849","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1021\/acs.analchem.9b02526","volume":"92","author":"SA Byrnes","year":"2020","unstructured":"Byrnes, S. A. et al. Wash-Free, Digital Immunoassay in Polydisperse Droplets. Anal. Chem. 92, 3535\u20133543 (2020).","journal-title":"Anal. Chem."},{"key":"2141_CR850","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.talanta.2018.04.086","volume":"187","author":"A Hemben","year":"2018","unstructured":"Hemben, A., Ashley, J. & Tothill, I. E. An immunosensor for parasite lactate dehydrogenase detection as a malaria biomarker - Comparison with commercial test kit. Talanta 187, 321\u2013329 (2018).","journal-title":"Talanta"},{"key":"2141_CR851","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1016\/j.bios.2011.01.031","volume":"26","author":"L Yang","year":"2011","unstructured":"Yang, L. et al. Optical analysis of lactate dehydrogenase and glucose by CdTe quantum dots and their dual simultaneous detection. Biosens. Bioelectron. 26, 3488\u20133493 (2011).","journal-title":"Biosens. Bioelectron."},{"key":"2141_CR852","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bios.2010.05.014","volume":"26","author":"X Ren","year":"2010","unstructured":"Ren, X. et al. Enzyme biosensor based on NAD-sensitive quantum dots. Biosens. Bioelectron. 26, 271\u2013274 (2010).","journal-title":"Biosens. Bioelectron."},{"key":"2141_CR853","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-biophys-060414-033901","volume":"44","author":"N Yan","year":"2015","unstructured":"Yan, N. Structural biology of the major facilitator superfamily transporters. Annu Rev. Biophys. 44, 257\u2013283 (2015).","journal-title":"Annu Rev. Biophys."},{"key":"2141_CR854","doi-asserted-by":"crossref","unstructured":"Lizak, B. et al. Glucose transport and transporters in the endomembranes. Int. J. Mol. Sci. 20, 5898 (2019).","DOI":"10.3390\/ijms20235898"},{"key":"2141_CR855","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.1152\/ajpendo.00712.2009","volume":"298","author":"B Thorens","year":"2010","unstructured":"Thorens, B. & Mueckler, M. Glucose transporters in the 21st Century. Am. J. Physiol. Endocrinol. Metab. 298, E141\u2013E145 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2141_CR856","first-page":"585","volume":"10","author":"X Song","year":"2020","unstructured":"Song, X. et al. Correlation of GLUT1 and GLUT4 with prognosis of patients with hypothyroidism and cardiac insufficiency. Am. J. Cardiovasc. Dis. 10, 585\u2013592 (2020).","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"2141_CR857","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2020.12.067","volume":"540","author":"K Gluchowska","year":"2021","unstructured":"Gluchowska, K., Pliszka, M. & Szablewski, L. Expression of glucose transporters in human neurodegenerative diseases. Biochem. Biophys. Res. Commun. 540, 8\u201315 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2141_CR858","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ehf2.13063","volume":"8","author":"J Mustroph","year":"2021","unstructured":"Mustroph, J. et al. Decreased GLUT1\/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19. ESC Heart Fail 8, 309\u2013316 (2021).","journal-title":"ESC Heart Fail"},{"key":"2141_CR859","doi-asserted-by":"crossref","unstructured":"Aldahmash, W. et al. Expression of glucose transporters 1 and 3 in the placenta of pregnant women with gestational Diabetes Mellitus. Life 13, 993 (2023).","DOI":"10.3390\/life13040993"},{"key":"2141_CR860","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00592-020-01558-w","volume":"57","author":"AM Bolla","year":"2020","unstructured":"Bolla, A. M. et al. Expression of glucose transporters in duodenal mucosa of patients with type 1 diabetes. Acta Diabetol. 57, 1367\u20131373 (2020).","journal-title":"Acta Diabetol."},{"key":"2141_CR861","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7","volume":"80","author":"M Younes","year":"1997","unstructured":"Younes, M. et al. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 80, 1046\u20131051 (1997).","journal-title":"Cancer"},{"key":"2141_CR862","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/sj.bjc.6601260","volume":"89","author":"PJ Hoskin","year":"2003","unstructured":"Hoskin, P. J., Sibtain, A., Daley, F. M. & Wilson, G. D. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br. J. Cancer 89, 1290\u20131297 (2003).","journal-title":"Br. J. Cancer"},{"key":"2141_CR863","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.3390\/molecules15042374","volume":"15","author":"FR Ayala","year":"2010","unstructured":"Ayala, F. R. et al. GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma. Molecules 15, 2374\u20132387 (2010).","journal-title":"Molecules"},{"key":"2141_CR864","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00005537-200202000-00034","volume":"112","author":"S Baer","year":"2002","unstructured":"Baer, S. et al. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival. Laryngoscope 112, 393\u2013396 (2002).","journal-title":"Laryngoscope"},{"key":"2141_CR865","doi-asserted-by":"publisher","first-page":"115820","DOI":"10.1016\/j.bios.2023.115820","volume":"244","author":"K Wang","year":"2024","unstructured":"Wang, K. et al. Detection of glucose transporter 1 in living cells for assessment of tumor development and therapy using an electrochemical biosensor. Biosens. Bioelectron. 244, 115820 (2024).","journal-title":"Biosens. Bioelectron."},{"key":"2141_CR866","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1039\/D1CC00343G","volume":"57","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. A GLUT1 inhibitor-based probe significantly ameliorates the sensitivity of tumor detection and diagnostic imaging. Chem. Commun. 57, 5530\u20135533 (2021).","journal-title":"Chem. Commun."},{"key":"2141_CR867","doi-asserted-by":"crossref","unstructured":"Zangari, J., Petrelli, F., Maillot, B. & Martinou, J. C. The multifaceted pyruvate metabolism: role of the mitochondrial pyruvate carrier. Biomolecules. 10, 1068 (2020).","DOI":"10.3390\/biom10071068"},{"key":"2141_CR868","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","volume":"20","author":"K Palikaras","year":"2018","unstructured":"Palikaras, K., Lionaki, E. & Tavernarakis, N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat. Cell Biol. 20, 1013\u20131022 (2018).","journal-title":"Nat. Cell Biol."},{"key":"2141_CR869","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.microc.2019.02.046","volume":"146","author":"CS Pundir","year":"2019","unstructured":"Pundir, C. S., Malik, M. & Chaudhary, R. Quantification of pyruvate with special emphasis on biosensors: a review. Microchem. J. 146, 1102\u20131112 (2019).","journal-title":"Microchem. J."},{"key":"2141_CR870","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/0973-029X.180955","volume":"20","author":"MA Bhat","year":"2016","unstructured":"Bhat, M. A. et al. Pyruvic acid levels in serum and saliva: a new course for oral cancer screening? J. Oral. Maxillofac. Pathol. 20, 102\u2013105 (2016).","journal-title":"J. Oral. Maxillofac. Pathol."},{"key":"2141_CR871","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.4317\/jced.52266","volume":"7","author":"A Bhat","year":"2015","unstructured":"Bhat, A. et al. Estimation of Pyruvic acid in serum and saliva among healthy and potentially malignant disorder subjects - a stepping stone for cancer screening? J. Clin. Exp. Dent. 7, e462\u2013e465 (2015).","journal-title":"J. Clin. Exp. Dent."},{"key":"2141_CR872","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1111\/jgh.12979","volume":"30","author":"U Sharma","year":"2015","unstructured":"Sharma, U. et al. Metabolic abnormalities of gastrointestinal mucosa in celiac disease: an in vitro proton nuclear magnetic resonance spectroscopy study. J. Gastroenterol. Hepatol. 30, 1492\u20131498 (2015).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2141_CR873","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.tube.2015.02.038","volume":"95","author":"A Zhou","year":"2015","unstructured":"Zhou, A. et al. Metabolomics specificity of tuberculosis plasma revealed by (1)H NMR spectroscopy. Tuberculosis 95, 294\u2013302 (2015).","journal-title":"Tuberculosis"},{"key":"2141_CR874","doi-asserted-by":"crossref","unstructured":"Yang, Q. W. M. Platinum nanoparticles modified MXene for highly sensitive detection of pyruvate. Mater. Lett. 322, 132496 (2022).","DOI":"10.1016\/j.matlet.2022.132496"},{"key":"2141_CR875","doi-asserted-by":"publisher","first-page":"120457","DOI":"10.1016\/j.saa.2021.120457","volume":"267","author":"K Rajalakshmi","year":"2022","unstructured":"Rajalakshmi, K. et al. A new recognition moiety diphenylborinate in the detection of pyruvate via Lewis acid\/base sensing pathway and its bioimaging applications. Spectrochim. Acta A Mol. Biomol. Spectrosc. 267, 120457 (2022).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"2141_CR876","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fimmu.2016.00145","volume":"7","author":"JC Alves-Filho","year":"2016","unstructured":"Alves-Filho, J. C. & Palsson-McDermott, E. M. Pyruvate Kinase M2: a potential target for regulating inflammation. Front. Immunol. 7, 145 (2016).","journal-title":"Front. Immunol."},{"key":"2141_CR877","doi-asserted-by":"crossref","unstructured":"Park, Y. S. et al. Pyruvate Kinase M2: a new biomarker for the early detection of diabetes-induced nephropathy. Int. J. Mol. Sci. 24, 2683 (2023).","DOI":"10.3390\/ijms24032683"},{"key":"2141_CR878","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5487\/TR.2016.32.1.047","volume":"32","author":"JH Cheon","year":"2016","unstructured":"Cheon, J. H. et al. Pyruvate Kinase M2: a novel biomarker for the early detection of acute kidney injury. Toxicol. Res. 32, 47\u201356 (2016).","journal-title":"Toxicol. Res."},{"key":"2141_CR879","doi-asserted-by":"publisher","first-page":"hcab100.074","DOI":"10.1093\/qjmed\/hcab100.074","volume":"114","author":"TM Youssef","year":"2021","unstructured":"Youssef, T. M. et al. Evaluation of plasma M2-Pyruvate Kinase as a novel biomarker in the differentiation between functional and organic colonic disorders. QJM: Int. J. Med. 114, hcab100.074 (2021).","journal-title":"QJM: Int. J. Med."},{"key":"2141_CR880","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.canlet.2020.11.018","volume":"503","author":"S Zhu","year":"2021","unstructured":"Zhu, S. et al. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics. Cancer Lett. 503, 240\u2013248 (2021).","journal-title":"Cancer Lett."},{"key":"2141_CR881","doi-asserted-by":"publisher","first-page":"12682","DOI":"10.1021\/acs.analchem.1c02529","volume":"93","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. TEPP-46-Based AIE fluorescent probe for detection and bioimaging of PKM2 in living cells. Anal. Chem. 93, 12682\u201312689 (2021).","journal-title":"Anal. Chem."},{"key":"2141_CR882","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1039\/D2CC01211A","volume":"58","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. A responsive fluorescent probe for detecting and imaging pyruvate kinase M2 in live cells. Chem. Commun. 58, 6494\u20136497 (2022).","journal-title":"Chem. Commun."},{"key":"2141_CR883","doi-asserted-by":"publisher","first-page":"9669","DOI":"10.1021\/acs.analchem.1c00208","volume":"93","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Discovery of a Fluorogenic Probe for In Situ Pyruvate Kinase M2 Isoform (PKM2) Labeling through Chemoselective S(N)Ar with a Binding Site Lysine Residue. Anal. Chem. 93, 9669\u20139676 (2021).","journal-title":"Anal. Chem."},{"key":"2141_CR884","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","volume":"6","author":"LE Navas","year":"2021","unstructured":"Navas, L. E. & Carnero, A. NAD(+) metabolism, stemness, the immune response, and cancer. Signal. Transduct. Target Ther. 6, 2 (2021).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2141_CR885","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.1038\/onc.2010.406","volume":"29","author":"Y Deng","year":"2010","unstructured":"Deng, Y. et al. Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1. Oncogene 29, 6603\u20136608 (2010).","journal-title":"Oncogene"},{"key":"2141_CR886","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/j.crmeth.2021.100116","volume":"1","author":"Q Hu","year":"2021","unstructured":"Hu, Q. et al. Genetically encoded biosensors for evaluating NAD(+)\/NADH ratio in cytosolic and mitochondrial compartments. Cell Rep. Methods. 1, 100116 (2021).","journal-title":"Cell Rep. Methods."},{"key":"2141_CR887","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2174\/0929867329666220322104552","volume":"30","author":"J Suwara","year":"2023","unstructured":"Suwara, J., Radzikowska-Cieciura, E., Chworos, A. & Pawlowska, R. The ATP-dependent Pathways and Human Diseases. Curr. Med. Chem. 30, 1232\u20131255 (2023).","journal-title":"Curr. Med. Chem."},{"key":"2141_CR888","doi-asserted-by":"publisher","DOI":"10.1177\/2398212818817494","volume":"2","author":"G Burnstock","year":"2018","unstructured":"Burnstock, G. Purine and purinergic receptors. Brain Neurosci. Adv. 2, 2398212818817494 (2018).","journal-title":"Brain Neurosci. Adv."},{"key":"2141_CR889","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","volume":"120","author":"G Burnstock","year":"2017","unstructured":"Burnstock, G. Purinergic signaling in the cardiovascular system. Circ. Res. 120, 207\u2013228 (2017).","journal-title":"Circ. Res."},{"key":"2141_CR890","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.imlet.2019.08.009","volume":"214","author":"JLG da Silva","year":"2019","unstructured":"da Silva, J. L. G., Passos, D. F., Bernardes, V. M. & Leal, D. B. R. ATP and adenosine: role in the immunopathogenesis of rheumatoid arthritis. Immunol. Lett. 214, 55\u201364 (2019).","journal-title":"Immunol. Lett."},{"key":"2141_CR891","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/1753-0407.12098","volume":"6","author":"C Wang","year":"2014","unstructured":"Wang, C. et al. Intracellular and extracellular adenosine triphosphate in regulation of insulin secretion from pancreatic beta cells (beta). J. Diab. 6, 113\u2013119 (2014).","journal-title":"J. Diab."},{"key":"2141_CR892","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1089\/scd.2012.0432","volume":"22","author":"M Ciciarello","year":"2013","unstructured":"Ciciarello, M. et al. Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages. Stem Cells Dev. 22, 1097\u20131111 (2013).","journal-title":"Stem Cells Dev."},{"key":"2141_CR893","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11302-013-9372-5","volume":"9","author":"G Burnstock","year":"2013","unstructured":"Burnstock, G. & Di Virgilio, F. Purinergic signalling and cancer. Purinergic Signal 9, 491\u2013540 (2013).","journal-title":"Purinergic Signal"},{"key":"2141_CR894","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","volume":"18","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio, F. et al. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat. Rev. Cancer 18, 601\u2013618 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"2141_CR895","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/bjc.2013.484","volume":"109","author":"WH Li","year":"2013","unstructured":"Li, W. H. et al. P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells. Br. J. Cancer 109, 1666\u20131675 (2013).","journal-title":"Br. J. Cancer"},{"key":"2141_CR896","doi-asserted-by":"publisher","first-page":"12104","DOI":"10.1021\/acs.analchem.3c02242","volume":"95","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. Gold nanocluster-based fluorescent microneedle platform toward visual detection of ATP. Anal. Chem. 95, 12104\u201312112 (2023).","journal-title":"Anal. Chem."},{"key":"2141_CR897","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1021\/acs.analchem.2c00613","volume":"94","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Electrochemical Aptamer Biosensor Based on ATP-Induced 2D DNA Structure Switching for Rapid and Ultrasensitive Detection of ATP. Anal. Chem. 94, 6819\u20136826 (2022).","journal-title":"Anal. Chem."},{"key":"2141_CR898","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2021.113832","volume":"198","author":"K Nishiyama","year":"2022","unstructured":"Nishiyama, K. et al. Electrochemical enzyme-based blood ATP and lactate sensor for a rapid and straightforward evaluation of illness severity. Biosens. Bioelectron. 198, 113832 (2022).","journal-title":"Biosens. Bioelectron."},{"key":"2141_CR899","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/chemosensors11070417","volume":"11","author":"Q-S Gu","year":"2023","unstructured":"Gu, Q.-S. et al. Recent advances in design strategies and imaging applications of fluorescent probes for ATP. Chemosensors 11, 417 (2023).","journal-title":"Chemosensors"},{"key":"2141_CR900","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.110742","volume":"201","author":"H Sun","year":"2024","unstructured":"Sun, H. et al. Nanopore single molecule ATP detection based on the dual effects of specific capturing and signal amplification. Microchem. J. 201, 110742 (2024).","journal-title":"Microchem. J."},{"key":"2141_CR901","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114402","volume":"212","author":"D Song","year":"2022","unstructured":"Song, D. et al. Dual-hairpin ligation amplification enabled ultra-sensitive and selective ATP detection for cancer monitor. Biosens. Bioelectron. 212, 114402 (2022).","journal-title":"Biosens. Bioelectron."},{"key":"2141_CR902","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1053\/j.gastro.2018.11.033","volume":"156","author":"X Hu","year":"2019","unstructured":"Hu, X. et al. ATF4 deficiency promotes intestinal inflammation in mice by reducing uptake of glutamine and expression of antimicrobial peptides. Gastroenterology 156, 1098\u20131111 (2019).","journal-title":"Gastroenterology"},{"key":"2141_CR903","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00726-021-03002-x","volume":"53","author":"G Galezowska","year":"2021","unstructured":"Galezowska, G., Ratajczyk, J. & Wolska, L. Determination of amino acids in human biological fluids by high-performance liquid chromatography: critical review. Amino Acids 53, 993\u20131009 (2021).","journal-title":"Amino Acids"},{"key":"2141_CR904","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jbiotec.2016.12.001","volume":"242","author":"F Manig","year":"2017","unstructured":"Manig, F. et al. The why and how of amino acid analytics in cancer diagnostics and therapy. J. Biotechnol. 242, 30\u201354 (2017).","journal-title":"J. Biotechnol."},{"key":"2141_CR905","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jpba.2013.03.019","volume":"81\u201382","author":"M Shamsipur","year":"2013","unstructured":"Shamsipur, M., Naseri, M. T. & Babri, M. Quantification of candidate prostate cancer metabolite biomarkers in urine using dispersive derivatization liquid-liquid microextraction followed by gas and liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 81\u201382, 65\u201375 (2013).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"2141_CR906","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11060-023-04329-z","volume":"163","author":"S Toklu","year":"2023","unstructured":"Toklu, S. et al. Tissue and plasma free amino acid detection by LC-MS\/MS method in high grade glioma patients. J. Neurooncol. 163, 293\u2013300 (2023).","journal-title":"J. Neurooncol."},{"key":"2141_CR907","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/jacs.2c11285","volume":"145","author":"L Dreisewerd","year":"2023","unstructured":"Dreisewerd, L. et al. NMR discrimination of d- and l-alpha-Amino acids at submicromolar concentration via parahydrogen-induced hyperpolarization. J. Am. Chem. Soc. 145, 1518\u20131523 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"2141_CR908","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3174\/ajnr.A7762","volume":"44","author":"N Soni","year":"2023","unstructured":"Soni, N. et al. Amino Acid Tracer PET MRI in glioma management: what a neuroradiologist needs to know. AJNR Am. J. Neuroradiol. 44, 236\u2013246 (2023).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"2141_CR909","doi-asserted-by":"crossref","unstructured":"Rodrigues, D. et al. GC-MS metabolomics reveals distinct profiles of low- and high-grade bladder cancer cultured cells. Metabolites 9, 18 (2019).","DOI":"10.3390\/metabo9010018"},{"key":"2141_CR910","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1042\/BST20170291","volume":"45","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Platelet mitochondrial dysfunction and the correlation with human diseases. Biochem. Soc. Trans. 45, 1213\u20131223 (2017).","journal-title":"Biochem. Soc. Trans."},{"key":"2141_CR911","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen, M. M. et al. Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics 21, e00292 (2024).","journal-title":"Neurotherapeutics"},{"key":"2141_CR912","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.freeradbiomed.2005.02.014","volume":"38","author":"SW Ballinger","year":"2005","unstructured":"Ballinger, S. W. Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 38, 1278\u20131295 (2005).","journal-title":"Free Radic. Biol. Med."},{"key":"2141_CR913","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/bja\/aer093","volume":"107","author":"HF Galley","year":"2011","unstructured":"Galley, H. F. Oxidative stress and mitochondrial dysfunction in sepsis. Br. J. Anaesth. 107, 57\u201364 (2011).","journal-title":"Br. J. Anaesth."},{"key":"2141_CR914","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102508","volume":"58","author":"SL Archer","year":"2022","unstructured":"Archer, S. L. et al. SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia. Redox Biol. 58, 102508 (2022).","journal-title":"Redox Biol."},{"key":"2141_CR915","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","volume":"39","author":"DC Wallace","year":"2005","unstructured":"Wallace, D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359\u2013407 (2005).","journal-title":"Annu. Rev. Genet."},{"key":"2141_CR916","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.mad.2010.07.003","volume":"131","author":"C Mammucari","year":"2010","unstructured":"Mammucari, C. & Rizzuto, R. Signaling pathways in mitochondrial dysfunction and aging. Mech. Ageing Dev. 131, 536\u2013543 (2010).","journal-title":"Mech. Ageing Dev."},{"key":"2141_CR917","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.tem.2023.06.004","volume":"34","author":"MS Wilkinson","year":"2023","unstructured":"Wilkinson, M. S. & Dunham-Snary, K. J. Blood-based bioenergetics: a liquid biopsy of mitochondrial dysfunction in disease. Trends Endocrinol. Metab. 34, 554\u2013570 (2023).","journal-title":"Trends Endocrinol. Metab."},{"key":"2141_CR918","doi-asserted-by":"publisher","first-page":"347","DOI":"10.33549\/physiolres.934032","volume":"68","author":"AT Petrus","year":"2019","unstructured":"Petrus, A. T. et al. Assessment of platelet respiration as emerging biomarker of disease. Physiol. Res. 68, 347\u2013363 (2019).","journal-title":"Physiol. Res."},{"key":"2141_CR919","doi-asserted-by":"publisher","first-page":"100835","DOI":"10.1016\/j.mam.2019.100835","volume":"71","author":"A Braganza","year":"2020","unstructured":"Braganza, A., Annarapu, G. K. & Shiva, S. Blood-based bioenergetics: an emerging translational and clinical tool. Mol. Asp. Med. 71, 100835 (2020).","journal-title":"Mol. Asp. Med."},{"key":"2141_CR920","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.redox.2013.12.026","volume":"2","author":"PA Kramer","year":"2014","unstructured":"Kramer, P. A. et al. A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers. Redox Biol. 2, 206\u2013210 (2014).","journal-title":"Redox Biol."},{"key":"2141_CR921","doi-asserted-by":"publisher","first-page":"105512","DOI":"10.1016\/j.nbd.2021.105512","volume":"159","author":"P Ferrer-Raventos","year":"2021","unstructured":"Ferrer-Raventos, P. & Beyer, K. Alternative platelet activation pathways and their role in neurodegenerative diseases. Neurobiol. Dis. 159, 105512 (2021).","journal-title":"Neurobiol. Dis."},{"key":"2141_CR922","doi-asserted-by":"publisher","first-page":"101681","DOI":"10.1016\/j.arr.2022.101681","volume":"80","author":"SK Beura","year":"2022","unstructured":"Beura, S. K., Panigrahi, A. R., Yadav, P. & Singh, S. K. Role of platelet in Parkinson\u2019s disease: insights into pathophysiology & theranostic solutions. Ageing Res. Rev. 80, 101681 (2022).","journal-title":"Ageing Res. Rev."},{"key":"2141_CR923","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2217\/bmm-2017-0041","volume":"11","author":"J Wojsiat","year":"2017","unstructured":"Wojsiat, J., Laskowska-Kaszub, K., Mietelska-Porowska, A. & Wojda, U. Search for Alzheimer\u2019s disease biomarkers in blood cells: hypotheses-driven approach. Biomark. Med. 11, 917\u2013931 (2017).","journal-title":"Biomark. Med."},{"key":"2141_CR924","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.clinbiochem.2019.04.003","volume":"72","author":"Z Fisar","year":"2019","unstructured":"Fisar, Z. et al. Plasma amyloid beta levels and platelet mitochondrial respiration in patients with Alzheimer\u2019s disease. Clin. Biochem. 72, 71\u201380 (2019).","journal-title":"Clin. Biochem."},{"key":"2141_CR925","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/alz.12731","volume":"19","author":"G Mahapatra","year":"2023","unstructured":"Mahapatra, G. et al. Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer\u2019s disease. Alzheimers Dement 19, 1466\u20131478 (2023).","journal-title":"Alzheimers Dement"},{"key":"2141_CR926","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10863-018-9782-8","volume":"51","author":"NJ Klinedinst","year":"2019","unstructured":"Klinedinst, N. J. et al. Post-stroke fatigue as an indicator of underlying bioenergetics alterations. J. Bioenerg. Biomembr. 51, 165\u2013174 (2019).","journal-title":"J. Bioenerg. Biomembr."},{"key":"2141_CR927","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1055\/s-0040-1722191","volume":"121","author":"ML Lin","year":"2021","unstructured":"Lin, M. L. et al. Cycling exercise training enhances platelet mitochondrial bioenergetics in patients with peripheral arterial disease: a randomized controlled trial. Thromb. Haemost. 121, 900\u2013912 (2021).","journal-title":"Thromb. Haemost."},{"key":"2141_CR928","doi-asserted-by":"crossref","unstructured":"McCann, M. R. et al. A multivariate metabolomics method for estimating platelet mitochondrial oxygen consumption rates in patients with sepsis. Metabolites 10, 139 (2020).","DOI":"10.3390\/metabo10040139"},{"key":"2141_CR929","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85775-5","volume":"11","author":"WA van der Heijden","year":"2021","unstructured":"van der Heijden, W. A. et al. Long-term treated HIV infection is associated with platelet mitochondrial dysfunction. Sci. Rep. 11, 6246 (2021).","journal-title":"Sci. Rep."},{"key":"2141_CR930","first-page":"9","volume":"123","author":"Z Sumbalova","year":"2022","unstructured":"Sumbalova, Z. et al. Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19. Bratisl. Lek. Listy 123, 9\u201315 (2022).","journal-title":"Bratisl. Lek. Listy"},{"key":"2141_CR931","doi-asserted-by":"publisher","DOI":"10.1186\/cc9337","volume":"14","author":"F Sjovall","year":"2010","unstructured":"Sjovall, F. et al. Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis. Crit. Care. 14, R214 (2010).","journal-title":"Crit. Care."},{"key":"2141_CR932","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097673","volume":"9","author":"F Sjovall","year":"2014","unstructured":"Sjovall, F. et al. Cytokine and nitric oxide levels in patients with sepsis\u2013temporal evolvement and relation to platelet mitochondrial respiratory function. PLoS ONE 9, e103756 (2014).","journal-title":"PLoS ONE"},{"key":"2141_CR933","doi-asserted-by":"publisher","first-page":"102507","DOI":"10.1016\/j.redox.2022.102507","volume":"57","author":"MJ Gao","year":"2022","unstructured":"Gao, M. J., Cui, N. H., Liu, X. & Wang, X. B. Inhibition of mitochondrial complex I leading to NAD(+)\/NADH imbalance in type 2 diabetic patients who developed late stent thrombosis: evidence from an integrative analysis of platelet bioenergetics and metabolomics. Redox Biol. 57, 102507 (2022).","journal-title":"Redox Biol."},{"key":"2141_CR934","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/ars.2009.2531","volume":"12","author":"WI Sivitz","year":"2010","unstructured":"Sivitz, W. I. & Yorek, M. A. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid. Redox Signal 12, 537\u2013577 (2010).","journal-title":"Antioxid. Redox Signal"},{"key":"2141_CR935","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s13244-011-0069-4","volume":"2","author":"T Beyer","year":"2011","unstructured":"Beyer, T., Townsend, D. W., Czernin, J. & Freudenberg, L. S. The future of hybrid imaging-part 2: PET\/CT. Insights Imaging 2, 225\u2013234 (2011).","journal-title":"Insights Imaging"},{"key":"2141_CR936","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1111\/jcmm.15712","volume":"24","author":"F Su","year":"2020","unstructured":"Su, F. et al. Quantitative proteomics identified 3 oxidative phosphorylation genes with clinical prognostic significance in gastric cancer. J. Cell. Mol. Med. 24, 10842\u201310854 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"2141_CR937","doi-asserted-by":"publisher","first-page":"662952","DOI":"10.3389\/fnut.2021.662952","volume":"8","author":"C Haskins","year":"2021","unstructured":"Haskins, C., Cohen, J., Kotecha, R. & Kaiser, A. Low carbohydrate diets in cancer therapeutics: current evidence. Front. Nutr. 8, 662952 (2021).","journal-title":"Front. Nutr."},{"key":"2141_CR938","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1743-7075-8-75","volume":"8","author":"RJ Klement","year":"2011","unstructured":"Klement, R. J. & Kammerer, U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr. Metab. 8, 75 (2011).","journal-title":"Nutr. Metab."},{"key":"2141_CR939","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cmdc.201600276","volume":"11","author":"H Siebeneicher","year":"2016","unstructured":"Siebeneicher, H. et al. Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876. ChemMedChem 11, 2261\u20132271 (2016).","journal-title":"ChemMedChem"},{"key":"2141_CR940","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3389\/fphar.2019.01311","volume":"10","author":"YL Li","year":"2019","unstructured":"Li, Y. L. et al. The combination of MK-2206 and WZB117 exerts a synergistic cytotoxic effect against breast cancer cells. Front. Pharmacol. 10, 1311 (2019).","journal-title":"Front. Pharmacol."},{"key":"2141_CR941","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu, L. et al. Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-alpha. Cell Metab. 35, 1580\u20131596.e1589 (2023).","journal-title":"Cell Metab."},{"key":"2141_CR942","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jfda.2017.03.009","volume":"26","author":"KH Wu","year":"2018","unstructured":"Wu, K. H. et al. The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter. J. Food Drug Anal. 26, 221\u2013231 (2018).","journal-title":"J. Food Drug Anal."},{"key":"2141_CR943","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-016-0315-4","volume":"16","author":"H Murad","year":"2016","unstructured":"Murad, H. et al. Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast cancer cells by sulfated polysaccharide extracted from Laurencia papillosa. Cancer Cell Int. 16, 39 (2016).","journal-title":"Cancer Cell Int."},{"key":"2141_CR944","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jfda.2016.10.016","volume":"25","author":"SH Tu","year":"2017","unstructured":"Tu, S. H., Chen, L. C. & Ho, Y. S. An apple a day to prevent cancer formation: Reducing cancer risk with flavonoids. J. Food Drug Anal. 25, 119\u2013124 (2017).","journal-title":"J. Food Drug Anal."},{"key":"2141_CR945","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00280-006-0291-9","volume":"59","author":"X Cao","year":"2007","unstructured":"Cao, X. et al. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother. Pharmacol. 59, 495\u2013505 (2007).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2141_CR946","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2174\/1568026618666180523111351","volume":"18","author":"NS Akins","year":"2018","unstructured":"Akins, N. S., Nielson, T. C. & Le, H. V. Inhibition of glycolysis and glutaminolysis: an emerging drug discovery approach to combat cancer. Curr. Top. Med. Chem. 18, 494\u2013504 (2018).","journal-title":"Curr. Top. Med. Chem."},{"key":"2141_CR947","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ejmech.2017.08.029","volume":"139","author":"C Wei","year":"2017","unstructured":"Wei, C. et al. Development of GLUT4-selective antagonists for multiple myeloma therapy. Eur. J. Med. Chem. 139, 573\u2013586 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"2141_CR948","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-14-1088","volume":"21","author":"S Dalva-Aydemir","year":"2015","unstructured":"Dalva-Aydemir, S. et al. Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin. Clin. Cancer Res. 21, 1161\u20131171 (2015).","journal-title":"Clin. Cancer Res."},{"key":"2141_CR949","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10863-008-9165-7","volume":"40","author":"PL Pedersen","year":"2008","unstructured":"Pedersen, P. L. Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment\u2019s roles together with hexokinase-2 in the \u201cWarburg effect\u201d in cancer. J. Bioenerg. Biomembr. 40, 123\u2013126 (2008).","journal-title":"J. Bioenerg. Biomembr."},{"key":"2141_CR950","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3835(01)00667-X","volume":"173","author":"YH Ko","year":"2001","unstructured":"Ko, Y. H., Pedersen, P. L. & Geschwind, J. F. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett. 173, 83\u201391 (2001).","journal-title":"Cancer Lett."},{"key":"2141_CR951","doi-asserted-by":"crossref","unstructured":"Pajak, B. et al. 2-Deoxy-d-Glucose and its analogs: from diagnostic to therapeutic agents. Int. J. Mol. Sci. 21, 234 (2019).","DOI":"10.3390\/ijms21010234"},{"key":"2141_CR952","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2174\/1871520614666140416105309","volume":"14","author":"L Gong","year":"2014","unstructured":"Gong, L. et al. 3-Bromopyruvic acid, a hexokinase II inhibitor, is an effective antitumor agent on the hepatoma cells : in vitro and in vivo findings. Anticancer Agents Med. Chem. 14, 771\u2013776 (2014).","journal-title":"Anticancer Agents Med. Chem."},{"key":"2141_CR953","first-page":"873175","volume":"2012","author":"Z Wang","year":"2012","unstructured":"Wang, Z., Wang, N., Chen, J. & Shen, J. Emerging glycolysis targeting and drug discovery from chinese medicine in cancer therapy. Evid. Based Complement. Altern. Med. 2012, 873175 (2012).","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"2141_CR954","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00280-003-0724-7","volume":"53","author":"JC Maher","year":"2004","unstructured":"Maher, J. C., Krishan, A. & Lampidis, T. J. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother. Pharmacol. 53, 116\u2013122 (2004).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2141_CR955","first-page":"3561","volume":"26","author":"XD Zhang","year":"2006","unstructured":"Zhang, X. D. et al. Effect of 2-deoxy-D-glucose on various malignant cell lines in vitro. Anticancer Res. 26, 3561\u20133566 (2006).","journal-title":"Anticancer Res."},{"key":"2141_CR956","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10863-016-9670-z","volume":"48","author":"J Azevedo-Silva","year":"2016","unstructured":"Azevedo-Silva, J. et al. The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside. J. Bioenerg. Biomembr. 48, 349\u2013362 (2016).","journal-title":"J. Bioenerg. Biomembr."},{"key":"2141_CR957","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07397-w","volume":"20","author":"C Linke","year":"2020","unstructured":"Linke, C., Wosle, M. & Harder, A. Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. BMC Cancer 20, 896 (2020).","journal-title":"BMC Cancer"},{"key":"2141_CR958","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10863-012-9484-6","volume":"44","author":"P Icard","year":"2012","unstructured":"Icard, P. et al. Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies. J. Bioenerg. Biomembr. 44, 81\u201390 (2012).","journal-title":"J. Bioenerg. Biomembr."},{"key":"2141_CR959","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3892\/or.2015.4147","volume":"34","author":"X Zou","year":"2015","unstructured":"Zou, X. et al. Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells. Oncol. Rep. 34, 1895\u20131904 (2015).","journal-title":"Oncol. Rep."},{"key":"2141_CR960","doi-asserted-by":"publisher","first-page":"393","DOI":"10.18632\/oncotarget.278","volume":"2","author":"K Bluemlein","year":"2011","unstructured":"Bluemlein, K. et al. No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis. Oncotarget 2, 393\u2013400 (2011).","journal-title":"Oncotarget"},{"key":"2141_CR961","doi-asserted-by":"crossref","unstructured":"Cheng, K. & Hao, M. Metformin Inhibits TGF-beta1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR\/p70s6k signaling pathway in cervical carcinoma cells. Int. J. Mol. Sci. 17, 2000 (2016).","DOI":"10.3390\/ijms17122000"},{"key":"2141_CR962","first-page":"31","volume":"21","author":"W Yin","year":"2021","unstructured":"Yin, W. et al. Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR\/HIF-1alpha\/PKM2\/STAT3 pathway. Oncol. Lett. 21, 31 (2021).","journal-title":"Oncol. Lett."},{"key":"2141_CR963","doi-asserted-by":"crossref","unstructured":"Puckett, D. L., Alquraishi, M., Chowanadisai, W. & Bettaieb, A. The role of PKM2 in metabolic reprogramming: insights into the regulatory roles of non-coding RNAs. Int. J. Mol. Sci. 22, 1171 (2021).","DOI":"10.3390\/ijms22031171"},{"key":"2141_CR964","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ijc.32756","volume":"147","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment. Int. J. Cancer 147, 139\u2013151 (2020).","journal-title":"Int. J. Cancer"},{"key":"2141_CR965","doi-asserted-by":"publisher","DOI":"10.1038\/srep45983","volume":"7","author":"X Wang","year":"2017","unstructured":"Wang, X., Zhang, F. & Wu, X. R. Inhibition of Pyruvate Kinase M2 markedly reduces chemoresistance of advanced bladder cancer to Cisplatin. Sci. Rep. 7, 45983 (2017).","journal-title":"Sci. Rep."},{"key":"2141_CR966","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.21873\/anticanres.14515","volume":"40","author":"U Thonsri","year":"2020","unstructured":"Thonsri, U. et al. Antitumor effect of Shikonin, a PKM2 inhibitor, in cholangiocarcinoma cell lines. Anticancer Res. 40, 5115\u20135124 (2020).","journal-title":"Anticancer Res."},{"key":"2141_CR967","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31615-y","volume":"8","author":"X Zhao","year":"2018","unstructured":"Zhao, X. et al. Shikonin inhibits tumor growth in mice by suppressing Pyruvate Kinase M2-mediated aerobic glycolysis. Sci. Rep. 8, 14517 (2018).","journal-title":"Sci. Rep."},{"key":"2141_CR968","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1021\/acs.jafc.6b04549","volume":"64","author":"H Wu","year":"2016","unstructured":"Wu, H. et al. Resveratrol induces cancer cell apoptosis through MiR-326\/PKM2-Mediated ER stress and mitochondrial fission. J. Agric. Food Chem. 64, 9356\u20139367 (2016).","journal-title":"J. Agric. Food Chem."},{"key":"2141_CR969","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.canlet.2011.10.039","volume":"316","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2. Cancer Lett. 316, 204\u2013210 (2012).","journal-title":"Cancer Lett."},{"key":"2141_CR970","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0223-5234(03)00082-5","volume":"38","author":"J Verrax","year":"2003","unstructured":"Verrax, J. et al. The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy. Eur. J. Med. Chem. 38, 451\u2013457 (2003).","journal-title":"Eur. J. Med. Chem."},{"key":"2141_CR971","first-page":"713","volume":"26","author":"M Hitomi","year":"2005","unstructured":"Hitomi, M. et al. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. Int. J. Oncol. 26, 713\u2013720 (2005).","journal-title":"Int. J. Oncol."},{"key":"2141_CR972","first-page":"323","volume":"31","author":"M Ogawa","year":"2007","unstructured":"Ogawa, M. et al. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int. J. Oncol. 31, 323\u2013331 (2007).","journal-title":"Int. J. Oncol."},{"key":"2141_CR973","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejmech.2017.06.064","volume":"138","author":"X Ning","year":"2017","unstructured":"Ning, X. et al. Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase. Eur. J. Med. Chem. 138, 343\u2013352 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"2141_CR974","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal. Transduct. Target Ther. 9, 132 (2024).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2141_CR975","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2014.11.046","volume":"358","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z. et al. Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the Akt-mTOR signaling pathway. Cancer Lett. 358, 17\u201326 (2015).","journal-title":"Cancer Lett."},{"key":"2141_CR976","doi-asserted-by":"crossref","unstructured":"Valvona, C. J. & Fillmore, H. L. Oxamate, but not selective targeting of LDH-A, inhibits medulloblastoma cell glycolysis, growth and motility. Brain Sci. 8, 56 (2018).","DOI":"10.3390\/brainsci8040056"},{"key":"2141_CR977","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/JLB.3A0718-274RR","volume":"105","author":"SC Stone","year":"2019","unstructured":"Stone, S. C. et al. Lactate secreted by cervical cancer cells modulates macrophage phenotype. J. Leukoc. Biol. 105, 1041\u20131054 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"2141_CR978","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/15384101.2018.1460023","volume":"17","author":"S Cassim","year":"2018","unstructured":"Cassim, S. et al. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment. Cell Cycle 17, 903\u2013916 (2018).","journal-title":"Cell Cycle"},{"key":"2141_CR979","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.632364","volume":"11","author":"T Qiao","year":"2021","unstructured":"Qiao, T. et al. Inhibition of LDH-A by oxamate enhances the efficacy of Anti-PD-1 treatment in an NSCLC humanized mouse model. Front. Oncol. 11, 632364 (2021).","journal-title":"Front. Oncol."},{"key":"2141_CR980","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF00234406","volume":"47","author":"CY Lee","year":"1982","unstructured":"Lee, C. Y., Moon, Y. S., Yuan, J. H. & Chen, A. F. Enzyme inactivation and inhibition by gossypol. Mol. Cell. Biochem. 47, 65\u201370 (1982).","journal-title":"Mol. Cell. Biochem."},{"key":"2141_CR981","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.1007\/s13277-015-3540-x","volume":"36","author":"ZY Xian","year":"2015","unstructured":"Xian, Z. Y. et al. Inhibition of LDHA suppresses tumor progression in prostate cancer. Tumour Biol. 36, 8093\u20138100 (2015).","journal-title":"Tumour Biol."},{"key":"2141_CR982","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/mc.22799","volume":"57","author":"Y He","year":"2018","unstructured":"He, Y. et al. LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma. Mol. Carcinog. 57, 772\u2013783 (2018).","journal-title":"Mol. Carcinog."},{"key":"2141_CR983","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.surg.2016.09.009","volume":"161","author":"EJ Rellinger","year":"2017","unstructured":"Rellinger, E. J. et al. FX11 inhibits aerobic glycolysis and growth of neuroblastoma cells. Surgery 161, 747\u2013752 (2017).","journal-title":"Surgery"},{"key":"2141_CR984","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1073\/pnas.0914433107","volume":"107","author":"A Le","year":"2010","unstructured":"Le, A. et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc. Natl Acad. Sci. USA 107, 2037\u20132042 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR985","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13045-014-0097-x","volume":"8","author":"X Han","year":"2015","unstructured":"Han, X. et al. Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells. J. Hematol. Oncol. 8, 2 (2015).","journal-title":"J. Hematol. Oncol."},{"key":"2141_CR986","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1097\/CAD.0b013e328363ae50","volume":"24","author":"M Vettraino","year":"2013","unstructured":"Vettraino, M., Manerba, M., Govoni, M. & Di Stefano, G. Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD\/NADH-dependent inhibition of sirtuin-1. Anticancer Drugs 24, 862\u2013870 (2013).","journal-title":"Anticancer Drugs"},{"key":"2141_CR987","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ejps.2012.08.012","volume":"47","author":"F Farabegoli","year":"2012","unstructured":"Farabegoli, F. et al. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. Eur. J. Pharm. Sci. 47, 729\u2013738 (2012).","journal-title":"Eur. J. Pharm. Sci."},{"key":"2141_CR988","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejps.2017.05.015","volume":"105","author":"M Manerba","year":"2017","unstructured":"Manerba, M. et al. LDH inhibition impacts on heat shock response and induces senescence of hepatocellular carcinoma cells. Eur. J. Pharm. Sci. 105, 91\u201398 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"2141_CR989","doi-asserted-by":"publisher","first-page":"153","DOI":"10.21873\/anticanres.13936","volume":"40","author":"EHU Wendt","year":"2020","unstructured":"Wendt, E. H. U., Schoenrogge, M., Vollmar, B. & Zechner, D. Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells. Anticancer Res. 40, 153\u2013160 (2020).","journal-title":"Anticancer Res."},{"key":"2141_CR990","doi-asserted-by":"publisher","first-page":"69219","DOI":"10.18632\/oncotarget.18215","volume":"8","author":"NJ Curtis","year":"2017","unstructured":"Curtis, N. J. et al. Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt\u2019s lymphoma anti-tumor activity. Oncotarget 8, 69219\u201369236 (2017).","journal-title":"Oncotarget"},{"key":"2141_CR991","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/1535-7163.MCT-17-1253","volume":"17","author":"M Quanz","year":"2018","unstructured":"Quanz, M. et al. Preclinical efficacy of the novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance. Mol. Cancer Ther. 17, 2285\u20132296 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"2141_CR992","doi-asserted-by":"publisher","first-page":"e007349","DOI":"10.1136\/jitc-2023-007349","volume":"11","author":"N Babl","year":"2023","unstructured":"Babl, N. et al. MCT4 blockade increases the efficacy of immune checkpoint blockade. J Immunother Cancer. 11, e007349 (2023).","journal-title":"J Immunother Cancer."},{"key":"2141_CR993","doi-asserted-by":"publisher","first-page":"e006287","DOI":"10.1136\/jitc-2022-006287","volume":"11","author":"E Lopez","year":"2023","unstructured":"Lopez, E. et al. Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies. J. Immunother Cancer. 11, e006287 (2023).","journal-title":"J. Immunother Cancer."},{"key":"2141_CR994","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.bmc.2004.11.028","volume":"13","author":"CS Esslinger","year":"2005","unstructured":"Esslinger, C. S., Cybulski, K. A. & Rhoderick, J. F. Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site. Bioorg. Med. Chem. 13, 1111\u20131118 (2005).","journal-title":"Bioorg. Med. Chem."},{"key":"2141_CR995","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.semcancer.2005.04.005","volume":"15","author":"BC Fuchs","year":"2005","unstructured":"Fuchs, B. C. & Bode, B. P. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin. Cancer Biol. 15, 254\u2013266 (2005).","journal-title":"Semin. Cancer Biol."},{"key":"2141_CR996","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin, P. et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136, 521\u2013534 (2009).","journal-title":"Cell"},{"key":"2141_CR997","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1078-0432.CCR-12-2334","volume":"19","author":"M Hassanein","year":"2013","unstructured":"Hassanein, M. et al. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin. Cancer Res. 19, 560\u2013570 (2013).","journal-title":"Clin. Cancer Res."},{"key":"2141_CR998","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/ijc.29535","volume":"137","author":"M Hassanein","year":"2015","unstructured":"Hassanein, M. et al. Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer. Int. J. Cancer 137, 1587\u20131597 (2015).","journal-title":"Int. J. Cancer"},{"key":"2141_CR999","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/path.4429","volume":"235","author":"P Ren","year":"2015","unstructured":"Ren, P. et al. ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation. J. Pathol. 235, 90\u2013100 (2015).","journal-title":"J. Pathol."},{"key":"2141_CR1000","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/path.4518","volume":"236","author":"Q Wang","year":"2015","unstructured":"Wang, Q. et al. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development. J. Pathol. 236, 278\u2013289 (2015).","journal-title":"J. Pathol."},{"key":"2141_CR1001","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood-2016-01-690743","volume":"128","author":"M Bolzoni","year":"2016","unstructured":"Bolzoni, M. et al. Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target. Blood 128, 667\u2013679 (2016).","journal-title":"Blood"},{"key":"2141_CR1002","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1038\/onc.2015.381","volume":"35","author":"M van Geldermalsen","year":"2016","unstructured":"van Geldermalsen, M. et al. ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene 35, 3201\u20133208 (2016).","journal-title":"Oncogene"},{"key":"2141_CR1003","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.70","volume":"6","author":"AD Marshall","year":"2017","unstructured":"Marshall, A. D. et al. ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogenesis 6, e367 (2017).","journal-title":"Oncogenesis"},{"key":"2141_CR1004","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3389\/fphar.2018.00785","volume":"9","author":"A Broer","year":"2018","unstructured":"Broer, A., Fairweather, S. & Broer, S. Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets. Front. Pharmacol. 9, 785 (2018).","journal-title":"Front. Pharmacol."},{"key":"2141_CR1005","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1113\/jphysiol.2004.062521","volume":"557","author":"C Grewer","year":"2004","unstructured":"Grewer, C. & Grabsch, E. New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+-dependent anion leak. J. Physiol. 557, 747\u2013759 (2004).","journal-title":"J. Physiol."},{"key":"2141_CR1006","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4599-8","volume":"18","author":"M van Geldermalsen","year":"2018","unstructured":"van Geldermalsen, M. et al. Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways. BMC Cancer 18, 689 (2018).","journal-title":"BMC Cancer"},{"key":"2141_CR1007","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.7314\/APJCP.2013.14.11.6379","volume":"14","author":"HJ Sun","year":"2013","unstructured":"Sun, H. J. et al. S-benzyl-cysteine-mediated cell cycle arrest and apoptosis involving activation of mitochondrial-dependent caspase cascade through the p53 pathway in human gastric cancer SGC-7901 cells. Asian Pac. J. Cancer Prev. 14, 6379\u20136384 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"2141_CR1008","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34064-4","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion. Nat. Commun. 13, 6308 (2022).","journal-title":"Nat. Commun."},{"key":"2141_CR1009","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","volume":"80","author":"JK Byun","year":"2020","unstructured":"Byun, J. K. et al. Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity. Mol. Cell. 80, 592\u2013606.e598 (2020).","journal-title":"Mol. Cell."},{"key":"2141_CR1010","doi-asserted-by":"publisher","first-page":"8981","DOI":"10.1158\/0008-5472.CAN-10-1666","volume":"70","author":"MJ Seltzer","year":"2010","unstructured":"Seltzer, M. J. et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res. 70, 8981\u20138987 (2010).","journal-title":"Cancer Res."},{"key":"2141_CR1011","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","volume":"15","author":"A Le","year":"2012","unstructured":"Le, A. et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15, 110\u2013121 (2012).","journal-title":"Cell Metab."},{"key":"2141_CR1012","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son, J. et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101\u2013105 (2013).","journal-title":"Nature"},{"key":"2141_CR1013","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/jcb.24684","volume":"115","author":"S Qie","year":"2014","unstructured":"Qie, S. et al. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation. J. Cell. Biochem. 115, 498\u2013509 (2014).","journal-title":"J. Cell. Biochem."},{"key":"2141_CR1014","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.4161\/cbt.21348","volume":"13","author":"AP van den Heuvel","year":"2012","unstructured":"van den Heuvel, A. P., Jing, J., Wooster, R. F. & Bachman, K. E. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol. Ther. 13, 1185\u20131194 (2012).","journal-title":"Cancer Biol. Ther."},{"key":"2141_CR1015","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1042\/BJ20070039","volume":"406","author":"MM Robinson","year":"2007","unstructured":"Robinson, M. M. et al. Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES). Biochem. J. 406, 407\u2013414 (2007).","journal-title":"Biochem. J."},{"key":"2141_CR1016","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1021\/acs.jmedchem.8b00961","volume":"62","author":"X Xu","year":"2019","unstructured":"Xu, X. et al. Overview of the development of glutaminase inhibitors: achievements and future directions. J. Med. Chem. 62, 1096\u20131115 (2019).","journal-title":"J. Med. Chem."},{"key":"2141_CR1017","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1158\/1535-7163.MCT-20-0430","volume":"20","author":"S Varghese","year":"2021","unstructured":"Varghese, S. et al. The glutaminase inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies. Mol. Cancer Ther. 20, 500\u2013511 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"2141_CR1018","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41589-022-00997-6","volume":"18","author":"DM Kremer","year":"2022","unstructured":"Kremer, D. M. & Lyssiotis, C. A. Targeting allosteric regulation of cancer metabolism. Nat. Chem. Biol. 18, 441\u2013450 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"2141_CR1019","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ccr.2010.08.009","volume":"18","author":"JB Wang","year":"2010","unstructured":"Wang, J. B. et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18, 207\u2013219 (2010).","journal-title":"Cancer Cell"},{"key":"2141_CR1020","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/ijc.29873","volume":"138","author":"UD Kahlert","year":"2016","unstructured":"Kahlert, U. D. et al. Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells. Int. J. Cancer 138, 1246\u20131255 (2016).","journal-title":"Int. J. Cancer"},{"key":"2141_CR1021","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2154","volume":"10","author":"JM Thornburg","year":"2008","unstructured":"Thornburg, J. M. et al. Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res. 10, R84 (2008).","journal-title":"Breast Cancer Res."},{"key":"2141_CR1022","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/ijc.23835","volume":"123","author":"MA Carvalho","year":"2008","unstructured":"Carvalho, M. A. et al. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int. J. Cancer 123, 2557\u20132565 (2008).","journal-title":"Int. J. Cancer"},{"key":"2141_CR1023","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1158\/1078-0432.CCR-07-1186","volume":"13","author":"H Orita","year":"2007","unstructured":"Orita, H. et al. Selective inhibition of fatty acid synthase for lung cancer treatment. Clin. Cancer Res. 13, 7139\u20137145 (2007).","journal-title":"Clin. Cancer Res."},{"key":"2141_CR1024","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100797","volume":"34","author":"G Falchook","year":"2021","unstructured":"Falchook, G. et al. First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors. EClinicalMedicine 34, 100797 (2021).","journal-title":"EClinicalMedicine"},{"key":"2141_CR1025","first-page":"89","volume":"58","author":"R Maxwell","year":"1988","unstructured":"Maxwell, R. et al. Natural history of experimental pulmonary atelectasis in dogs with closed chest. Arch. Inst. Cardiol. Mex. 58, 89\u201393 (1988).","journal-title":"Arch. Inst. Cardiol. Mex."},{"key":"2141_CR1026","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11060-014-1452-z","volume":"118","author":"S Grube","year":"2014","unstructured":"Grube, S. et al. Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis. J. Neurooncol. 118, 277\u2013287 (2014).","journal-title":"J. Neurooncol."},{"key":"2141_CR1027","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1667\/RR13828.1","volume":"183","author":"J Mims","year":"2015","unstructured":"Mims, J. et al. Energy metabolism in a matched model of radiation resistance for head and neck squamous cell cancer. Radiat. Res. 183, 291\u2013304 (2015).","journal-title":"Radiat. Res."},{"key":"2141_CR1028","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1158\/1078-0432.CCR-16-2770","volume":"23","author":"CF Li","year":"2017","unstructured":"Li, C. F. et al. Overexpressed fatty acid synthase in gastrointestinal stromal tumors: targeting a progression-associated metabolic driver enhances the antitumor effect of Imatinib. Clin. Cancer Res. 23, 4908\u20134918 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2141_CR1029","first-page":"6321","volume":"37","author":"E Sokolowska","year":"2017","unstructured":"Sokolowska, E. et al. Orlistat reduces proliferation and enhances apoptosis in human pancreatic cancer cells (PANC-1). Anticancer Res. 37, 6321\u20136327 (2017).","journal-title":"Anticancer Res."},{"key":"2141_CR1030","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1021\/acs.chemrestox.8b00269","volume":"32","author":"BJ You","year":"2019","unstructured":"You, B. J. et al. Orlistat displays antitumor activity and enhances the efficacy of Paclitaxel in Human Hepatoma Hep3B Cells. Chem. Res. Toxicol. 32, 255\u2013264 (2019).","journal-title":"Chem. Res. Toxicol."},{"key":"2141_CR1031","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1073\/pnas.97.7.3450","volume":"97","author":"FP Kuhajda","year":"2000","unstructured":"Kuhajda, F. P. et al. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc. Natl Acad. Sci. USA 97, 3450\u20133454 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR1032","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/17460441.2016.1245286","volume":"11","author":"TS Angeles","year":"2016","unstructured":"Angeles, T. S. & Hudkins, R. L. Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors. Expert Opin. Drug Discov. 11, 1187\u20131199 (2016).","journal-title":"Expert Opin. Drug Discov."},{"key":"2141_CR1033","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.adro.2020.06.022","volume":"5","author":"C Rae","year":"2020","unstructured":"Rae, C., Fragkoulis, G. I. & Chalmers, A. J. Cytotoxicity and radiosensitizing activity of the fatty acid synthase inhibitor C75 is enhanced by blocking fatty acid uptake in prostate cancer cells. Adv. Radiat. Oncol. 5, 994\u20131005 (2020).","journal-title":"Adv. Radiat. Oncol."},{"key":"2141_CR1034","doi-asserted-by":"publisher","first-page":"978","DOI":"10.4161\/cbt.5.8.2883","volume":"5","author":"Y Gao","year":"2006","unstructured":"Gao, Y. et al. Growth arrest induced by C75, a fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma. Cancer Biol. Ther. 5, 978\u2013985 (2006).","journal-title":"Cancer Biol. Ther."},{"key":"2141_CR1035","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1803917","volume":"380","author":"KK Ray","year":"2019","unstructured":"Ray, K. K. et al. Safety and efficacy of bempedoic acid to reduce LDL Cholesterol. N. Engl. J. Med. 380, 1022\u20131032 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2141_CR1036","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1094-6","volume":"568","author":"J Wei","year":"2019","unstructured":"Wei, J. et al. An allosteric mechanism for potent inhibition of human ATP-citrate lyase. Nature 568, 566\u2013570 (2019).","journal-title":"Nature"},{"key":"2141_CR1037","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1158\/1535-7163.MCT-14-0183","volume":"13","author":"IR Schlaepfer","year":"2014","unstructured":"Schlaepfer, I. R. et al. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol. Cancer Ther. 13, 2361\u20132371 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"2141_CR1038","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.7150\/thno.21451","volume":"8","author":"Z Tan","year":"2018","unstructured":"Tan, Z. et al. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy. Theranostics 8, 2329\u20132347 (2018).","journal-title":"Theranostics"},{"key":"2141_CR1039","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcab035","volume":"3","author":"N Jariwala","year":"2021","unstructured":"Jariwala, N. et al. CPT1A and fatty acid beta-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer. NAR Cancer 3, zcab035 (2021).","journal-title":"NAR Cancer"},{"key":"2141_CR1040","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29137-3","volume":"13","author":"N Jiang","year":"2022","unstructured":"Jiang, N. et al. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat. Commun. 13, 1511 (2022).","journal-title":"Nat. Commun."},{"key":"2141_CR1041","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1021\/jm020979u","volume":"46","author":"F Giannessi","year":"2003","unstructured":"Giannessi, F. et al. Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity. J. Med. Chem. 46, 303\u2013309 (2003).","journal-title":"J. Med. Chem."},{"key":"2141_CR1042","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.str.2006.01.008","volume":"14","author":"AC Rufer","year":"2006","unstructured":"Rufer, A. C. et al. The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment. Structure 14, 713\u2013723 (2006).","journal-title":"Structure"},{"key":"2141_CR1043","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1182\/blood-2014-12-617498","volume":"126","author":"MR Ricciardi","year":"2015","unstructured":"Ricciardi, M. R. et al. Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias. Blood 126, 1925\u20131929 (2015).","journal-title":"Blood"},{"key":"2141_CR1044","doi-asserted-by":"publisher","first-page":"e531","DOI":"10.3324\/haematol.2017.175414","volume":"103","author":"E Gugiatti","year":"2018","unstructured":"Gugiatti, E. et al. A reversible carnitine palmitoyltransferase (CPT1) inhibitor offsets the proliferation of chronic lymphocytic leukemia cells. Haematologica 103, e531\u2013e536 (2018).","journal-title":"Haematologica"},{"key":"2141_CR1045","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02848-9","volume":"19","author":"S Mao","year":"2021","unstructured":"Mao, S. et al. Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199. J. Transl. Med. 19, 181 (2021).","journal-title":"J. Transl. Med."},{"key":"2141_CR1046","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00008390-199205000-00004","volume":"2","author":"D Mascagna","year":"1992","unstructured":"Mascagna, D. et al. Synthesis and cytotoxic properties of new N-substituted 4-aminophenol derivatives with a potential as antimelanoma agents. Melanoma Res. 2, 25\u201332 (1992).","journal-title":"Melanoma Res."},{"key":"2141_CR1047","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1158\/0008-5472.CAN-14-2676","volume":"75","author":"EA Lee","year":"2015","unstructured":"Lee, E. A. et al. Targeting mitochondria with Avocatin B induces selective leukemia cell death. Cancer Res. 75, 2478\u20132488 (2015).","journal-title":"Cancer Res."},{"key":"2141_CR1048","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1038\/onc.2016.103","volume":"35","author":"PP Liu","year":"2016","unstructured":"Liu, P. P. et al. Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline. Oncogene 35, 5663\u20135673 (2016).","journal-title":"Oncogene"},{"key":"2141_CR1049","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1527-3466.2007.00006.x","volume":"25","author":"H Ashrafian","year":"2007","unstructured":"Ashrafian, H., Horowitz, J. D. & Frenneaux, M. P. Perhexiline. Cardiovasc. Drug Rev. 25, 76\u201397 (2007).","journal-title":"Cardiovasc. Drug Rev."},{"key":"2141_CR1050","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1158\/2159-8290.CD-16-1034","volume":"7","author":"K Yen","year":"2017","unstructured":"Yen, K. et al. AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 Mutations. Cancer Discov. 7, 478\u2013493 (2017).","journal-title":"Cancer Discov."},{"key":"2141_CR1051","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-019-0173-z","volume":"7","author":"X Liu","year":"2019","unstructured":"Liu, X. & Gong, Y. Isocitrate dehydrogenase inhibitors in acute myeloid leukemia. Biomark. Res. 7, 22 (2019).","journal-title":"Biomark. Res."},{"key":"2141_CR1052","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1021\/acs.jmedchem.9b01423","volume":"63","author":"JA Caravella","year":"2020","unstructured":"Caravella, J. A. et al. Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor. J. Med. Chem. 63, 1612\u20131623 (2020).","journal-title":"J. Med. Chem."},{"key":"2141_CR1053","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s40265-017-0813-2","volume":"77","author":"ES Kim","year":"2017","unstructured":"Kim, E. S. Enasidenib: first global approval. Drugs 77, 1705\u20131711 (2017).","journal-title":"Drugs"},{"key":"2141_CR1054","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.1234769","volume":"340","author":"F Wang","year":"2013","unstructured":"Wang, F. et al. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science 340, 622\u2013626 (2013).","journal-title":"Science"},{"key":"2141_CR1055","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036\u20131046 (2018).","journal-title":"Nat. Med."},{"key":"2141_CR1056","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mc.20583","volume":"49","author":"YT Deng","year":"2010","unstructured":"Deng, Y. T., Huang, H. C. & Lin, J. K. Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol. Carcinog. 49, 141\u2013151 (2010).","journal-title":"Mol. Carcinog."},{"key":"2141_CR1057","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0014-5793(94)80380-3","volume":"339","author":"EJ Wolvetang","year":"1994","unstructured":"Wolvetang, E. J. et al. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett. 339, 40\u201344 (1994).","journal-title":"FEBS Lett."},{"key":"2141_CR1058","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1038\/onc.2008.69","volume":"27","author":"LF Dong","year":"2008","unstructured":"Dong, L. F. et al. Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 27, 4324\u20134335 (2008).","journal-title":"Oncogene"},{"key":"2141_CR1059","doi-asserted-by":"publisher","first-page":"30151","DOI":"10.1074\/jbc.M802529200","volume":"283","author":"D Xiao","year":"2008","unstructured":"Xiao, D., Powolny, A. A. & Singh, S. V. Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J. Biol. Chem. 283, 30151\u201330163 (2008).","journal-title":"J. Biol. Chem."},{"key":"2141_CR1060","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur, J. A. & Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493\u2013506 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2141_CR1061","doi-asserted-by":"publisher","first-page":"164","DOI":"10.18632\/aging.101382","volume":"10","author":"DD Weber","year":"2018","unstructured":"Weber, D. D., Aminazdeh-Gohari, S. & Kofler, B. Ketogenic diet in cancer therapy. Aging 10, 164\u2013165 (2018).","journal-title":"Aging"},{"key":"2141_CR1062","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks, O. D. K. et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature 544, 372\u2013376 (2017).","journal-title":"Nature"},{"key":"2141_CR1063","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41\u201345 (2017).","journal-title":"Nature"},{"key":"2141_CR1064","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41586-021-04075-0","volume":"599","author":"G Pascual","year":"2021","unstructured":"Pascual, G. et al. Dietary palmitic acid promotes a prometastatic memory via Schwann cells. Nature 599, 485\u2013490 (2021).","journal-title":"Nature"},{"key":"2141_CR1065","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.omto.2020.11.004","volume":"20","author":"L Guo","year":"2021","unstructured":"Guo, L. et al. Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways. Mol. Ther. Oncolytics 20, 119\u2013131 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"2141_CR1066","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv, Z. & Guo, Y. Metformin and its benefits for various diseases. Front. Endocrinol. 11, 191 (2020).","journal-title":"Front. Endocrinol."},{"key":"2141_CR1067","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103497","volume":"24","author":"J Yoshida","year":"2021","unstructured":"Yoshida, J. et al. Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment. iScience 24, 103497 (2021).","journal-title":"iScience"},{"key":"2141_CR1068","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","volume":"25","author":"D Benjamin","year":"2018","unstructured":"Benjamin, D. et al. Dual inhibition of the lactate transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells. Cell Rep. 25, 3047\u20133058.e3044 (2018).","journal-title":"Cell Rep."},{"key":"2141_CR1069","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.tips.2020.09.001","volume":"41","author":"L He","year":"2020","unstructured":"He, L. Metformin and systemic metabolism. Trends Pharmacol. Sci. 41, 868\u2013881 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"2141_CR1070","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-00703-x","volume":"13","author":"KC Wen","year":"2020","unstructured":"Wen, K. C. et al. Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer. J. Ovarian Res. 13, 95 (2020).","journal-title":"J. Ovarian Res."},{"key":"2141_CR1071","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-022-01284-5","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen, Z. & Kang, Y. Cold snap for cancer: cold-induced brown fat thermogenesis starves tumor growth. Signal Transduct. Target Ther. 8, 10 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2141_CR1072","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-022-05030-3","volume":"608","author":"T Seki","year":"2022","unstructured":"Seki, T. et al. Brown-fat-mediated tumour suppression by cold-altered global metabolism. Nature 608, 421\u2013428 (2022).","journal-title":"Nature"},{"key":"2141_CR1073","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43350-8","volume":"14","author":"X Sun","year":"2023","unstructured":"Sun, X. et al. Mirabegron displays anticancer effects by globally browning adipose tissues. Nat. Commun. 14, 7610 (2023).","journal-title":"Nat. Commun."},{"key":"2141_CR1074","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14928-3","volume":"11","author":"V Jayashankar","year":"2020","unstructured":"Jayashankar, V. & Edinger, A. L. Macropinocytosis confers resistance to therapies targeting cancer anabolism. Nat. Commun. 11, 1121 (2020).","journal-title":"Nat. Commun."},{"key":"2141_CR1075","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2021.11.022","volume":"94","author":"JL Schultz","year":"2022","unstructured":"Schultz, J. L. et al. A pilot to assess target engagement of terazosin in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 94, 79\u201383 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"2141_CR1076","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/jnc.12127","volume":"125","author":"M Zilberter","year":"2013","unstructured":"Zilberter, M. et al. Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer\u2019s disease. J. Neurochem. 125, 157\u2013171 (2013).","journal-title":"J. Neurochem."},{"key":"2141_CR1077","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12924","volume":"18","author":"P Theurey","year":"2019","unstructured":"Theurey, P. et al. Systems biology identifies preserved integrity but impaired metabolism of mitochondria due to a glycolytic defect in Alzheimer\u2019s disease neurons. Aging Cell 18, e12924 (2019).","journal-title":"Aging Cell"},{"key":"2141_CR1078","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/jnc.13545","volume":"137","author":"HM Wilkins","year":"2016","unstructured":"Wilkins, H. M. et al. Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure. J. Neurochem. 137, 76\u201387 (2016).","journal-title":"J. Neurochem."},{"key":"2141_CR1079","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/jcbfm.2015.29","volume":"35","author":"M Roy","year":"2015","unstructured":"Roy, M. et al. Rapid adaptation of rat brain and liver metabolism to a ketogenic diet: an integrated study using (1)H- and (13)C-NMR spectroscopy. J. Cereb. Blood Flow. Metab. 35, 1154\u20131162 (2015).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"2141_CR1080","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnut.2019.00046","volume":"6","author":"V St-Pierre","year":"2019","unstructured":"St-Pierre, V. et al. Plasma ketone and medium chain fatty acid response in humans consuming different medium chain triglycerides during a metabolic study day. Front. Nutr. 6, 46 (2019).","journal-title":"Front. Nutr."},{"key":"2141_CR1081","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1002\/jnr.24111","volume":"95","author":"F Mochel","year":"2017","unstructured":"Mochel, F. Triheptanoin for the treatment of brain energy deficit: A 14-year experience. J. Neurosci. Res. 95, 2236\u20132243 (2017).","journal-title":"J. Neurosci. Res."},{"key":"2141_CR1082","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/jcbfm.2012.151","volume":"33","author":"I Marin-Valencia","year":"2013","unstructured":"Marin-Valencia, I. et al. Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain. J. Cereb. Blood Flow. Metab. 33, 175\u2013182 (2013).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"2141_CR1083","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejpb.2022.11.022","volume":"182","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Modeling digestion, absorption, and ketogenesis after administration of tricaprilin formulations to humans. Eur. J. Pharm. Biopharm. 182, 41\u201352 (2023).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2141_CR1084","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2019.09.015","volume":"86","author":"BJ Neth","year":"2020","unstructured":"Neth, B. J. et al. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer\u2019s disease: a pilot study. Neurobiol. Aging 86, 54\u201363 (2020).","journal-title":"Neurobiol. Aging"},{"key":"2141_CR1085","doi-asserted-by":"publisher","first-page":"601","DOI":"10.18632\/aging.204498","volume":"15","author":"PS Marra","year":"2023","unstructured":"Marra, P. S. et al. Metformin use history and genome-wide DNA methylation profile: potential molecular mechanism for aging and longevity. Aging 15, 601\u2013616 (2023).","journal-title":"Aging"},{"key":"2141_CR1086","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s11095-022-03302-1","volume":"39","author":"MK Mahapatra","year":"2022","unstructured":"Mahapatra, M. K., Karuppasamy, M. & Sahoo, B. M. Therapeutic Potential of Semaglutide, a Newer GLP-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: a narrative review. Pharm. Res. 39, 1233\u20131248 (2022).","journal-title":"Pharm. Res."},{"key":"2141_CR1087","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jocn.2020.09.054","volume":"81","author":"YF Chang","year":"2020","unstructured":"Chang, Y. F. et al. Semaglutide-mediated protection against Abeta correlated with enhancement of autophagy and inhibition of apotosis. J. Clin. Neurosci. 81, 234\u2013239 (2020).","journal-title":"J. Clin. Neurosci."},{"key":"2141_CR1088","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JPD-181503","volume":"9","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Zhang, L., Li, L. & Holscher, C. Semaglutide is Neuroprotective and Reduces alpha-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson\u2019s Disease. J. Parkinsons Dis. 9, 157\u2013171 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"2141_CR1089","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature25143","volume":"552","author":"V Sorrentino","year":"2017","unstructured":"Sorrentino, V. et al. Enhancing mitochondrial proteostasis reduces amyloid-beta proteotoxicity. Nature 552, 187\u2013193 (2017).","journal-title":"Nature"},{"key":"2141_CR1090","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cmet.2019.03.004","volume":"29","author":"AA Polyzos","year":"2019","unstructured":"Polyzos, A. A. et al. Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in huntington mice. Cell Metab. 29, 1258\u20131273.e1211 (2019).","journal-title":"Cell Metab."},{"key":"2141_CR1091","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuint.2017.05.019","volume":"117","author":"SJ Koppel","year":"2018","unstructured":"Koppel, S. J. & Swerdlow, R. H. Neuroketotherapeutics: a modern review of a century-old therapy. Neurochem. Int. 117, 114\u2013125 (2018).","journal-title":"Neurochem. Int."},{"key":"2141_CR1092","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ebiom.2015.03.009","volume":"2","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer\u2019s Disease. EBioMedicine 2, 294\u2013305 (2015).","journal-title":"EBioMedicine"},{"key":"2141_CR1093","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.mcn.2019.06.009","volume":"98","author":"PJ Flannery","year":"2019","unstructured":"Flannery, P. J. & Trushina, E. Mitochondrial dynamics and transport in Alzheimer\u2019s disease. Mol. Cell. Neurosci. 98, 109\u2013120 (2019).","journal-title":"Mol. Cell. Neurosci."},{"key":"2141_CR1094","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/JAD-170077","volume":"59","author":"HM Wilkins","year":"2017","unstructured":"Wilkins, H. M. et al. A mitochondrial biomarker-based study of S-Equol in Alzheimer\u2019s disease subjects: results of a single-arm, pilot trial. J. Alzheimers Dis. 59, 291\u2013300 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"2141_CR1095","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.expneurol.2017.03.020","volume":"293","author":"B Wu","year":"2017","unstructured":"Wu, B. et al. 2,4 DNP improves motor function, preserves medium spiny neuronal identity, and reduces oxidative stress in a mouse model of Huntington\u2019s disease. Exp. Neurol. 293, 83\u201390 (2017).","journal-title":"Exp. Neurol."},{"key":"2141_CR1096","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.mito.2021.06.008","volume":"59","author":"KN Belosludtsev","year":"2021","unstructured":"Belosludtsev, K. N. et al. Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL\/6NCrl mice with high-fat diet\/streptozotocin-induced diabetes mellitus. Mitochondrion 59, 246\u2013254 (2021).","journal-title":"Mitochondrion"},{"key":"2141_CR1097","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrd.2018.109","volume":"17","author":"B Boland","year":"2018","unstructured":"Boland, B. et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat. Rev. Drug Discov. 17, 660\u2013688 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2141_CR1098","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneurol.2014.228","volume":"11","author":"F Burte","year":"2015","unstructured":"Burte, F., Carelli, V., Chinnery, P. F. & Yu-Wai-Man, P. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11, 11\u201324 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"2141_CR1099","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/hmg\/ddy335","volume":"28","author":"M Manczak","year":"2019","unstructured":"Manczak, M., Kandimalla, R., Yin, X. & Reddy, P. H. Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity. Hum. Mol. Genet. 28, 177\u2013199 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"2141_CR1100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07181-0","volume":"7","author":"S Bido","year":"2017","unstructured":"Bido, S. et al. Mitochondrial division inhibitor-1 is neuroprotective in the A53T-alpha-synuclein rat model of Parkinson\u2019s disease. Sci. Rep. 7, 7495 (2017).","journal-title":"Sci. Rep."},{"key":"2141_CR1101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109415","volume":"120","author":"AI Borja-Magno","year":"2023","unstructured":"Borja-Magno, A. I. et al. Supplementation with EPA and DHA omega-3 fatty acids improves peripheral immune cell mitochondrial dysfunction and inflammation in subjects with obesity. J. Nutr. Biochem. 120, 109415 (2023).","journal-title":"J. Nutr. Biochem."},{"key":"2141_CR1102","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2021.131389","volume":"373","author":"B Xiao","year":"2022","unstructured":"Xiao, B. et al. Eicosapentaenoic acid (EPA) exhibits antioxidant activity via mitochondrial modulation. Food Chem. 373, 131389 (2022).","journal-title":"Food Chem."},{"key":"2141_CR1103","doi-asserted-by":"publisher","first-page":"15703","DOI":"10.1523\/JNEUROSCI.0552-11.2011","volume":"31","author":"MJ McManus","year":"2011","unstructured":"McManus, M. J., Murphy, M. P. & Franklin, J. L. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer\u2019s disease. J. Neurosci. 31, 15703\u201315715 (2011).","journal-title":"J. Neurosci."},{"key":"2141_CR1104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02394-3","volume":"8","author":"E Dehghan","year":"2017","unstructured":"Dehghan, E. et al. Hydralazine induces stress resistance and extends C. elegans lifespan by activating the NRF2\/SKN-1 signalling pathway. Nat. Commun. 8, 2223 (2017).","journal-title":"Nat. Commun."},{"key":"2141_CR1105","doi-asserted-by":"publisher","first-page":"102294","DOI":"10.1016\/j.ctim.2019.102294","volume":"49","author":"L Cassidy","year":"2020","unstructured":"Cassidy, L. et al. Oxidative stress in alzheimer\u2019s disease: a review on emergent natural polyphenolic therapeutics. Complement. Ther. Med. 49, 102294 (2020).","journal-title":"Complement. Ther. Med."},{"key":"2141_CR1106","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar, D. & Craft, S. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 19, 758\u2013766 (2020).","journal-title":"Lancet Neurol."},{"key":"2141_CR1107","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41430-021-00950-1","volume":"76","author":"A Singh","year":"2022","unstructured":"Singh, A. et al. Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population. Eur. J. Clin. Nutr. 76, 297\u2013308 (2022).","journal-title":"Eur. J. Clin. Nutr."},{"key":"2141_CR1108","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13662","volume":"21","author":"D D\u2019Amico","year":"2022","unstructured":"D\u2019Amico, D. et al. Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis. Aging Cell 21, e13662 (2022).","journal-title":"Aging Cell"},{"key":"2141_CR1109","unstructured":"Chin, R. M. et al. Pharmacological PINK1 activation ameliorates Pathology in Parkinson\u2019s Disease models. Preprint at http:\/\/biorxiv.org\/content\/early\/2023\/02\/15\/2023.02.14.528378.1 (2023)."},{"key":"2141_CR1110","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1089\/hum.2019.190","volume":"30","author":"V Poletti","year":"2019","unstructured":"Poletti, V. & Biffi, A. Gene-Based approaches to inherited neurometabolic diseases. Hum. Gene Ther. 30, 1222\u20131235 (2019).","journal-title":"Hum. Gene Ther."},{"key":"2141_CR1111","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri, E. et al. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. N. Engl. J. Med. 378, 625\u2013635 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2141_CR1112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2017.03.004","volume":"156","author":"MJ Millan","year":"2017","unstructured":"Millan, M. J. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer\u2019s disease: an integrative review. Prog. Neurobiol. 156, 1\u201368 (2017).","journal-title":"Prog. Neurobiol."},{"key":"2141_CR1113","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1002\/glia.23484","volume":"66","author":"M Fumagalli","year":"2018","unstructured":"Fumagalli, M., Lombardi, M., Gressens, P. & Verderio, C. How to reprogram microglia toward beneficial functions. Glia 66, 2531\u20132549 (2018).","journal-title":"Glia"},{"key":"2141_CR1114","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/mds.27849","volume":"34","author":"EJ Wild","year":"2019","unstructured":"Wild, E. J. & Tabrizi, S. J. One decade ago, one decade ahead in huntington\u2019s disease. Mov. Disord. 34, 1434\u20131439 (2019).","journal-title":"Mov. Disord."},{"key":"2141_CR1115","doi-asserted-by":"crossref","unstructured":"Cappella, M., Ciotti, C., Cohen-Tannoudji, M. & Biferi, M. G. Gene therapy for ALS-A Perspective. Int. J. Mol. Sci. 20, 4388 (2019).","DOI":"10.3390\/ijms20184388"},{"key":"2141_CR1116","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40265-019-01104-1","volume":"79","author":"D Savitt","year":"2019","unstructured":"Savitt, D. & Jankovic, J. Targeting alpha-Synuclein in Parkinson\u2019s disease: progress towards the development of disease-modifying therapeutics. Drugs 79, 797\u2013810 (2019).","journal-title":"Drugs"},{"key":"2141_CR1117","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrd.2018.110","volume":"17","author":"BE Deverman","year":"2018","unstructured":"Deverman, B. E. et al. Gene therapy for neurological disorders: progress and prospects. Nat. Rev. Drug Discov. 17, 641\u2013659 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2141_CR1118","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JND-190403","volume":"6","author":"SA Al-Zaidy","year":"2019","unstructured":"Al-Zaidy, S. A. et al. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: comparative study with a prospective natural history cohort. J. Neuromuscul. Dis. 6, 307\u2013317 (2019).","journal-title":"J. Neuromuscul. Dis."},{"key":"2141_CR1119","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00702-016-1616-4","volume":"124","author":"CJ Choong","year":"2017","unstructured":"Choong, C. J. & Mochizuki, H. Gene therapy targeting mitochondrial pathway in Parkinson\u2019s disease. J. Neural Transm. 124, 193\u2013207 (2017).","journal-title":"J. Neural Transm."},{"key":"2141_CR1120","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4172\/2161-0460.1000439","volume":"8","author":"TT Rohn","year":"2018","unstructured":"Rohn, T. T., Kim, N., Isho, N. F. & Mack, J. M. The Potential of CRISPR\/Cas9 gene editing as a treatment strategy for Alzheimer\u2019s disease. J. Alzheimers Dis. Parkinsonism. 8, 439 (2018).","journal-title":"J. Alzheimers Dis. Parkinsonism."},{"key":"2141_CR1121","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","volume":"56","author":"MS Uddin","year":"2019","unstructured":"Uddin, M. S. et al. APOE and Alzheimer\u2019s disease: evidence mounts that targeting APOE4 may Combat Alzheimer\u2019s Pathogenesis. Mol. Neurobiol. 56, 2450\u20132465 (2019).","journal-title":"Mol. Neurobiol."},{"key":"2141_CR1122","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1093\/brain\/awz230","volume":"142","author":"J Creus-Muncunill","year":"2019","unstructured":"Creus-Muncunill, J. et al. Increased translation as a novel pathogenic mechanism in Huntington\u2019s disease. Brain 142, 3158\u20133175 (2019).","journal-title":"Brain"},{"key":"2141_CR1123","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","volume":"76","author":"D Takahashi","year":"2019","unstructured":"Takahashi, D. et al. AUTACs: cargo-specific degraders using selective autophagy. Mol. Cell. 76, 797\u2013810.e710 (2019).","journal-title":"Mol. Cell."},{"key":"2141_CR1124","doi-asserted-by":"crossref","unstructured":"Fontana, L., Ghezzi, L., Cross, A. H. & Piccio, L. Effects of dietary restriction on neuroinflammation in neurodegenerative diseases. J. Exp. Med. 218, e20190086 (2021).","DOI":"10.1084\/jem.20190086"},{"key":"2141_CR1125","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1172\/JCI200318797","volume":"112","author":"K Tieu","year":"2003","unstructured":"Tieu, K. et al. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Investig. 112, 892\u2013901 (2003).","journal-title":"J. Clin. Investig."},{"key":"2141_CR1126","doi-asserted-by":"publisher","first-page":"782657","DOI":"10.3389\/fnut.2021.782657","volume":"8","author":"SM Gough","year":"2021","unstructured":"Gough, S. M., Casella, A., Ortega, K. J. & Hackam, A. S. Neuroprotection by the Ketogenic Diet: evidence and Controversies. Front. Nutr. 8, 782657 (2021).","journal-title":"Front. Nutr."},{"key":"2141_CR1127","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1471-4159.2008.05460.x","volume":"106","author":"SG Jarrett","year":"2008","unstructured":"Jarrett, S. G., Milder, J. B., Liang, L. P. & Patel, M. The ketogenic diet increases mitochondrial glutathione levels. J. Neurochem. 106, 1044\u20131051 (2008).","journal-title":"J. Neurochem."},{"key":"2141_CR1128","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1182519","volume":"15","author":"A Buchholz","year":"2024","unstructured":"Buchholz, A. et al. A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer\u2019s disease. Front. Endocrinol. 15, 1182519 (2024).","journal-title":"Front. Endocrinol."},{"key":"2141_CR1129","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.2174\/1570159X20666220830102628","volume":"20","author":"Y Tao","year":"2022","unstructured":"Tao, Y., Leng, S. X. & Zhang, H. Ketogenic diet: an effective treatment approach for neurodegenerative diseases. Curr. Neuropharmacol. 20, 2303\u20132319 (2022).","journal-title":"Curr. Neuropharmacol."},{"key":"2141_CR1130","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(18)30338-7","volume":"17","author":"N Scarmeas","year":"2018","unstructured":"Scarmeas, N., Anastasiou, C. A. & Yannakoulia, M. Nutrition and prevention of cognitive impairment. Lancet Neurol. 17, 1006\u20131015 (2018).","journal-title":"Lancet Neurol."},{"key":"2141_CR1131","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JAD-179901","volume":"64","author":"J Cummings","year":"2018","unstructured":"Cummings, J., Ritter, A. & Zhong, K. Clinical trials for disease-modifying therapies in Alzheimer\u2019s disease: a primer, lessons learned, and a blueprint for the future. J. Alzheimers Dis. 64, S3\u2013S22 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"2141_CR1132","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4103\/1673-5374.245463","volume":"14","author":"MM Ibrahim","year":"2019","unstructured":"Ibrahim, M. M. & Gabr, M. T. Multitarget therapeutic strategies for Alzheimer\u2019s disease. Neural Regen. Res. 14, 437\u2013440 (2019).","journal-title":"Neural Regen. Res."},{"key":"2141_CR1133","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","volume":"119","author":"MG Savelieff","year":"2019","unstructured":"Savelieff, M. G. et al. Development of multifunctional molecules as potential therapeutic candidates for Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis in the last decade. Chem. Rev. 119, 1221\u20131322 (2019).","journal-title":"Chem. Rev."},{"key":"2141_CR1134","doi-asserted-by":"publisher","first-page":"H239","DOI":"10.1152\/ajpheart.01269.2005","volume":"291","author":"L Bertrand","year":"2006","unstructured":"Bertrand, L. et al. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am. J. Physiol. Heart Circ. Physiol. 291, H239\u2013H250 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2141_CR1135","doi-asserted-by":"crossref","unstructured":"Legchenko, E. et al. PPARgamma agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation. Sci. Transl. Med. 10, eaao0303 (2018).","DOI":"10.1126\/scitranslmed.aao0303"},{"key":"2141_CR1136","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10557-008-6115-x","volume":"22","author":"J Li","year":"2008","unstructured":"Li, J. et al. Antiapoptosis and mitochondrial effect of pioglitazone preconditioning in the ischemic\/reperfused heart of rat. Cardiovasc. Drugs Ther. 22, 283\u2013291 (2008).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"2141_CR1137","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.707399","volume":"12","author":"H Shu","year":"2021","unstructured":"Shu, H. et al. Trimetazidine attenuates heart failure by improving myocardial metabolism via AMPK. Front. Pharmacol. 12, 707399 (2021).","journal-title":"Front. Pharmacol."},{"key":"2141_CR1138","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tcm.2018.08.001","volume":"29","author":"G Fragasso","year":"2019","unstructured":"Fragasso, G., Margonato, A., Spoladore, R. & Lopaschuk, G. D. Metabolic effects of cardiovascular drugs. Trends Cardiovasc. Med. 29, 176\u2013187 (2019).","journal-title":"Trends Cardiovasc. Med."},{"key":"2141_CR1139","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1161\/01.RES.0000129255.19569.8f","volume":"94","author":"JR Dyck","year":"2004","unstructured":"Dyck, J. R. et al. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ. Res. 94, e78\u2013e84 (2004).","journal-title":"Circ. Res."},{"key":"2141_CR1140","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3389\/fphar.2020.01255","volume":"11","author":"H Li","year":"2020","unstructured":"Li, H. et al. Trimetazidine ameliorates myocardial metabolic remodeling in isoproterenol-induced rats through regulating ketone body metabolism via activating AMPK and PPAR alpha. Front. Pharmacol. 11, 1255 (2020).","journal-title":"Front. Pharmacol."},{"key":"2141_CR1141","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1054\/jcaf.2002.130238","volume":"8","author":"M Podbregar","year":"2002","unstructured":"Podbregar, M. & Voga, G. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure. J. Card. Fail. 8, 369\u2013378 (2002).","journal-title":"J. Card. Fail."},{"key":"2141_CR1142","doi-asserted-by":"crossref","unstructured":"Trang, N. N. et al. Empagliflozin and Liraglutide differentially modulate cardiac metabolism in diabetic cardiomyopathy in rats. Int. J. Mol. Sci. 22, 1177 (2021).","DOI":"10.3390\/ijms22031177"},{"key":"2141_CR1143","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.bbrc.2015.06.067","volume":"463","author":"W Cheng","year":"2015","unstructured":"Cheng, W. et al. Puerarin improves cardiac function through regulation of energy metabolism in Streptozotocin-Nicotinamide induced diabetic mice after myocardial infarction. Biochem. Biophys. Res. Commun. 463, 1108\u20131114 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2141_CR1144","doi-asserted-by":"publisher","first-page":"12355","DOI":"10.1111\/jcmm.15725","volume":"24","author":"BC Ren","year":"2020","unstructured":"Ren, B. C. et al. Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways. J. Cell. Mol. Med. 24, 12355\u201312367 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"2141_CR1145","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1016\/j.bbagen.2017.07.027","volume":"1861","author":"GN Kanaan","year":"2017","unstructured":"Kanaan, G. N. & Harper, M. E. Cellular redox dysfunction in the development of cardiovascular diseases. Biochim Biophys. Acta Gen. Subj. 1861, 2822\u20132829 (2017).","journal-title":"Biochim Biophys. Acta Gen. Subj."},{"key":"2141_CR1146","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/cvr\/cvq237","volume":"88","author":"SB Ong","year":"2010","unstructured":"Ong, S. B. & Hausenloy, D. J. Mitochondrial morphology and cardiovascular disease. Cardiovasc. Res. 88, 16\u201329 (2010).","journal-title":"Cardiovasc. Res."},{"key":"2141_CR1147","first-page":"22","volume":"48","author":"S Ojha","year":"2011","unstructured":"Ojha, S. et al. Effect of Inula racemosa root extract on cardiac function and oxidative stress against isoproterenol-induced myocardial infarction. Indian J. Biochem. Biophys. 48, 22\u201328 (2011).","journal-title":"Indian J. Biochem. Biophys."},{"key":"2141_CR1148","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2004.12.003","volume":"179","author":"T Kurosawa","year":"2005","unstructured":"Kurosawa, T. et al. Suppressive effects of cacao liquor polyphenols (CLP) on LDL oxidation and the development of atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic rabbits. Atherosclerosis 179, 237\u2013246 (2005).","journal-title":"Atherosclerosis"},{"key":"2141_CR1149","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jbt.20369","volume":"25","author":"MN Nagi","year":"2011","unstructured":"Nagi, M. N., Al-Shabanah, O. A., Hafez, M. M. & Sayed-Ahmed, M. M. Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats. J. Biochem. Mol. Toxicol. 25, 135\u2013142 (2011).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"2141_CR1150","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.pharmthera.2009.07.003","volume":"124","author":"A Kumar","year":"2009","unstructured":"Kumar, A., Kaur, H., Devi, P. & Mohan, V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol. Ther. 124, 259\u2013268 (2009).","journal-title":"Pharmacol. Ther."},{"key":"2141_CR1151","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/434195","volume":"2012","author":"AE Ashour","year":"2012","unstructured":"Ashour, A. E. et al. Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats. Oxid. Med. Cell. Longev. 2012, 434195 (2012).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2141_CR1152","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65098-7","volume":"10","author":"N Bogh","year":"2020","unstructured":"Bogh, N. et al. Increasing carbohydrate oxidation improves contractile reserves and prevents hypertrophy in porcine right heart failure. Sci. Rep. 10, 8158 (2020).","journal-title":"Sci. Rep."},{"key":"2141_CR1153","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1172\/JCI138538","volume":"130","author":"B Zhou","year":"2020","unstructured":"Zhou, B. et al. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure. J. Clin. Investig. 130, 6054\u20136063 (2020).","journal-title":"J. Clin. Investig."},{"key":"2141_CR1154","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.biochi.2006.09.006","volume":"89","author":"C Angeloni","year":"2007","unstructured":"Angeloni, C. et al. Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress. Biochimie 89, 73\u201382 (2007).","journal-title":"Biochimie"},{"key":"2141_CR1155","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/febs.13195","volume":"282","author":"K Skemiene","year":"2015","unstructured":"Skemiene, K., Liobikas, J. & Borutaite, V. Anthocyanins as substrates for mitochondrial complex I - protective effect against heart ischemic injury. FEBS J. 282, 963\u2013971 (2015).","journal-title":"FEBS J."},{"key":"2141_CR1156","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112423","volume":"145","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. The molecular mechanisms of ferroptosis and its role in cardiovascular disease. Biomed. Pharmacother. 145, 112423 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"2141_CR1157","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1042\/cs0990027","volume":"99","author":"S Schmidt-Schweda","year":"2000","unstructured":"Schmidt-Schweda, S. & Holubarsch, C. First clinical trial with etomoxir in patients with chronic congestive heart failure. Clin. Sci. 99, 27\u201335 (2000).","journal-title":"Clin. Sci."},{"key":"2141_CR1158","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","volume":"112","author":"L Lee","year":"2005","unstructured":"Lee, L. et al. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation 112, 3280\u20133288 (2005).","journal-title":"Circulation"},{"key":"2141_CR1159","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yjmcc.2012.12.014","volume":"55","author":"X Yin","year":"2013","unstructured":"Yin, X. et al. Effects of perhexiline-induced fuel switch on the cardiac proteome and metabolome. J. Mol. Cell. Cardiol. 55, 27\u201330 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2141_CR1160","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/14756366.2011.636360","volume":"28","author":"GJ Gatto Jr.","year":"2013","unstructured":"Gatto, G. J. Jr. et al. NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation. J. Enzym. Inhib. Med. Chem. 28, 95\u2013104 (2013).","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"2141_CR1161","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehi816","volume":"27","author":"G Fragasso","year":"2006","unstructured":"Fragasso, G. et al. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine\/adenosine triphosphate ratio in patients with heart failure. Eur. Heart J. 27, 942\u2013948 (2006).","journal-title":"Eur. Heart J."},{"key":"2141_CR1162","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/hrt.2011.226332","volume":"97","author":"G Fragasso","year":"2011","unstructured":"Fragasso, G. et al. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure. Heart 97, 1495\u20131500 (2011).","journal-title":"Heart"},{"key":"2141_CR1163","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.108.778019","volume":"118","author":"H Tuunanen","year":"2008","unstructured":"Tuunanen, H. et al. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation 118, 1250\u20131258 (2008).","journal-title":"Circulation"},{"key":"2141_CR1164","first-page":"1388","volume":"379","author":"RAH Stewart","year":"2018","unstructured":"Stewart, R. A. H. Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. N. Engl. J. Med. 379, 1388 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2141_CR1165","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14970","volume":"9","author":"CN Steele","year":"2021","unstructured":"Steele, C. N. et al. Fasting and postprandial trimethylamine N-oxide in sedentary and endurance-trained males following a short-term high-fat diet. Physiol. Rep. 9, e14970 (2021).","journal-title":"Physiol. Rep."},{"key":"2141_CR1166","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1093\/eurheartj\/ehr448","volume":"33","author":"AJ Flammer","year":"2012","unstructured":"Flammer, A. J. et al. Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. Eur. Heart J. 33, 2172\u20132180 (2012).","journal-title":"Eur. Heart J."},{"key":"2141_CR1167","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10557-012-6427-8","volume":"27","author":"J Tome-Carneiro","year":"2013","unstructured":"Tome-Carneiro, J. et al. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 27, 37\u201348 (2013).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"2141_CR1168","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.41752","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel, L. et al. 2021 American College of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 73, 1108\u20131123 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"2141_CR1169","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","volume":"20","author":"AN Macintyre","year":"2014","unstructured":"Macintyre, A. N. et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20, 61\u201372 (2014).","journal-title":"Cell Metab."},{"key":"2141_CR1170","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fimmu.2019.00833","volume":"10","author":"W Li","year":"2019","unstructured":"Li, W. et al. Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters. Front. Immunol. 10, 833 (2019).","journal-title":"Front. Immunol."},{"key":"2141_CR1171","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3389\/fimmu.2018.01973","volume":"9","author":"G Abboud","year":"2018","unstructured":"Abboud, G. et al. Inhibition of glycolysis reduces disease severity in an autoimmune model of rheumatoid arthritis. Front. Immunol. 9, 1973 (2018).","journal-title":"Front. Immunol."},{"key":"2141_CR1172","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108875","volume":"115","author":"K Chen","year":"2019","unstructured":"Chen, K. et al. Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR\/PI3K\/AKT\/m-TOR pathway. Biomed. Pharmacother. 115, 108875 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"2141_CR1173","doi-asserted-by":"publisher","first-page":"274ra218","DOI":"10.1126\/scitranslmed.aaa0835","volume":"7","author":"Y Yin","year":"2015","unstructured":"Yin, Y. et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 7, 274ra218 (2015).","journal-title":"Sci. Transl. Med."},{"key":"2141_CR1174","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13075-019-1865-3","volume":"21","author":"G Song","year":"2019","unstructured":"Song, G. et al. Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis. Arthritis Res. Ther. 21, 87 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"2141_CR1175","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13075-021-02437-7","volume":"23","author":"P Kvacskay","year":"2021","unstructured":"Kvacskay, P. et al. Increase of aerobic glycolysis mediated by activated T helper cells drives synovial fibroblasts towards an inflammatory phenotype: new targets for therapy? Arthritis Res. Ther. 23, 56 (2021).","journal-title":"Arthritis Res. Ther."},{"key":"2141_CR1176","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","volume":"191","author":"ZW Lai","year":"2013","unstructured":"Lai, Z. W. et al. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. J. Immunol. 191, 2236\u20132246 (2013).","journal-title":"J. Immunol."},{"key":"2141_CR1177","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/art.40380","volume":"70","author":"H Kato","year":"2018","unstructured":"Kato, H. & Perl, A. Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 70, 427\u2013438 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"2141_CR1178","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13075-023-03161-0","volume":"25","author":"S Ahmed","year":"2023","unstructured":"Ahmed, S. et al. Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis. Arthritis Res. Ther. 25, 176 (2023).","journal-title":"Arthritis Res. Ther."},{"key":"2141_CR1179","doi-asserted-by":"publisher","DOI":"10.1038\/srep45184","volume":"7","author":"D Tewari","year":"2017","unstructured":"Tewari, D., Majumdar, D., Vallabhaneni, S. & Bera, A. K. Aspirin induces cell death by directly modulating mitochondrial voltage-dependent anion channel (VDAC). Sci. Rep. 7, 45184 (2017).","journal-title":"Sci. Rep."},{"key":"2141_CR1180","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3892\/etm.2021.10016","volume":"21","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway. Exp. Ther. Med. 21, 584 (2021).","journal-title":"Exp. Ther. Med."},{"key":"2141_CR1181","doi-asserted-by":"publisher","first-page":"117727191880100","DOI":"10.1177\/1177271918801005","volume":"13","author":"L Shervington","year":"2018","unstructured":"Shervington, L. et al. Identifying Reliable Diagnostic\/Predictive Biomarkers for Rheumatoid Arthritis. Biomark. Insights 13, 1177271918801005 (2018).","journal-title":"Biomark. Insights"},{"key":"2141_CR1182","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.757616","volume":"13","author":"Z Bai","year":"2022","unstructured":"Bai, Z. et al. Iguratimod restrains circulating follicular helper T cell function by inhibiting glucose metabolism via Hif1alpha-HK2 Axis in Rheumatoid Arthritis. Front. Immunol. 13, 757616 (2022).","journal-title":"Front. Immunol."},{"key":"2141_CR1183","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/art.40569","volume":"70","author":"T McGarry","year":"2018","unstructured":"McGarry, T. et al. JAK\/STAT Blockade Alters Synovial Bioenergetics, Mitochondrial Function, and Proinflammatory Mediators in Rheumatoid Arthritis. Arthritis Rheumatol. 70, 1959\u20131970 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"2141_CR1184","doi-asserted-by":"publisher","first-page":"1103231","DOI":"10.3389\/fimmu.2023.1103231","volume":"14","author":"A Torres","year":"2023","unstructured":"Torres, A. et al. Role of mitochondria-bound HK2 in rheumatoid arthritis fibroblast-like synoviocytes. Front. Immunol. 14, 1103231 (2023).","journal-title":"Front. Immunol."},{"key":"2141_CR1185","doi-asserted-by":"crossref","unstructured":"Oster, C. et al. BTLA Expression on Th1, Th2 and Th17 effector T-Cells of patients with systemic Lupus Erythematosus is associated with active disease. Int. J. Mol. Sci. 20, 4505 (2019).","DOI":"10.3390\/ijms20184505"},{"key":"2141_CR1186","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/art.34502","volume":"64","author":"ZW Lai","year":"2012","unstructured":"Lai, Z. W. et al. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 64, 2937\u20132946 (2012).","journal-title":"Arthritis Rheum."},{"key":"2141_CR1187","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1172\/JCI0216029","volume":"110","author":"NB Blatt","year":"2002","unstructured":"Blatt, N. B. et al. Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility. J. Clin. Investig. 110, 1123\u20131132 (2002).","journal-title":"J. Clin. Investig."},{"key":"2141_CR1188","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","volume":"198","author":"SY Lee","year":"2017","unstructured":"Lee, S. Y. et al. Metformin Suppresses Systemic Autoimmunity in Roquin(san\/san) mice through inhibiting B cell differentiation into plasma cells via regulation of AMPK\/mTOR\/STAT3. J. Immunol. 198, 2661\u20132670 (2017).","journal-title":"J. Immunol."},{"key":"2141_CR1189","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/art.39296","volume":"67","author":"H Wang","year":"2015","unstructured":"Wang, H. et al. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of Metformin. Arthritis Rheumatol. 67, 3190\u20133200 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"2141_CR1190","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi, L. Z. et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367\u20131376 (2011).","journal-title":"J. Exp. Med."},{"key":"2141_CR1191","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou, V. et al. Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. Cell Metab. 24, 158\u2013166 (2016).","journal-title":"Cell Metab."},{"key":"2141_CR1192","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1021\/acs.jproteome.6b00654","volume":"15","author":"F Michopoulos","year":"2016","unstructured":"Michopoulos, F. et al. Targeted Metabolic Profiling of the Tg197 Mouse Model Reveals Itaconic Acid as a Marker of Rheumatoid Arthritis. J. Proteome Res. 15, 4579\u20134590 (2016).","journal-title":"J. Proteome Res."},{"key":"2141_CR1193","doi-asserted-by":"publisher","first-page":"683","DOI":"10.5301\/jn.5000218","volume":"26","author":"G Xin","year":"2013","unstructured":"Xin, G. et al. Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features. J. Nephrol. 26, 683\u2013690 (2013).","journal-title":"J. Nephrol."},{"key":"2141_CR1194","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/0961203315608254","volume":"25","author":"DC Salazar-Camarena","year":"2016","unstructured":"Salazar-Camarena, D. C. et al. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Lupus 25, 582\u2013592 (2016).","journal-title":"Lupus"},{"key":"2141_CR1195","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","volume":"192","author":"A Caro-Maldonado","year":"2014","unstructured":"Caro-Maldonado, A. et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626\u20133636 (2014).","journal-title":"J. Immunol."},{"key":"2141_CR1196","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","volume":"20","author":"M Thien","year":"2004","unstructured":"Thien, M. et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20, 785\u2013798 (2004).","journal-title":"Immunity"},{"key":"2141_CR1197","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/art.34400","volume":"64","author":"W Stohl","year":"2012","unstructured":"Stohl, W. et al. Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum. 64, 2328\u20132337 (2012).","journal-title":"Arthritis Rheum."},{"key":"2141_CR1198","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1007\/s00018-015-1976-1","volume":"72","author":"Q Zeng","year":"2015","unstructured":"Zeng, Q. et al. Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1\/2 signaling pathway in normal and neoplastic B-lymphoid cells. Cell. Mol. Life Sci. 72, 4867\u20134884 (2015).","journal-title":"Cell. Mol. Life Sci."},{"key":"2141_CR1199","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112149","volume":"134","author":"S Cao","year":"2024","unstructured":"Cao, S. et al. Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus. Int. Immunopharmacol. 134, 112149 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"2141_CR1200","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clim.2013.07.002","volume":"149","author":"W Zhao","year":"2013","unstructured":"Zhao, W. et al. The peroxisome-proliferator activated receptor-gamma agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus. Clin. Immunol. 149, 119\u2013132 (2013).","journal-title":"Clin. Immunol."},{"key":"2141_CR1201","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature11132","volume":"486","author":"D Cipolletta","year":"2012","unstructured":"Cipolletta, D. et al. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549\u2013553 (2012).","journal-title":"Nature"},{"key":"2141_CR1202","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1172\/JCI69571","volume":"124","author":"G McDonald","year":"2014","unstructured":"McDonald, G. et al. Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients. J. Clin. Investig. 124, 712\u2013724 (2014).","journal-title":"J. Clin. Investig."},{"key":"2141_CR1203","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/nutrit\/nuaa033","volume":"79","author":"E Philippou","year":"2021","unstructured":"Philippou, E., Petersson, S. D., Rodomar, C. & Nikiphorou, E. Rheumatoid arthritis and dietary interventions: systematic review of clinical trials. Nutr. Rev. 79, 410\u2013428 (2021).","journal-title":"Nutr. Rev."},{"key":"2141_CR1204","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/0961203317751851","volume":"27","author":"SGL da Silva","year":"2018","unstructured":"da Silva, S. G. L. et al. The effect of nutritional intervention on the lipid profile and dietary intake of adolescents with juvenile systemic lupus erythematosus: a randomized, controlled trial. Lupus 27, 820\u2013827 (2018).","journal-title":"Lupus"},{"key":"2141_CR1205","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41423-020-00625-0","volume":"18","author":"CH Kim","year":"2021","unstructured":"Kim, C. H. Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids. Cell. Mol. Immunol. 18, 1161\u20131171 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"2141_CR1206","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19176-z","volume":"11","author":"EA Gomez","year":"2020","unstructured":"Gomez, E. A. et al. Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis. Nat. Commun. 11, 5420 (2020).","journal-title":"Nat. Commun."},{"key":"2141_CR1207","doi-asserted-by":"publisher","first-page":"103408","DOI":"10.1016\/j.autrev.2023.103408","volume":"22","author":"M Barati","year":"2023","unstructured":"Barati, M., Ghahremani, A. & Namdar Ahmadabad, H. Intermittent fasting: a promising dietary intervention for autoimmune diseases. Autoimmun. Rev. 22, 103408 (2023).","journal-title":"Autoimmun. Rev."},{"key":"2141_CR1208","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","volume":"24","author":"A Baysoy","year":"2023","unstructured":"Baysoy, A., Bai, Z., Satija, R. & Fan, R. The technological landscape and applications of single-cell multi-omics. Nat. Rev. Mol. Cell Biol. 24, 695\u2013713 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2141_CR1209","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41586-023-06473-y","volume":"621","author":"C Li","year":"2023","unstructured":"Li, C. et al. Single-cell brain organoid screening identifies developmental defects in autism. Nature 621, 373\u2013380 (2023).","journal-title":"Nature"},{"key":"2141_CR1210","doi-asserted-by":"crossref","unstructured":"Baldwin, J. G. et al. Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy. Cell 187, 6614\u20136630 (2024).","DOI":"10.1016\/j.cell.2024.08.029"},{"key":"2141_CR1211","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s13402-018-0385-5","volume":"41","author":"D Kraus","year":"2018","unstructured":"Kraus, D. et al. Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation. Cell. Oncol. 41, 485\u2013494 (2018).","journal-title":"Cell. Oncol."},{"key":"2141_CR1212","doi-asserted-by":"publisher","first-page":"11262","DOI":"10.1080\/07391102.2022.2161010","volume":"41","author":"MK Temre","year":"2023","unstructured":"Temre, M. K. et al. Molecular characterization of glutor-GLUT interaction and prediction of glutor\u2019s drug-likeness: implications for its utility as an antineoplastic agent. J. Biomol. Struct. Dyn. 41, 11262\u201311273 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"2141_CR1213","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41420-024-02106-z","volume":"10","author":"ZA Miller","year":"2024","unstructured":"Miller, Z. A. et al. GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells. Cell Death Discov. 10, 339 (2024).","journal-title":"Cell Death Discov."},{"key":"2141_CR1214","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1158\/1535-7163.MCT-21-0925","volume":"21","author":"L Guo","year":"2022","unstructured":"Guo, L. et al. Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells. Mol. Cancer Ther. 21, 740\u2013750 (2022).","journal-title":"Mol. Cancer Ther."},{"key":"2141_CR1215","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.redox.2014.03.004","volume":"2","author":"S Andrisse","year":"2014","unstructured":"Andrisse, S. et al. Role of GLUT1 in regulation of reactive oxygen species. Redox Biol. 2, 764\u2013771 (2014).","journal-title":"Redox Biol."},{"key":"2141_CR1216","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","volume":"11","author":"Y Liu","year":"2012","unstructured":"Liu, Y. et al. A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol. Cancer Ther. 11, 1672\u20131682 (2012).","journal-title":"Mol. Cancer Ther."},{"key":"2141_CR1217","doi-asserted-by":"publisher","first-page":"6826","DOI":"10.1021\/acs.jafc.6b02861","volume":"64","author":"ST Lin","year":"2016","unstructured":"Lin, S. T. et al. Apple Polyphenol Phloretin inhibits colorectal cancer cell growth via inhibition of the Type 2 Glucose Transporter and Activation of p53-Mediated Signaling. J. Agric. Food Chem. 64, 6826\u20136837 (2016).","journal-title":"J. Agric. Food Chem."},{"key":"2141_CR1218","doi-asserted-by":"publisher","first-page":"105367","DOI":"10.1016\/j.phrs.2020.105367","volume":"164","author":"M Zheng","year":"2021","unstructured":"Zheng, M. et al. Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis. Pharmacol. Res. 164, 105367 (2021).","journal-title":"Pharmacol. Res."},{"key":"2141_CR1219","doi-asserted-by":"crossref","unstructured":"Juszczak, K., Szczepankiewicz, W. & Walczak, K. Synthesis and primary activity assay of novel Benitrobenrazide and Benserazide Derivatives. Molecule 29, 629 (2024).","DOI":"10.3390\/molecules29030629"},{"key":"2141_CR1220","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1039\/D2SC02297D","volume":"13","author":"LL Zhou","year":"2022","unstructured":"Zhou, L. L. et al. Ambient synthesis of an iminium-linked covalent organic framework for synergetic RNA interference and metabolic therapy of fibrosarcoma. Chem. Sci. 13, 7846\u20137854 (2022).","journal-title":"Chem. Sci."},{"key":"2141_CR1221","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202102272","volume":"11","author":"Y Pan","year":"2022","unstructured":"Pan, Y. et al. Dendritic Polyglycerol-Conjugated gold nanostars for metabolism inhibition and targeted photothermal therapy in breast cancer stem cells. Adv. Health. Mater. 11, e2102272 (2022).","journal-title":"Adv. Health. Mater."},{"key":"2141_CR1222","doi-asserted-by":"publisher","first-page":"617","DOI":"10.7150\/ijbs.29689","volume":"15","author":"M Liu","year":"2019","unstructured":"Liu, M. et al. Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2. Int. J. Biol. Sci. 15, 617\u2013627 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"2141_CR1223","doi-asserted-by":"publisher","first-page":"e36764","DOI":"10.1371\/journal.pone.0036764","volume":"7","author":"MA Iqbal","year":"2012","unstructured":"Iqbal, M. A. & Bamezai, R. N. Resveratrol inhibits cancer cell metabolism by down regulating pyruvate kinase M2 via inhibition of mammalian target of rapamycin. PLoS ONE 7, e36764 (2012).","journal-title":"PLoS ONE"},{"key":"2141_CR1224","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-20-4190","volume":"81","author":"M Apostolidi","year":"2021","unstructured":"Apostolidi, M. et al. Targeting Pyruvate Kinase M2 phosphorylation reverses aggressive cancer phenotypes. Cancer Res. 81, 4346\u20134359 (2021).","journal-title":"Cancer Res."},{"key":"2141_CR1225","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0304-3835(98)00302-4","volume":"135","author":"MD Shelley","year":"1999","unstructured":"Shelley, M. D. et al. Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines. Cancer Lett. 135, 171\u2013180 (1999).","journal-title":"Cancer Lett."},{"key":"2141_CR1226","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1158\/1535-7163.MCT-09-0507","volume":"9","author":"SR Volate","year":"2010","unstructured":"Volate, S. R. et al. Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Mol. Cancer Ther. 9, 461\u2013470 (2010).","journal-title":"Mol. Cancer Ther."},{"key":"2141_CR1227","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.molonc.2015.03.014","volume":"9","author":"L Lan","year":"2015","unstructured":"Lan, L. et al. Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1. Mol. Oncol. 9, 1406\u20131420 (2015).","journal-title":"Mol. Oncol."},{"key":"2141_CR1228","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1158\/0008-5472.CAN-16-2686","volume":"77","author":"M Beloueche-Babari","year":"2017","unstructured":"Beloueche-Babari, M. et al. MCT1 inhibitor AZD3965 increases mitochondrial metabolism, facilitating combination therapy and noninvasive magnetic resonance spectroscopy. Cancer Res. 77, 5913\u20135924 (2017).","journal-title":"Cancer Res."},{"key":"2141_CR1229","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1200\/JCO.2021.39.15_suppl.3115","volume":"39","author":"SER Halford","year":"2021","unstructured":"Halford, S. E. R. et al. Phase I expansion study of the first-in-class monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL). J. Clin. Oncol. 39, 3115 (2021).","journal-title":"J. Clin. Oncol."},{"key":"2141_CR1230","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110595","volume":"499","author":"CL Liu","year":"2020","unstructured":"Liu, C. L. et al. Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells. Mol. Cell. Endocrinol. 499, 110595 (2020).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2141_CR1231","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm.4464","volume":"24","author":"ML Schulte","year":"2018","unstructured":"Schulte, M. L. et al. Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat. Med. 24, 194\u2013202 (2018).","journal-title":"Nat. Med."},{"key":"2141_CR1232","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.tranon.2019.05.013","volume":"12","author":"AR Hanaford","year":"2019","unstructured":"Hanaford, A. R. et al. Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma. Transl. Oncol. 12, 1314\u20131322 (2019).","journal-title":"Transl. Oncol."},{"key":"2141_CR1233","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.1021\/acs.jmedchem.7b00966","volume":"60","author":"MT Nedelcovych","year":"2017","unstructured":"Nedelcovych, M. T. et al. N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a potential treatment for hiv associated neurocognitive disorders. J. Med. Chem. 60, 7186\u20137198 (2017).","journal-title":"J. Med. Chem."},{"key":"2141_CR1234","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ijc.31392","volume":"143","author":"E Papaevangelou","year":"2018","unstructured":"Papaevangelou, E. et al. The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model. Int. J. Cancer 143, 992\u20131002 (2018).","journal-title":"Int. J. Cancer"},{"key":"2141_CR1235","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1126\/science.288.5475.2379","volume":"288","author":"TM Loftus","year":"2000","unstructured":"Loftus, T. M. et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379\u20132381 (2000).","journal-title":"Science"},{"key":"2141_CR1236","first-page":"2745","volume":"56","author":"ES Pizer","year":"1996","unstructured":"Pizer, E. S. et al. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res. 56, 2745\u20132747 (1996).","journal-title":"Cancer Res."},{"key":"2141_CR1237","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/s41591-021-01489-1","volume":"27","author":"RA Calle","year":"2021","unstructured":"Calle, R. A. et al. ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials. Nat. Med. 27, 1836\u20131848 (2021).","journal-title":"Nat. Med."},{"key":"2141_CR1238","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s13046-021-02207-y","volume":"40","author":"L Lang","year":"2021","unstructured":"Lang, L. et al. Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer. J. Exp. Clin. Cancer Res. 40, 393 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2141_CR1239","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1158\/1078-0432.CCR-17-2282","volume":"24","author":"TS Pardee","year":"2018","unstructured":"Pardee, T. S. et al. A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for relapsed or refractory acute myeloid leukemia. Clin. Cancer Res. 24, 2060\u20132073 (2018).","journal-title":"Clin. Cancer Res."},{"key":"2141_CR1240","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s40265-018-0978-3","volume":"78","author":"S Dhillon","year":"2018","unstructured":"Dhillon, S. Ivosidenib: first global approval. Drugs 78, 1509\u20131516 (2018).","journal-title":"Drugs"},{"key":"2141_CR1241","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00280-020-04064-6","volume":"85","author":"B Fan","year":"2020","unstructured":"Fan, B. et al. Clinical pharmacokinetics and pharmacodynamics of ivosidenib in patients with advanced hematologic malignancies with an IDH1 mutation. Cancer Chemother. Pharmacol. 85, 959\u2013968 (2020).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2141_CR1242","doi-asserted-by":"crossref","unstructured":"Radoul, M. et al. Early noninvasive metabolic biomarkers of mutant IDH Inhibition in Glioma. Metabolites 11, 109 (2021).","DOI":"10.3390\/metabo11020109"},{"key":"2141_CR1243","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1038\/leu.2017.46","volume":"31","author":"A Chaturvedi","year":"2017","unstructured":"Chaturvedi, A. et al. Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo. Leukemia 31, 2020\u20132028 (2017).","journal-title":"Leukemia"},{"key":"2141_CR1244","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3324\/haematol.2019.236992","volume":"106","author":"A Chaturvedi","year":"2021","unstructured":"Chaturvedi, A. et al. Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia. Haematologica 106, 565\u2013573 (2021).","journal-title":"Haematologica"},{"key":"2141_CR1245","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton, W. W. et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife 3, e02242 (2014).","journal-title":"Elife"},{"key":"2141_CR1246","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108687","volume":"209","author":"E Korhonen","year":"2021","unstructured":"Korhonen, E. et al. Antimycin A-induced mitochondrial dysfunction regulates inflammasome signaling in human retinal pigment epithelial cells. Exp. Eye Res. 209, 108687 (2021).","journal-title":"Exp. Eye Res."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02141-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02141-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02141-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:46:48Z","timestamp":1739850408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02141-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":1246,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2141"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02141-x","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}